id sid tid token lemma pos cord-266359-uf1ao1x1 1 1 key key JJ cord-266359-uf1ao1x1 1 2 : : : cord-266359-uf1ao1x1 1 3 cord-266359-uf1ao1x1 cord-266359-uf1ao1x1 NNP cord-266359-uf1ao1x1 1 4 authors author NNS cord-266359-uf1ao1x1 1 5 : : : cord-266359-uf1ao1x1 1 6 Hakki Hakki NNP cord-266359-uf1ao1x1 1 7 , , , cord-266359-uf1ao1x1 1 8 Morgan Morgan NNP cord-266359-uf1ao1x1 1 9 ; ; : cord-266359-uf1ao1x1 1 10 Rattray Rattray NNP cord-266359-uf1ao1x1 1 11 , , , cord-266359-uf1ao1x1 1 12 Rogan Rogan NNP cord-266359-uf1ao1x1 1 13 M. M. NNP cord-266359-uf1ao1x1 1 14 ; ; : cord-266359-uf1ao1x1 1 15 Press Press NNP cord-266359-uf1ao1x1 1 16 , , , cord-266359-uf1ao1x1 1 17 Richard Richard NNP cord-266359-uf1ao1x1 1 18 D. D. NNP cord-266359-uf1ao1x1 1 19 title title NN cord-266359-uf1ao1x1 1 20 : : : cord-266359-uf1ao1x1 2 1 The the DT cord-266359-uf1ao1x1 2 2 clinical clinical JJ cord-266359-uf1ao1x1 2 3 impact impact NN cord-266359-uf1ao1x1 2 4 of of IN cord-266359-uf1ao1x1 2 5 coronavirus coronavirus NN cord-266359-uf1ao1x1 2 6 infection infection NN cord-266359-uf1ao1x1 2 7 in in IN cord-266359-uf1ao1x1 2 8 patients patient NNS cord-266359-uf1ao1x1 2 9 with with IN cord-266359-uf1ao1x1 2 10 hematologic hematologic JJ cord-266359-uf1ao1x1 2 11 malignancies malignancy NNS cord-266359-uf1ao1x1 2 12 and and CC cord-266359-uf1ao1x1 2 13 hematopoietic hematopoietic JJ cord-266359-uf1ao1x1 2 14 stem stem NN cord-266359-uf1ao1x1 2 15 cell cell NN cord-266359-uf1ao1x1 2 16 transplant transplant NN cord-266359-uf1ao1x1 2 17 recipients recipient NNS cord-266359-uf1ao1x1 2 18 date date NN cord-266359-uf1ao1x1 2 19 : : : cord-266359-uf1ao1x1 2 20 2015 2015 CD cord-266359-uf1ao1x1 2 21 - - HYPH cord-266359-uf1ao1x1 2 22 04 04 CD cord-266359-uf1ao1x1 2 23 - - SYM cord-266359-uf1ao1x1 2 24 15 15 CD cord-266359-uf1ao1x1 2 25 journal journal NN cord-266359-uf1ao1x1 2 26 : : : cord-266359-uf1ao1x1 3 1 J J NNP cord-266359-uf1ao1x1 3 2 Clin Clin NNP cord-266359-uf1ao1x1 3 3 Virol Virol NNP cord-266359-uf1ao1x1 3 4 DOI DOI NNP cord-266359-uf1ao1x1 3 5 : : : cord-266359-uf1ao1x1 3 6 10.1016 10.1016 CD cord-266359-uf1ao1x1 3 7 / / SYM cord-266359-uf1ao1x1 3 8 j.jcv.2015.04.012 j.jcv.2015.04.012 NNP cord-266359-uf1ao1x1 3 9 sha sha NNP cord-266359-uf1ao1x1 3 10 : : : cord-266359-uf1ao1x1 4 1 432a9661e8c0a00f31e4e276a808a0a47860bbb5 432a9661e8c0a00f31e4e276a808a0a47860bbb5 LS cord-266359-uf1ao1x1 4 2 doc_id doc_id CD cord-266359-uf1ao1x1 4 3 : : : cord-266359-uf1ao1x1 4 4 266359 266359 CD cord-266359-uf1ao1x1 4 5 cord_uid cord_uid NNS cord-266359-uf1ao1x1 4 6 : : : cord-266359-uf1ao1x1 4 7 uf1ao1x1 uf1ao1x1 NNP cord-266359-uf1ao1x1 4 8 BACKGROUND background NN cord-266359-uf1ao1x1 4 9 : : : cord-266359-uf1ao1x1 5 1 Compared compare VBN cord-266359-uf1ao1x1 5 2 to to IN cord-266359-uf1ao1x1 5 3 other other JJ cord-266359-uf1ao1x1 5 4 respiratory respiratory JJ cord-266359-uf1ao1x1 5 5 viruses virus NNS cord-266359-uf1ao1x1 5 6 , , , cord-266359-uf1ao1x1 5 7 relatively relatively RB cord-266359-uf1ao1x1 5 8 little little JJ cord-266359-uf1ao1x1 5 9 is be VBZ cord-266359-uf1ao1x1 5 10 known know VBN cord-266359-uf1ao1x1 5 11 about about IN cord-266359-uf1ao1x1 5 12 the the DT cord-266359-uf1ao1x1 5 13 clinical clinical JJ cord-266359-uf1ao1x1 5 14 impact impact NN cord-266359-uf1ao1x1 5 15 of of IN cord-266359-uf1ao1x1 5 16 coronavirus coronavirus NN cord-266359-uf1ao1x1 5 17 ( ( -LRB- cord-266359-uf1ao1x1 5 18 CoV CoV NNP cord-266359-uf1ao1x1 5 19 ) ) -RRB- cord-266359-uf1ao1x1 5 20 infection infection NN cord-266359-uf1ao1x1 5 21 after after IN cord-266359-uf1ao1x1 5 22 hematopoietic hematopoietic JJ cord-266359-uf1ao1x1 5 23 stem stem NN cord-266359-uf1ao1x1 5 24 cell cell NN cord-266359-uf1ao1x1 5 25 transplant transplant NN cord-266359-uf1ao1x1 5 26 ( ( -LRB- cord-266359-uf1ao1x1 5 27 HSCT HSCT NNP cord-266359-uf1ao1x1 5 28 ) ) -RRB- cord-266359-uf1ao1x1 5 29 or or CC cord-266359-uf1ao1x1 5 30 in in IN cord-266359-uf1ao1x1 5 31 patients patient NNS cord-266359-uf1ao1x1 5 32 with with IN cord-266359-uf1ao1x1 5 33 hematologic hematologic JJ cord-266359-uf1ao1x1 5 34 malignancies malignancy NNS cord-266359-uf1ao1x1 5 35 . . . cord-266359-uf1ao1x1 6 1 OBJECTIVES objectives NN cord-266359-uf1ao1x1 6 2 : : : cord-266359-uf1ao1x1 7 1 To to TO cord-266359-uf1ao1x1 7 2 characterize characterize VB cord-266359-uf1ao1x1 7 3 the the DT cord-266359-uf1ao1x1 7 4 role role NN cord-266359-uf1ao1x1 7 5 of of IN cord-266359-uf1ao1x1 7 6 CoV cov NN cord-266359-uf1ao1x1 7 7 in in IN cord-266359-uf1ao1x1 7 8 respiratory respiratory JJ cord-266359-uf1ao1x1 7 9 tract tract NN cord-266359-uf1ao1x1 7 10 infections infection NNS cord-266359-uf1ao1x1 7 11 among among IN cord-266359-uf1ao1x1 7 12 HSCT HSCT NNP cord-266359-uf1ao1x1 7 13 and and CC cord-266359-uf1ao1x1 7 14 hematologic hematologic JJ cord-266359-uf1ao1x1 7 15 malignancy malignancy NN cord-266359-uf1ao1x1 7 16 patients patient NNS cord-266359-uf1ao1x1 7 17 . . . cord-266359-uf1ao1x1 8 1 STUDY study NN cord-266359-uf1ao1x1 8 2 DESIGN design NN cord-266359-uf1ao1x1 8 3 : : : cord-266359-uf1ao1x1 9 1 We -PRON- PRP cord-266359-uf1ao1x1 9 2 conducted conduct VBD cord-266359-uf1ao1x1 9 3 a a DT cord-266359-uf1ao1x1 9 4 retrospective retrospective JJ cord-266359-uf1ao1x1 9 5 review review NN cord-266359-uf1ao1x1 9 6 of of IN cord-266359-uf1ao1x1 9 7 all all DT cord-266359-uf1ao1x1 9 8 cases case NNS cord-266359-uf1ao1x1 9 9 of of IN cord-266359-uf1ao1x1 9 10 CoV cov NN cord-266359-uf1ao1x1 9 11 infection infection NN cord-266359-uf1ao1x1 9 12 documented document VBN cord-266359-uf1ao1x1 9 13 by by IN cord-266359-uf1ao1x1 9 14 polymerase polymerase NN cord-266359-uf1ao1x1 9 15 chain chain NN cord-266359-uf1ao1x1 9 16 reaction reaction NN cord-266359-uf1ao1x1 9 17 , , , cord-266359-uf1ao1x1 9 18 ( ( -LRB- cord-266359-uf1ao1x1 9 19 PCR)-based pcr)-base VBN cord-266359-uf1ao1x1 9 20 testing testing NN cord-266359-uf1ao1x1 9 21 on on IN cord-266359-uf1ao1x1 9 22 nasopharyngeal nasopharyngeal JJ cord-266359-uf1ao1x1 9 23 and and CC cord-266359-uf1ao1x1 9 24 bronchoalveolar bronchoalveolar JJ cord-266359-uf1ao1x1 9 25 lavage lavage NN cord-266359-uf1ao1x1 9 26 fluid fluid NN cord-266359-uf1ao1x1 9 27 samples sample NNS cord-266359-uf1ao1x1 9 28 between between IN cord-266359-uf1ao1x1 9 29 June June NNP cord-266359-uf1ao1x1 9 30 2010 2010 CD cord-266359-uf1ao1x1 9 31 and and CC cord-266359-uf1ao1x1 9 32 2013 2013 CD cord-266359-uf1ao1x1 9 33 . . . cord-266359-uf1ao1x1 10 1 Cases case NNS cord-266359-uf1ao1x1 10 2 of of IN cord-266359-uf1ao1x1 10 3 CoV cov NN cord-266359-uf1ao1x1 10 4 infection infection NN cord-266359-uf1ao1x1 10 5 occurring occur VBG cord-266359-uf1ao1x1 10 6 in in IN cord-266359-uf1ao1x1 10 7 HSCT HSCT NNP cord-266359-uf1ao1x1 10 8 and and CC cord-266359-uf1ao1x1 10 9 hematologic hematologic JJ cord-266359-uf1ao1x1 10 10 malignancy malignancy NN cord-266359-uf1ao1x1 10 11 patients patient NNS cord-266359-uf1ao1x1 10 12 were be VBD cord-266359-uf1ao1x1 10 13 identified identify VBN cord-266359-uf1ao1x1 10 14 and and CC cord-266359-uf1ao1x1 10 15 the the DT cord-266359-uf1ao1x1 10 16 clinical clinical JJ cord-266359-uf1ao1x1 10 17 characteristics characteristic NNS cord-266359-uf1ao1x1 10 18 of of IN cord-266359-uf1ao1x1 10 19 these these DT cord-266359-uf1ao1x1 10 20 cases case NNS cord-266359-uf1ao1x1 10 21 were be VBD cord-266359-uf1ao1x1 10 22 compared compare VBN cord-266359-uf1ao1x1 10 23 to to IN cord-266359-uf1ao1x1 10 24 other other JJ cord-266359-uf1ao1x1 10 25 respiratory respiratory JJ cord-266359-uf1ao1x1 10 26 viruses virus NNS cord-266359-uf1ao1x1 10 27 . . . cord-266359-uf1ao1x1 11 1 RESULTS result NNS cord-266359-uf1ao1x1 11 2 : : : cord-266359-uf1ao1x1 12 1 CoV CoV NNP cord-266359-uf1ao1x1 12 2 was be VBD cord-266359-uf1ao1x1 12 3 identified identify VBN cord-266359-uf1ao1x1 12 4 in in IN cord-266359-uf1ao1x1 12 5 2.6 2.6 CD cord-266359-uf1ao1x1 12 6 % % NN cord-266359-uf1ao1x1 12 7 ( ( -LRB- cord-266359-uf1ao1x1 12 8 n n NN cord-266359-uf1ao1x1 12 9 = = SYM cord-266359-uf1ao1x1 12 10 43 43 CD cord-266359-uf1ao1x1 12 11 ) ) -RRB- cord-266359-uf1ao1x1 12 12 of of IN cord-266359-uf1ao1x1 12 13 all all DT cord-266359-uf1ao1x1 12 14 samples sample NNS cord-266359-uf1ao1x1 12 15 analyzed analyze VBN cord-266359-uf1ao1x1 12 16 ( ( -LRB- cord-266359-uf1ao1x1 12 17 n n NN cord-266359-uf1ao1x1 12 18 = = SYM cord-266359-uf1ao1x1 12 19 1661 1661 CD cord-266359-uf1ao1x1 12 20 ) ) -RRB- cord-266359-uf1ao1x1 12 21 and and CC cord-266359-uf1ao1x1 12 22 in in IN cord-266359-uf1ao1x1 12 23 6.8 6.8 CD cord-266359-uf1ao1x1 12 24 % % NN cord-266359-uf1ao1x1 12 25 of of IN cord-266359-uf1ao1x1 12 26 all all DT cord-266359-uf1ao1x1 12 27 samples sample NNS cord-266359-uf1ao1x1 12 28 testing test VBG cord-266359-uf1ao1x1 12 29 positive positive JJ cord-266359-uf1ao1x1 12 30 for for IN cord-266359-uf1ao1x1 12 31 a a DT cord-266359-uf1ao1x1 12 32 respiratory respiratory JJ cord-266359-uf1ao1x1 12 33 virus virus NN cord-266359-uf1ao1x1 12 34 ( ( -LRB- cord-266359-uf1ao1x1 12 35 n n NN cord-266359-uf1ao1x1 12 36 = = SYM cord-266359-uf1ao1x1 12 37 631 631 CD cord-266359-uf1ao1x1 12 38 ) ) -RRB- cord-266359-uf1ao1x1 12 39 . . . cord-266359-uf1ao1x1 13 1 33 33 CD cord-266359-uf1ao1x1 13 2 of of IN cord-266359-uf1ao1x1 13 3 38 38 CD cord-266359-uf1ao1x1 13 4 ( ( -LRB- cord-266359-uf1ao1x1 13 5 86.8 86.8 CD cord-266359-uf1ao1x1 13 6 % % NN cord-266359-uf1ao1x1 13 7 ) ) -RRB- cord-266359-uf1ao1x1 13 8 of of IN cord-266359-uf1ao1x1 13 9 patients patient NNS cord-266359-uf1ao1x1 13 10 in in IN cord-266359-uf1ao1x1 13 11 whom whom WP cord-266359-uf1ao1x1 13 12 CoV CoV NNP cord-266359-uf1ao1x1 13 13 was be VBD cord-266359-uf1ao1x1 13 14 identified identify VBN cord-266359-uf1ao1x1 13 15 were be VBD cord-266359-uf1ao1x1 13 16 HSCT HSCT NNP cord-266359-uf1ao1x1 13 17 and and CC cord-266359-uf1ao1x1 13 18 hematologic hematologic JJ cord-266359-uf1ao1x1 13 19 malignancy malignancy NN cord-266359-uf1ao1x1 13 20 patients patient NNS cord-266359-uf1ao1x1 13 21 . . . cord-266359-uf1ao1x1 14 1 Among among IN cord-266359-uf1ao1x1 14 2 these these DT cord-266359-uf1ao1x1 14 3 patients patient NNS cord-266359-uf1ao1x1 14 4 , , , cord-266359-uf1ao1x1 14 5 CoV CoV NNP cord-266359-uf1ao1x1 14 6 was be VBD cord-266359-uf1ao1x1 14 7 detected detect VBN cord-266359-uf1ao1x1 14 8 in in IN cord-266359-uf1ao1x1 14 9 9.7 9.7 CD cord-266359-uf1ao1x1 14 10 % % NN cord-266359-uf1ao1x1 14 11 of of IN cord-266359-uf1ao1x1 14 12 unique unique JJ cord-266359-uf1ao1x1 14 13 infection infection NN cord-266359-uf1ao1x1 14 14 episodes episode NNS cord-266359-uf1ao1x1 14 15 , , , cord-266359-uf1ao1x1 14 16 with with IN cord-266359-uf1ao1x1 14 17 only only JJ cord-266359-uf1ao1x1 14 18 rhinovirus rhinovirus NN cord-266359-uf1ao1x1 14 19 / / SYM cord-266359-uf1ao1x1 14 20 enterovirus enterovirus NN cord-266359-uf1ao1x1 14 21 ( ( -LRB- cord-266359-uf1ao1x1 14 22 RhV RhV NNP cord-266359-uf1ao1x1 14 23 / / SYM cord-266359-uf1ao1x1 14 24 EnV env NN cord-266359-uf1ao1x1 14 25 ) ) -RRB- cord-266359-uf1ao1x1 14 26 infection infection NN cord-266359-uf1ao1x1 14 27 being be VBG cord-266359-uf1ao1x1 14 28 more more RBR cord-266359-uf1ao1x1 14 29 common common JJ cord-266359-uf1ao1x1 14 30 . . . cord-266359-uf1ao1x1 15 1 Group Group NNP cord-266359-uf1ao1x1 15 2 I -PRON- PRP cord-266359-uf1ao1x1 15 3 CoV cov NN cord-266359-uf1ao1x1 15 4 subtypes subtype NNS cord-266359-uf1ao1x1 15 5 accounted account VBD cord-266359-uf1ao1x1 15 6 for for IN cord-266359-uf1ao1x1 15 7 76.3 76.3 CD cord-266359-uf1ao1x1 15 8 % % NN cord-266359-uf1ao1x1 15 9 of of IN cord-266359-uf1ao1x1 15 10 cases case NNS cord-266359-uf1ao1x1 15 11 , , , cord-266359-uf1ao1x1 15 12 and and CC cord-266359-uf1ao1x1 15 13 57 57 CD cord-266359-uf1ao1x1 15 14 % % NN cord-266359-uf1ao1x1 15 15 of of IN cord-266359-uf1ao1x1 15 16 infections infection NNS cord-266359-uf1ao1x1 15 17 were be VBD cord-266359-uf1ao1x1 15 18 diagnosed diagnose VBN cord-266359-uf1ao1x1 15 19 between between IN cord-266359-uf1ao1x1 15 20 December December NNP cord-266359-uf1ao1x1 15 21 and and CC cord-266359-uf1ao1x1 15 22 March March NNP cord-266359-uf1ao1x1 15 23 . . . cord-266359-uf1ao1x1 16 1 CoV CoV NNP cord-266359-uf1ao1x1 16 2 infection infection NN cord-266359-uf1ao1x1 16 3 was be VBD cord-266359-uf1ao1x1 16 4 associated associate VBN cord-266359-uf1ao1x1 16 5 with with IN cord-266359-uf1ao1x1 16 6 upper upper JJ cord-266359-uf1ao1x1 16 7 respiratory respiratory JJ cord-266359-uf1ao1x1 16 8 tract tract NN cord-266359-uf1ao1x1 16 9 symptoms symptom NNS cord-266359-uf1ao1x1 16 10 in in IN cord-266359-uf1ao1x1 16 11 most most JJS cord-266359-uf1ao1x1 16 12 patients patient NNS cord-266359-uf1ao1x1 16 13 , , , cord-266359-uf1ao1x1 16 14 similar similar JJ cord-266359-uf1ao1x1 16 15 to to IN cord-266359-uf1ao1x1 16 16 other other JJ cord-266359-uf1ao1x1 16 17 respiratory respiratory JJ cord-266359-uf1ao1x1 16 18 viruses virus NNS cord-266359-uf1ao1x1 16 19 . . . cord-266359-uf1ao1x1 17 1 Possible possible JJ cord-266359-uf1ao1x1 17 2 and and CC cord-266359-uf1ao1x1 17 3 proven prove VBN cord-266359-uf1ao1x1 17 4 lower low JJR cord-266359-uf1ao1x1 17 5 respiratory respiratory JJ cord-266359-uf1ao1x1 17 6 tract tract NN cord-266359-uf1ao1x1 17 7 disease disease NN cord-266359-uf1ao1x1 17 8 was be VBD cord-266359-uf1ao1x1 17 9 less less RBR cord-266359-uf1ao1x1 17 10 common common JJ cord-266359-uf1ao1x1 17 11 compared compare VBN cord-266359-uf1ao1x1 17 12 to to IN cord-266359-uf1ao1x1 17 13 other other JJ cord-266359-uf1ao1x1 17 14 respiratory respiratory JJ cord-266359-uf1ao1x1 17 15 viruses virus NNS cord-266359-uf1ao1x1 17 16 except except IN cord-266359-uf1ao1x1 18 1 RhV RhV NNP cord-266359-uf1ao1x1 18 2 / / SYM cord-266359-uf1ao1x1 18 3 EnV. env. JJ cord-266359-uf1ao1x1 18 4 CONCLUSIONS conclusion NNS cord-266359-uf1ao1x1 18 5 : : : cord-266359-uf1ao1x1 18 6 CoV CoV NNP cord-266359-uf1ao1x1 18 7 is be VBZ cord-266359-uf1ao1x1 18 8 frequently frequently RB cord-266359-uf1ao1x1 18 9 detected detect VBN cord-266359-uf1ao1x1 18 10 in in IN cord-266359-uf1ao1x1 18 11 HSCT HSCT NNP cord-266359-uf1ao1x1 18 12 and and CC cord-266359-uf1ao1x1 18 13 hematologic hematologic JJ cord-266359-uf1ao1x1 18 14 malignancy malignancy NN cord-266359-uf1ao1x1 18 15 patients patient NNS cord-266359-uf1ao1x1 18 16 in in IN cord-266359-uf1ao1x1 18 17 whom whom WP cord-266359-uf1ao1x1 18 18 suspicion suspicion NN cord-266359-uf1ao1x1 18 19 for for IN cord-266359-uf1ao1x1 18 20 a a DT cord-266359-uf1ao1x1 18 21 respiratory respiratory JJ cord-266359-uf1ao1x1 18 22 viral viral JJ cord-266359-uf1ao1x1 18 23 infection infection NN cord-266359-uf1ao1x1 18 24 exists exist VBZ cord-266359-uf1ao1x1 18 25 , , , cord-266359-uf1ao1x1 18 26 but but CC cord-266359-uf1ao1x1 18 27 is be VBZ cord-266359-uf1ao1x1 18 28 less less RBR cord-266359-uf1ao1x1 18 29 likely likely JJ cord-266359-uf1ao1x1 18 30 to to TO cord-266359-uf1ao1x1 18 31 progress progress VB cord-266359-uf1ao1x1 18 32 to to TO cord-266359-uf1ao1x1 18 33 lower lower VB cord-266359-uf1ao1x1 18 34 respiratory respiratory JJ cord-266359-uf1ao1x1 18 35 tract tract NN cord-266359-uf1ao1x1 18 36 disease disease NN cord-266359-uf1ao1x1 18 37 than than IN cord-266359-uf1ao1x1 18 38 most most JJS cord-266359-uf1ao1x1 18 39 other other JJ cord-266359-uf1ao1x1 18 40 respiratory respiratory JJ cord-266359-uf1ao1x1 18 41 viruses virus NNS cord-266359-uf1ao1x1 18 42 . . . cord-266359-uf1ao1x1 19 1 The the DT cord-266359-uf1ao1x1 19 2 clinical clinical JJ cord-266359-uf1ao1x1 19 3 significance significance NN cord-266359-uf1ao1x1 19 4 of of IN cord-266359-uf1ao1x1 19 5 respiratory respiratory JJ cord-266359-uf1ao1x1 19 6 viruses virus NNS cord-266359-uf1ao1x1 19 7 such such JJ cord-266359-uf1ao1x1 19 8 as as IN cord-266359-uf1ao1x1 19 9 influenza influenza NN cord-266359-uf1ao1x1 19 10 , , , cord-266359-uf1ao1x1 19 11 respiratory respiratory JJ cord-266359-uf1ao1x1 19 12 syncytial syncytial JJ cord-266359-uf1ao1x1 19 13 virus virus NN cord-266359-uf1ao1x1 19 14 ( ( -LRB- cord-266359-uf1ao1x1 19 15 RSV RSV NNP cord-266359-uf1ao1x1 19 16 ) ) -RRB- cord-266359-uf1ao1x1 19 17 , , , cord-266359-uf1ao1x1 19 18 parainfluenza parainfluenza NNP cord-266359-uf1ao1x1 19 19 viruses virus NNS cord-266359-uf1ao1x1 19 20 ( ( -LRB- cord-266359-uf1ao1x1 19 21 PIVs PIVs NNP cord-266359-uf1ao1x1 19 22 ) ) -RRB- cord-266359-uf1ao1x1 19 23 , , , cord-266359-uf1ao1x1 19 24 human human JJ cord-266359-uf1ao1x1 19 25 metapneumovirus metapneumovirus NNP cord-266359-uf1ao1x1 19 26 ( ( -LRB- cord-266359-uf1ao1x1 19 27 hMPV hMPV NNP cord-266359-uf1ao1x1 19 28 ) ) -RRB- cord-266359-uf1ao1x1 19 29 , , , cord-266359-uf1ao1x1 19 30 rhinovirus rhinovirus NN cord-266359-uf1ao1x1 19 31 ( ( -LRB- cord-266359-uf1ao1x1 19 32 RhV RhV NNP cord-266359-uf1ao1x1 19 33 ) ) -RRB- cord-266359-uf1ao1x1 19 34 , , , cord-266359-uf1ao1x1 19 35 and and CC cord-266359-uf1ao1x1 19 36 adenovirus adenovirus NN cord-266359-uf1ao1x1 19 37 ( ( -LRB- cord-266359-uf1ao1x1 19 38 AdV adv NN cord-266359-uf1ao1x1 19 39 ) ) -RRB- cord-266359-uf1ao1x1 19 40 in in IN cord-266359-uf1ao1x1 19 41 patients patient NNS cord-266359-uf1ao1x1 19 42 with with IN cord-266359-uf1ao1x1 19 43 hematologic hematologic JJ cord-266359-uf1ao1x1 19 44 malignancies malignancy NNS cord-266359-uf1ao1x1 19 45 or or CC cord-266359-uf1ao1x1 19 46 recipients recipient NNS cord-266359-uf1ao1x1 19 47 of of IN cord-266359-uf1ao1x1 19 48 autologous autologous JJ cord-266359-uf1ao1x1 19 49 or or CC cord-266359-uf1ao1x1 19 50 allogeneic allogeneic IN cord-266359-uf1ao1x1 19 51 hematopoietic hematopoietic JJ cord-266359-uf1ao1x1 19 52 stem stem NN cord-266359-uf1ao1x1 19 53 cell cell NN cord-266359-uf1ao1x1 19 54 transplant transplant NN cord-266359-uf1ao1x1 19 55 ( ( -LRB- cord-266359-uf1ao1x1 19 56 HSCT HSCT NNP cord-266359-uf1ao1x1 19 57 ) ) -RRB- cord-266359-uf1ao1x1 19 58 is be VBZ cord-266359-uf1ao1x1 19 59 well well RB cord-266359-uf1ao1x1 19 60 described describe VBN cord-266359-uf1ao1x1 19 61 [ [ -LRB- cord-266359-uf1ao1x1 19 62 1 1 CD cord-266359-uf1ao1x1 19 63 ] ] -RRB- cord-266359-uf1ao1x1 19 64 [ [ -LRB- cord-266359-uf1ao1x1 19 65 2 2 CD cord-266359-uf1ao1x1 19 66 ] ] -RRB- cord-266359-uf1ao1x1 19 67 [ [ -LRB- cord-266359-uf1ao1x1 19 68 3 3 CD cord-266359-uf1ao1x1 19 69 ] ] -RRB- cord-266359-uf1ao1x1 20 1 [ [ -LRB- cord-266359-uf1ao1x1 20 2 4 4 CD cord-266359-uf1ao1x1 20 3 ] ] -RRB- cord-266359-uf1ao1x1 20 4 [ [ -LRB- cord-266359-uf1ao1x1 20 5 5 5 CD cord-266359-uf1ao1x1 20 6 ] ] -RRB- cord-266359-uf1ao1x1 20 7 [ [ -LRB- cord-266359-uf1ao1x1 20 8 6 6 CD cord-266359-uf1ao1x1 20 9 ] ] -RRB- cord-266359-uf1ao1x1 20 10 [ [ -LRB- cord-266359-uf1ao1x1 20 11 7 7 CD cord-266359-uf1ao1x1 20 12 ] ] -RRB- cord-266359-uf1ao1x1 20 13 [ [ -LRB- cord-266359-uf1ao1x1 20 14 8 8 CD cord-266359-uf1ao1x1 20 15 ] ] -RRB- cord-266359-uf1ao1x1 20 16 . . . cord-266359-uf1ao1x1 21 1 Far far RB cord-266359-uf1ao1x1 21 2 less less JJR cord-266359-uf1ao1x1 21 3 data datum NNS cord-266359-uf1ao1x1 21 4 have have VBP cord-266359-uf1ao1x1 21 5 been be VBN cord-266359-uf1ao1x1 21 6 published publish VBN cord-266359-uf1ao1x1 21 7 that that WDT cord-266359-uf1ao1x1 21 8 specifically specifically RB cord-266359-uf1ao1x1 21 9 address address VB cord-266359-uf1ao1x1 21 10 the the DT cord-266359-uf1ao1x1 21 11 impact impact NN cord-266359-uf1ao1x1 21 12 of of IN cord-266359-uf1ao1x1 21 13 coronavirus coronavirus NN cord-266359-uf1ao1x1 21 14 ( ( -LRB- cord-266359-uf1ao1x1 21 15 CoV CoV NNP cord-266359-uf1ao1x1 21 16 ) ) -RRB- cord-266359-uf1ao1x1 21 17 infection infection NN cord-266359-uf1ao1x1 21 18 in in IN cord-266359-uf1ao1x1 21 19 these these DT cord-266359-uf1ao1x1 21 20 patients patient NNS cord-266359-uf1ao1x1 21 21 [ [ -LRB- cord-266359-uf1ao1x1 21 22 9 9 CD cord-266359-uf1ao1x1 21 23 ] ] -RRB- cord-266359-uf1ao1x1 21 24 . . . cord-266359-uf1ao1x1 22 1 Lower low JJR cord-266359-uf1ao1x1 22 2 respiratory respiratory JJ cord-266359-uf1ao1x1 22 3 tract tract NN cord-266359-uf1ao1x1 22 4 disease disease NN cord-266359-uf1ao1x1 22 5 ( ( -LRB- cord-266359-uf1ao1x1 22 6 LRTD LRTD NNP cord-266359-uf1ao1x1 22 7 ) ) -RRB- cord-266359-uf1ao1x1 22 8 due due IN cord-266359-uf1ao1x1 22 9 to to IN cord-266359-uf1ao1x1 22 10 CoV CoV NNP cord-266359-uf1ao1x1 22 11 has have VBZ cord-266359-uf1ao1x1 22 12 been be VBN cord-266359-uf1ao1x1 22 13 described describe VBN cord-266359-uf1ao1x1 22 14 on on IN cord-266359-uf1ao1x1 22 15 a a DT cord-266359-uf1ao1x1 22 16 case case NN cord-266359-uf1ao1x1 22 17 - - HYPH cord-266359-uf1ao1x1 22 18 report report NN cord-266359-uf1ao1x1 22 19 level level NN cord-266359-uf1ao1x1 22 20 [ [ -LRB- cord-266359-uf1ao1x1 22 21 10 10 CD cord-266359-uf1ao1x1 22 22 ] ] -RRB- cord-266359-uf1ao1x1 23 1 [ [ -LRB- cord-266359-uf1ao1x1 23 2 11 11 CD cord-266359-uf1ao1x1 23 3 ] ] -RRB- cord-266359-uf1ao1x1 23 4 [ [ -LRB- cord-266359-uf1ao1x1 23 5 12 12 CD cord-266359-uf1ao1x1 23 6 ] ] -RRB- cord-266359-uf1ao1x1 23 7 [ [ -LRB- cord-266359-uf1ao1x1 23 8 13 13 CD cord-266359-uf1ao1x1 23 9 ] ] -RRB- cord-266359-uf1ao1x1 24 1 [ [ -LRB- cord-266359-uf1ao1x1 24 2 14 14 CD cord-266359-uf1ao1x1 24 3 ] ] -RRB- cord-266359-uf1ao1x1 24 4 , , , cord-266359-uf1ao1x1 24 5 but but CC cord-266359-uf1ao1x1 24 6 a a DT cord-266359-uf1ao1x1 24 7 retrospective retrospective JJ cord-266359-uf1ao1x1 24 8 analysis analysis NN cord-266359-uf1ao1x1 24 9 of of IN cord-266359-uf1ao1x1 24 10 46 46 CD cord-266359-uf1ao1x1 24 11 bronchoalveolar bronchoalveolar NNP cord-266359-uf1ao1x1 24 12 lavage lavage NN cord-266359-uf1ao1x1 24 13 ( ( -LRB- cord-266359-uf1ao1x1 24 14 BAL BAL NNP cord-266359-uf1ao1x1 24 15 ) ) -RRB- cord-266359-uf1ao1x1 24 16 samples sample NNS cord-266359-uf1ao1x1 24 17 obtained obtain VBN cord-266359-uf1ao1x1 24 18 from from IN cord-266359-uf1ao1x1 24 19 HSCT HSCT NNP cord-266359-uf1ao1x1 24 20 recipients recipient NNS cord-266359-uf1ao1x1 24 21 with with IN cord-266359-uf1ao1x1 24 22 any any DT cord-266359-uf1ao1x1 24 23 acute acute JJ cord-266359-uf1ao1x1 24 24 pulmonary pulmonary JJ cord-266359-uf1ao1x1 24 25 process process NN cord-266359-uf1ao1x1 24 26 did do VBD cord-266359-uf1ao1x1 24 27 not not RB cord-266359-uf1ao1x1 24 28 identify identify VB cord-266359-uf1ao1x1 24 29 CoV cov NN cord-266359-uf1ao1x1 24 30 in in IN cord-266359-uf1ao1x1 24 31 any any DT cord-266359-uf1ao1x1 24 32 sample sample NN cord-266359-uf1ao1x1 24 33 [ [ -LRB- cord-266359-uf1ao1x1 24 34 3 3 CD cord-266359-uf1ao1x1 24 35 ] ] -RRB- cord-266359-uf1ao1x1 24 36 . . . cord-266359-uf1ao1x1 25 1 Later later RB cord-266359-uf1ao1x1 25 2 , , , cord-266359-uf1ao1x1 25 3 a a DT cord-266359-uf1ao1x1 25 4 prospective prospective JJ cord-266359-uf1ao1x1 25 5 surveillance surveillance NN cord-266359-uf1ao1x1 25 6 study study NN cord-266359-uf1ao1x1 25 7 in in IN cord-266359-uf1ao1x1 25 8 allogeneic allogeneic JJ cord-266359-uf1ao1x1 25 9 HSCT HSCT NNP cord-266359-uf1ao1x1 25 10 recipients recipient NNS cord-266359-uf1ao1x1 25 11 performed perform VBN cord-266359-uf1ao1x1 25 12 at at IN cord-266359-uf1ao1x1 25 13 a a DT cord-266359-uf1ao1x1 25 14 single single JJ cord-266359-uf1ao1x1 25 15 center center NN cord-266359-uf1ao1x1 25 16 over over IN cord-266359-uf1ao1x1 25 17 the the DT cord-266359-uf1ao1x1 25 18 course course NN cord-266359-uf1ao1x1 25 19 of of IN cord-266359-uf1ao1x1 25 20 one one CD cord-266359-uf1ao1x1 25 21 year year NN cord-266359-uf1ao1x1 25 22 found find VBD cord-266359-uf1ao1x1 25 23 a a DT cord-266359-uf1ao1x1 25 24 relatively relatively RB cord-266359-uf1ao1x1 25 25 high high JJ cord-266359-uf1ao1x1 25 26 cumulative cumulative JJ cord-266359-uf1ao1x1 25 27 incidence incidence NN cord-266359-uf1ao1x1 25 28 of of IN cord-266359-uf1ao1x1 25 29 CoV cov NN cord-266359-uf1ao1x1 25 30 infection infection NN cord-266359-uf1ao1x1 25 31 ( ( -LRB- cord-266359-uf1ao1x1 25 32 11 11 CD cord-266359-uf1ao1x1 25 33 % % NN cord-266359-uf1ao1x1 25 34 ) ) -RRB- cord-266359-uf1ao1x1 25 35 in in IN cord-266359-uf1ao1x1 25 36 the the DT cord-266359-uf1ao1x1 25 37 first first JJ cord-266359-uf1ao1x1 25 38 100 100 CD cord-266359-uf1ao1x1 25 39 days day NNS cord-266359-uf1ao1x1 25 40 following follow VBG cord-266359-uf1ao1x1 25 41 allogeneic allogeneic IN cord-266359-uf1ao1x1 25 42 HSCT HSCT NNP cord-266359-uf1ao1x1 25 43 , , , cord-266359-uf1ao1x1 25 44 but but CC cord-266359-uf1ao1x1 25 45 only only RB cord-266359-uf1ao1x1 25 46 one one CD cord-266359-uf1ao1x1 25 47 case case NN cord-266359-uf1ao1x1 25 48 in in IN cord-266359-uf1ao1x1 25 49 which which WDT cord-266359-uf1ao1x1 25 50 CoV CoV NNP cord-266359-uf1ao1x1 25 51 was be VBD cord-266359-uf1ao1x1 25 52 detected detect VBN cord-266359-uf1ao1x1 25 53 in in IN cord-266359-uf1ao1x1 25 54 a a DT cord-266359-uf1ao1x1 25 55 lower low JJR cord-266359-uf1ao1x1 25 56 respiratory respiratory JJ cord-266359-uf1ao1x1 25 57 tract tract NN cord-266359-uf1ao1x1 25 58 sample sample NN cord-266359-uf1ao1x1 25 59 [ [ -LRB- cord-266359-uf1ao1x1 25 60 15 15 CD cord-266359-uf1ao1x1 25 61 ] ] -RRB- cord-266359-uf1ao1x1 25 62 . . . cord-266359-uf1ao1x1 26 1 Other other JJ cord-266359-uf1ao1x1 26 2 series series NN cord-266359-uf1ao1x1 26 3 studying study VBG cord-266359-uf1ao1x1 26 4 the the DT cord-266359-uf1ao1x1 26 5 impact impact NN cord-266359-uf1ao1x1 26 6 of of IN cord-266359-uf1ao1x1 26 7 respiratory respiratory JJ cord-266359-uf1ao1x1 26 8 viral viral JJ cord-266359-uf1ao1x1 26 9 infections infection NNS cord-266359-uf1ao1x1 26 10 have have VBP cord-266359-uf1ao1x1 26 11 not not RB cord-266359-uf1ao1x1 26 12 specifically specifically RB cord-266359-uf1ao1x1 26 13 or or CC cord-266359-uf1ao1x1 26 14 directly directly RB cord-266359-uf1ao1x1 26 15 assessed assess VBD cord-266359-uf1ao1x1 26 16 the the DT cord-266359-uf1ao1x1 26 17 clinical clinical JJ cord-266359-uf1ao1x1 26 18 impact impact NN cord-266359-uf1ao1x1 26 19 of of IN cord-266359-uf1ao1x1 26 20 CoV CoV NNP cord-266359-uf1ao1x1 26 21 in in IN cord-266359-uf1ao1x1 26 22 patients patient NNS cord-266359-uf1ao1x1 26 23 with with IN cord-266359-uf1ao1x1 26 24 hematologic hematologic JJ cord-266359-uf1ao1x1 26 25 malignancies malignancy NNS cord-266359-uf1ao1x1 26 26 and and CC cord-266359-uf1ao1x1 26 27 HSCT HSCT NNP cord-266359-uf1ao1x1 26 28 recipients recipient NNS cord-266359-uf1ao1x1 26 29 [ [ -LRB- cord-266359-uf1ao1x1 26 30 16 16 CD cord-266359-uf1ao1x1 26 31 ] ] -RRB- cord-266359-uf1ao1x1 27 1 [ [ -LRB- cord-266359-uf1ao1x1 27 2 17 17 CD cord-266359-uf1ao1x1 27 3 ] ] -RRB- cord-266359-uf1ao1x1 27 4 [ [ -LRB- cord-266359-uf1ao1x1 27 5 18 18 CD cord-266359-uf1ao1x1 27 6 ] ] -RRB- cord-266359-uf1ao1x1 27 7 [ [ -LRB- cord-266359-uf1ao1x1 27 8 19 19 CD cord-266359-uf1ao1x1 27 9 ] ] -RRB- cord-266359-uf1ao1x1 28 1 [ [ -LRB- cord-266359-uf1ao1x1 28 2 20 20 CD cord-266359-uf1ao1x1 28 3 ] ] -RRB- cord-266359-uf1ao1x1 28 4 [ [ -LRB- cord-266359-uf1ao1x1 28 5 21 21 CD cord-266359-uf1ao1x1 28 6 ] ] -RRB- cord-266359-uf1ao1x1 28 7 [ [ -LRB- cord-266359-uf1ao1x1 28 8 22 22 CD cord-266359-uf1ao1x1 28 9 ] ] -RRB- cord-266359-uf1ao1x1 28 10 . . . cord-266359-uf1ao1x1 29 1 With with IN cord-266359-uf1ao1x1 29 2 an an DT cord-266359-uf1ao1x1 29 3 apparently apparently RB cord-266359-uf1ao1x1 29 4 high high JJ cord-266359-uf1ao1x1 29 5 frequency frequency NN cord-266359-uf1ao1x1 29 6 of of IN cord-266359-uf1ao1x1 29 7 infection infection NN cord-266359-uf1ao1x1 29 8 but but CC cord-266359-uf1ao1x1 29 9 relative relative JJ cord-266359-uf1ao1x1 29 10 paucity paucity NN cord-266359-uf1ao1x1 29 11 of of IN cord-266359-uf1ao1x1 29 12 information information NN cord-266359-uf1ao1x1 29 13 pertaining pertain VBG cord-266359-uf1ao1x1 29 14 to to IN cord-266359-uf1ao1x1 29 15 the the DT cord-266359-uf1ao1x1 29 16 impact impact NN cord-266359-uf1ao1x1 29 17 of of IN cord-266359-uf1ao1x1 29 18 CoV CoV NNP cord-266359-uf1ao1x1 29 19 in in IN cord-266359-uf1ao1x1 29 20 patients patient NNS cord-266359-uf1ao1x1 29 21 with with IN cord-266359-uf1ao1x1 29 22 hematologic hematologic JJ cord-266359-uf1ao1x1 29 23 malignancies malignancy NNS cord-266359-uf1ao1x1 29 24 and and CC cord-266359-uf1ao1x1 29 25 HSCT HSCT NNP cord-266359-uf1ao1x1 29 26 recipients recipient NNS cord-266359-uf1ao1x1 29 27 , , , cord-266359-uf1ao1x1 29 28 we -PRON- PRP cord-266359-uf1ao1x1 29 29 conducted conduct VBD cord-266359-uf1ao1x1 29 30 a a DT cord-266359-uf1ao1x1 29 31 retrospective retrospective JJ cord-266359-uf1ao1x1 29 32 review review NN cord-266359-uf1ao1x1 29 33 of of IN cord-266359-uf1ao1x1 29 34 all all DT cord-266359-uf1ao1x1 29 35 CoV cov NN cord-266359-uf1ao1x1 29 36 infections infection NNS cord-266359-uf1ao1x1 29 37 at at IN cord-266359-uf1ao1x1 29 38 our -PRON- PRP$ cord-266359-uf1ao1x1 29 39 institution institution NN cord-266359-uf1ao1x1 29 40 over over IN cord-266359-uf1ao1x1 29 41 a a DT cord-266359-uf1ao1x1 29 42 three three CD cord-266359-uf1ao1x1 29 43 year year NN cord-266359-uf1ao1x1 29 44 period period NN cord-266359-uf1ao1x1 29 45 in in IN cord-266359-uf1ao1x1 29 46 order order NN cord-266359-uf1ao1x1 29 47 to to TO cord-266359-uf1ao1x1 29 48 further further RB cord-266359-uf1ao1x1 29 49 characterize characterize VB cord-266359-uf1ao1x1 29 50 the the DT cord-266359-uf1ao1x1 29 51 role role NN cord-266359-uf1ao1x1 29 52 of of IN cord-266359-uf1ao1x1 29 53 CoV cov NN cord-266359-uf1ao1x1 29 54 in in IN cord-266359-uf1ao1x1 29 55 respiratory respiratory JJ cord-266359-uf1ao1x1 29 56 tract tract NN cord-266359-uf1ao1x1 29 57 infections infection NNS cord-266359-uf1ao1x1 29 58 in in IN cord-266359-uf1ao1x1 29 59 these these DT cord-266359-uf1ao1x1 29 60 patients patient NNS cord-266359-uf1ao1x1 29 61 . . . cord-266359-uf1ao1x1 30 1 All all DT cord-266359-uf1ao1x1 30 2 nasopharyngeal nasopharyngeal JJ cord-266359-uf1ao1x1 30 3 ( ( -LRB- cord-266359-uf1ao1x1 30 4 NP NP NNP cord-266359-uf1ao1x1 30 5 ) ) -RRB- cord-266359-uf1ao1x1 30 6 and and CC cord-266359-uf1ao1x1 30 7 BAL BAL NNP cord-266359-uf1ao1x1 30 8 samples sample NNS cord-266359-uf1ao1x1 30 9 submitted submit VBN cord-266359-uf1ao1x1 30 10 from from IN cord-266359-uf1ao1x1 30 11 outpatient outpatient NN cord-266359-uf1ao1x1 30 12 clinics clinic NNS cord-266359-uf1ao1x1 30 13 and and CC cord-266359-uf1ao1x1 30 14 inpatient inpatient JJ cord-266359-uf1ao1x1 30 15 wards ward NNS cord-266359-uf1ao1x1 30 16 for for IN cord-266359-uf1ao1x1 30 17 respiratory respiratory JJ cord-266359-uf1ao1x1 30 18 virus virus NN cord-266359-uf1ao1x1 30 19 testing testing NN cord-266359-uf1ao1x1 30 20 between between IN cord-266359-uf1ao1x1 30 21 June June NNP cord-266359-uf1ao1x1 30 22 01 01 CD cord-266359-uf1ao1x1 30 23 , , , cord-266359-uf1ao1x1 30 24 2010 2010 CD cord-266359-uf1ao1x1 30 25 and and CC cord-266359-uf1ao1x1 30 26 July July NNP cord-266359-uf1ao1x1 30 27 01 01 CD cord-266359-uf1ao1x1 30 28 , , , cord-266359-uf1ao1x1 30 29 2013 2013 CD cord-266359-uf1ao1x1 30 30 at at IN cord-266359-uf1ao1x1 30 31 Oregon Oregon NNP cord-266359-uf1ao1x1 30 32 Health Health NNP cord-266359-uf1ao1x1 30 33 and and CC cord-266359-uf1ao1x1 30 34 Science Science NNP cord-266359-uf1ao1x1 30 35 University University NNP cord-266359-uf1ao1x1 30 36 ( ( -LRB- cord-266359-uf1ao1x1 30 37 OHSU OHSU NNP cord-266359-uf1ao1x1 30 38 ) ) -RRB- cord-266359-uf1ao1x1 30 39 were be VBD cord-266359-uf1ao1x1 30 40 included include VBN cord-266359-uf1ao1x1 30 41 in in IN cord-266359-uf1ao1x1 30 42 this this DT cord-266359-uf1ao1x1 30 43 study study NN cord-266359-uf1ao1x1 30 44 . . . cord-266359-uf1ao1x1 31 1 Demographic demographic JJ cord-266359-uf1ao1x1 31 2 and and CC cord-266359-uf1ao1x1 31 3 clinical clinical JJ cord-266359-uf1ao1x1 31 4 information information NN cord-266359-uf1ao1x1 31 5 pertaining pertain VBG cord-266359-uf1ao1x1 31 6 to to IN cord-266359-uf1ao1x1 31 7 each each DT cord-266359-uf1ao1x1 31 8 patient patient JJ cord-266359-uf1ao1x1 31 9 testing test VBG cord-266359-uf1ao1x1 31 10 positive positive JJ cord-266359-uf1ao1x1 31 11 for for IN cord-266359-uf1ao1x1 31 12 CoV cov NN cord-266359-uf1ao1x1 31 13 or or CC cord-266359-uf1ao1x1 31 14 other other JJ cord-266359-uf1ao1x1 31 15 respiratory respiratory JJ cord-266359-uf1ao1x1 31 16 viruses virus NNS cord-266359-uf1ao1x1 31 17 assayed assay VBN cord-266359-uf1ao1x1 31 18 as as IN cord-266359-uf1ao1x1 31 19 part part NN cord-266359-uf1ao1x1 31 20 of of IN cord-266359-uf1ao1x1 31 21 a a DT cord-266359-uf1ao1x1 31 22 multiplex multiplex JJ cord-266359-uf1ao1x1 31 23 PCR pcr NN cord-266359-uf1ao1x1 31 24 panel panel NN cord-266359-uf1ao1x1 31 25 ( ( -LRB- cord-266359-uf1ao1x1 31 26 described describe VBN cord-266359-uf1ao1x1 31 27 below below IN cord-266359-uf1ao1x1 31 28 ) ) -RRB- cord-266359-uf1ao1x1 31 29 , , , cord-266359-uf1ao1x1 31 30 were be VBD cord-266359-uf1ao1x1 31 31 obtained obtain VBN cord-266359-uf1ao1x1 31 32 by by IN cord-266359-uf1ao1x1 31 33 medical medical JJ cord-266359-uf1ao1x1 31 34 chart chart NN cord-266359-uf1ao1x1 31 35 review review NN cord-266359-uf1ao1x1 31 36 . . . cord-266359-uf1ao1x1 32 1 A a DT cord-266359-uf1ao1x1 32 2 patient patient NN cord-266359-uf1ao1x1 32 3 was be VBD cord-266359-uf1ao1x1 32 4 considered consider VBN cord-266359-uf1ao1x1 32 5 to to TO cord-266359-uf1ao1x1 32 6 have have VB cord-266359-uf1ao1x1 32 7 a a DT cord-266359-uf1ao1x1 32 8 hematologic hematologic JJ cord-266359-uf1ao1x1 32 9 malignancy malignancy NN cord-266359-uf1ao1x1 32 10 if if IN cord-266359-uf1ao1x1 32 11 they -PRON- PRP cord-266359-uf1ao1x1 32 12 were be VBD cord-266359-uf1ao1x1 32 13 diagnosed diagnose VBN cord-266359-uf1ao1x1 32 14 with with IN cord-266359-uf1ao1x1 32 15 , , , cord-266359-uf1ao1x1 32 16 and and CC cord-266359-uf1ao1x1 32 17 were be VBD cord-266359-uf1ao1x1 32 18 receiving receive VBG cord-266359-uf1ao1x1 32 19 treatment treatment NN cord-266359-uf1ao1x1 32 20 for for IN cord-266359-uf1ao1x1 32 21 , , , cord-266359-uf1ao1x1 32 22 any any DT cord-266359-uf1ao1x1 32 23 type type NN cord-266359-uf1ao1x1 32 24 of of IN cord-266359-uf1ao1x1 32 25 leukemia leukemia NN cord-266359-uf1ao1x1 32 26 , , , cord-266359-uf1ao1x1 32 27 lymphoma lymphoma NN cord-266359-uf1ao1x1 32 28 , , , cord-266359-uf1ao1x1 32 29 multiple multiple JJ cord-266359-uf1ao1x1 32 30 myeloma myeloma NN cord-266359-uf1ao1x1 32 31 , , , cord-266359-uf1ao1x1 32 32 aplastic aplastic JJ cord-266359-uf1ao1x1 32 33 anemia anemia NN cord-266359-uf1ao1x1 32 34 , , , cord-266359-uf1ao1x1 32 35 mastocytosis mastocytosis NN cord-266359-uf1ao1x1 32 36 , , , cord-266359-uf1ao1x1 32 37 myelodysplastic myelodysplastic JJ cord-266359-uf1ao1x1 32 38 syndrome syndrome NN cord-266359-uf1ao1x1 32 39 , , , cord-266359-uf1ao1x1 32 40 or or CC cord-266359-uf1ao1x1 32 41 amyloidosis amyloidosis NN cord-266359-uf1ao1x1 32 42 . . . cord-266359-uf1ao1x1 33 1 All all DT cord-266359-uf1ao1x1 33 2 patients patient NNS cord-266359-uf1ao1x1 33 3 who who WP cord-266359-uf1ao1x1 33 4 underwent undergo VBD cord-266359-uf1ao1x1 33 5 allogeneic allogeneic JJ cord-266359-uf1ao1x1 33 6 or or CC cord-266359-uf1ao1x1 33 7 autologous autologous JJ cord-266359-uf1ao1x1 33 8 HSCT HSCT NNP cord-266359-uf1ao1x1 33 9 , , , cord-266359-uf1ao1x1 33 10 or or CC cord-266359-uf1ao1x1 33 11 cord cord NN cord-266359-uf1ao1x1 33 12 blood blood NN cord-266359-uf1ao1x1 33 13 transplant transplant NN cord-266359-uf1ao1x1 33 14 ( ( -LRB- cord-266359-uf1ao1x1 33 15 CBT CBT NNP cord-266359-uf1ao1x1 33 16 ) ) -RRB- cord-266359-uf1ao1x1 33 17 , , , cord-266359-uf1ao1x1 33 18 were be VBD cord-266359-uf1ao1x1 33 19 included include VBN cord-266359-uf1ao1x1 33 20 and and CC cord-266359-uf1ao1x1 33 21 classified classify VBN cord-266359-uf1ao1x1 33 22 as as IN cord-266359-uf1ao1x1 33 23 such such JJ cord-266359-uf1ao1x1 33 24 regardless regardless RB cord-266359-uf1ao1x1 33 25 of of IN cord-266359-uf1ao1x1 33 26 the the DT cord-266359-uf1ao1x1 33 27 underlying underlie VBG cord-266359-uf1ao1x1 33 28 disease disease NN cord-266359-uf1ao1x1 33 29 necessitating necessitate VBG cord-266359-uf1ao1x1 33 30 transplant transplant NN cord-266359-uf1ao1x1 33 31 . . . cord-266359-uf1ao1x1 34 1 Testing testing NN cord-266359-uf1ao1x1 34 2 was be VBD cord-266359-uf1ao1x1 34 3 performed perform VBN cord-266359-uf1ao1x1 34 4 using use VBG cord-266359-uf1ao1x1 34 5 a a DT cord-266359-uf1ao1x1 34 6 multiplex multiplex JJ cord-266359-uf1ao1x1 34 7 respiratory respiratory JJ cord-266359-uf1ao1x1 34 8 virus virus NN cord-266359-uf1ao1x1 34 9 PCR PCR NNP cord-266359-uf1ao1x1 34 10 panel panel NN cord-266359-uf1ao1x1 34 11 assay assay NN cord-266359-uf1ao1x1 34 12 ( ( -LRB- cord-266359-uf1ao1x1 34 13 xTAG xtag JJ cord-266359-uf1ao1x1 34 14 RVP RVP NNP cord-266359-uf1ao1x1 34 15 ; ; : cord-266359-uf1ao1x1 34 16 Luminex Luminex NNP cord-266359-uf1ao1x1 34 17 ) ) -RRB- cord-266359-uf1ao1x1 34 18 [ [ -LRB- cord-266359-uf1ao1x1 34 19 23 23 CD cord-266359-uf1ao1x1 34 20 ] ] -RRB- cord-266359-uf1ao1x1 34 21 per per IN cord-266359-uf1ao1x1 34 22 manufacturer manufacturer NN cord-266359-uf1ao1x1 34 23 's 's POS cord-266359-uf1ao1x1 34 24 instructions instruction NNS cord-266359-uf1ao1x1 34 25 . . . cord-266359-uf1ao1x1 35 1 Since since IN cord-266359-uf1ao1x1 35 2 this this DT cord-266359-uf1ao1x1 35 3 assay assay NN cord-266359-uf1ao1x1 35 4 does do VBZ cord-266359-uf1ao1x1 35 5 not not RB cord-266359-uf1ao1x1 35 6 distinguish distinguish VB cord-266359-uf1ao1x1 35 7 between between IN cord-266359-uf1ao1x1 35 8 RhV rhv NN cord-266359-uf1ao1x1 35 9 and and CC cord-266359-uf1ao1x1 35 10 enterovirus enterovirus NN cord-266359-uf1ao1x1 35 11 ( ( -LRB- cord-266359-uf1ao1x1 35 12 EnV EnV NNP cord-266359-uf1ao1x1 35 13 ) ) -RRB- cord-266359-uf1ao1x1 35 14 , , , cord-266359-uf1ao1x1 35 15 these these DT cord-266359-uf1ao1x1 35 16 results result NNS cord-266359-uf1ao1x1 35 17 are be VBP cord-266359-uf1ao1x1 35 18 grouped group VBN cord-266359-uf1ao1x1 35 19 together together RB cord-266359-uf1ao1x1 35 20 in in IN cord-266359-uf1ao1x1 35 21 this this DT cord-266359-uf1ao1x1 35 22 analysis analysis NN cord-266359-uf1ao1x1 35 23 . . . cord-266359-uf1ao1x1 36 1 The the DT cord-266359-uf1ao1x1 36 2 CoV cov NN cord-266359-uf1ao1x1 36 3 PCR pcr NN cord-266359-uf1ao1x1 36 4 reagents reagent NNS cord-266359-uf1ao1x1 36 5 that that WDT cord-266359-uf1ao1x1 36 6 are be VBP cord-266359-uf1ao1x1 36 7 included include VBN cord-266359-uf1ao1x1 36 8 in in IN cord-266359-uf1ao1x1 36 9 the the DT cord-266359-uf1ao1x1 36 10 RVP RVP NNP cord-266359-uf1ao1x1 36 11 testing testing NN cord-266359-uf1ao1x1 36 12 kit kit NN cord-266359-uf1ao1x1 36 13 were be VBD cord-266359-uf1ao1x1 36 14 further further RB cord-266359-uf1ao1x1 36 15 validated validate VBN cord-266359-uf1ao1x1 36 16 for for IN cord-266359-uf1ao1x1 36 17 clinical clinical JJ cord-266359-uf1ao1x1 36 18 testing testing NN cord-266359-uf1ao1x1 36 19 ( ( -LRB- cord-266359-uf1ao1x1 36 20 under under IN cord-266359-uf1ao1x1 36 21 College College NNP cord-266359-uf1ao1x1 36 22 of of IN cord-266359-uf1ao1x1 36 23 American American NNP cord-266359-uf1ao1x1 36 24 Pathologists Pathologists NNPS cord-266359-uf1ao1x1 36 25 ( ( -LRB- cord-266359-uf1ao1x1 36 26 CAP)-and CAP)-and NNP cord-266359-uf1ao1x1 36 27 Clinical Clinical NNP cord-266359-uf1ao1x1 36 28 Laboratory Laboratory NNP cord-266359-uf1ao1x1 36 29 Improvement Improvement NNP cord-266359-uf1ao1x1 36 30 Amendments Amendments NNP cord-266359-uf1ao1x1 36 31 ( ( -LRB- cord-266359-uf1ao1x1 36 32 CLIA)-regulatory clia)-regulatory CD cord-266359-uf1ao1x1 36 33 conditions condition NNS cord-266359-uf1ao1x1 36 34 ) ) -RRB- cord-266359-uf1ao1x1 36 35 by by IN cord-266359-uf1ao1x1 36 36 the the DT cord-266359-uf1ao1x1 36 37 OHSU OHSU NNP cord-266359-uf1ao1x1 36 38 molecular molecular JJ cord-266359-uf1ao1x1 36 39 diagnostics diagnostic NNS cord-266359-uf1ao1x1 36 40 lab lab NN cord-266359-uf1ao1x1 36 41 . . . cord-266359-uf1ao1x1 37 1 A a DT cord-266359-uf1ao1x1 37 2 unique unique JJ cord-266359-uf1ao1x1 37 3 episode episode NN cord-266359-uf1ao1x1 37 4 of of IN cord-266359-uf1ao1x1 37 5 infection infection NN cord-266359-uf1ao1x1 37 6 was be VBD cord-266359-uf1ao1x1 37 7 counted count VBN cord-266359-uf1ao1x1 37 8 at at IN cord-266359-uf1ao1x1 37 9 the the DT cord-266359-uf1ao1x1 37 10 initial initial JJ cord-266359-uf1ao1x1 37 11 identification identification NN cord-266359-uf1ao1x1 37 12 of of IN cord-266359-uf1ao1x1 37 13 a a DT cord-266359-uf1ao1x1 37 14 respiratory respiratory JJ cord-266359-uf1ao1x1 37 15 virus virus NN cord-266359-uf1ao1x1 37 16 in in IN cord-266359-uf1ao1x1 37 17 an an DT cord-266359-uf1ao1x1 37 18 NP NP NNP cord-266359-uf1ao1x1 37 19 or or CC cord-266359-uf1ao1x1 37 20 BAL bal NN cord-266359-uf1ao1x1 37 21 sample sample NN cord-266359-uf1ao1x1 37 22 . . . cord-266359-uf1ao1x1 38 1 When when WRB cord-266359-uf1ao1x1 38 2 the the DT cord-266359-uf1ao1x1 38 3 same same JJ cord-266359-uf1ao1x1 38 4 respiratory respiratory JJ cord-266359-uf1ao1x1 38 5 virus virus NN cord-266359-uf1ao1x1 38 6 was be VBD cord-266359-uf1ao1x1 38 7 identified identify VBN cord-266359-uf1ao1x1 38 8 in in IN cord-266359-uf1ao1x1 38 9 multiple multiple JJ cord-266359-uf1ao1x1 38 10 consecutive consecutive JJ cord-266359-uf1ao1x1 38 11 samples sample NNS cord-266359-uf1ao1x1 38 12 from from IN cord-266359-uf1ao1x1 38 13 the the DT cord-266359-uf1ao1x1 38 14 same same JJ cord-266359-uf1ao1x1 38 15 patient patient NN cord-266359-uf1ao1x1 38 16 without without IN cord-266359-uf1ao1x1 38 17 interim interim JJ cord-266359-uf1ao1x1 38 18 negative negative JJ cord-266359-uf1ao1x1 38 19 test test NN cord-266359-uf1ao1x1 38 20 results result NNS cord-266359-uf1ao1x1 38 21 , , , cord-266359-uf1ao1x1 38 22 this this DT cord-266359-uf1ao1x1 38 23 was be VBD cord-266359-uf1ao1x1 38 24 considered consider VBN cord-266359-uf1ao1x1 38 25 as as IN cord-266359-uf1ao1x1 38 26 representative representative NN cord-266359-uf1ao1x1 38 27 of of IN cord-266359-uf1ao1x1 38 28 prolonged prolonged JJ cord-266359-uf1ao1x1 38 29 shedding shedding NN cord-266359-uf1ao1x1 38 30 , , , cord-266359-uf1ao1x1 38 31 and and CC cord-266359-uf1ao1x1 38 32 was be VBD cord-266359-uf1ao1x1 38 33 therefore therefore RB cord-266359-uf1ao1x1 38 34 counted count VBN cord-266359-uf1ao1x1 38 35 as as IN cord-266359-uf1ao1x1 38 36 a a DT cord-266359-uf1ao1x1 38 37 single single JJ cord-266359-uf1ao1x1 38 38 unique unique JJ cord-266359-uf1ao1x1 38 39 episode episode NN cord-266359-uf1ao1x1 38 40 of of IN cord-266359-uf1ao1x1 38 41 infection infection NN cord-266359-uf1ao1x1 38 42 . . . cord-266359-uf1ao1x1 39 1 Mortality mortality NN cord-266359-uf1ao1x1 39 2 was be VBD cord-266359-uf1ao1x1 39 3 attributed attribute VBN cord-266359-uf1ao1x1 39 4 to to IN cord-266359-uf1ao1x1 39 5 respiratory respiratory JJ cord-266359-uf1ao1x1 39 6 virus virus NN cord-266359-uf1ao1x1 39 7 infection infection NN cord-266359-uf1ao1x1 39 8 if if IN cord-266359-uf1ao1x1 39 9 death death NN cord-266359-uf1ao1x1 39 10 was be VBD cord-266359-uf1ao1x1 39 11 due due JJ cord-266359-uf1ao1x1 39 12 to to IN cord-266359-uf1ao1x1 39 13 respiratory respiratory JJ cord-266359-uf1ao1x1 39 14 failure failure NN cord-266359-uf1ao1x1 39 15 without without IN cord-266359-uf1ao1x1 39 16 identification identification NN cord-266359-uf1ao1x1 39 17 of of IN cord-266359-uf1ao1x1 39 18 a a DT cord-266359-uf1ao1x1 39 19 cause cause NN cord-266359-uf1ao1x1 39 20 other other JJ cord-266359-uf1ao1x1 39 21 than than IN cord-266359-uf1ao1x1 39 22 a a DT cord-266359-uf1ao1x1 39 23 respiratory respiratory JJ cord-266359-uf1ao1x1 39 24 virus virus NN cord-266359-uf1ao1x1 39 25 [ [ -LRB- cord-266359-uf1ao1x1 39 26 19 19 CD cord-266359-uf1ao1x1 39 27 ] ] -RRB- cord-266359-uf1ao1x1 39 28 . . . cord-266359-uf1ao1x1 40 1 Respiratory respiratory JJ cord-266359-uf1ao1x1 40 2 virus virus NN cord-266359-uf1ao1x1 40 3 inpatient inpatient RB cord-266359-uf1ao1x1 40 4 - - HYPH cord-266359-uf1ao1x1 40 5 acquired acquire VBN cord-266359-uf1ao1x1 40 6 infection infection NN cord-266359-uf1ao1x1 40 7 was be VBD cord-266359-uf1ao1x1 40 8 defined define VBN cord-266359-uf1ao1x1 40 9 as as IN cord-266359-uf1ao1x1 40 10 onset onset NN cord-266359-uf1ao1x1 40 11 of of IN cord-266359-uf1ao1x1 40 12 new new JJ cord-266359-uf1ao1x1 40 13 symptoms symptom NNS cord-266359-uf1ao1x1 40 14 , , , cord-266359-uf1ao1x1 40 15 4 4 CD cord-266359-uf1ao1x1 40 16 days day NNS cord-266359-uf1ao1x1 40 17 or or CC cord-266359-uf1ao1x1 40 18 more more JJR cord-266359-uf1ao1x1 40 19 after after IN cord-266359-uf1ao1x1 40 20 admission admission NN cord-266359-uf1ao1x1 40 21 to to IN cord-266359-uf1ao1x1 40 22 an an DT cord-266359-uf1ao1x1 40 23 inpatient inpatient JJ cord-266359-uf1ao1x1 40 24 ward ward NN cord-266359-uf1ao1x1 40 25 . . . cord-266359-uf1ao1x1 41 1 Criteria criterion NNS cord-266359-uf1ao1x1 41 2 for for IN cord-266359-uf1ao1x1 41 3 possible possible JJ cord-266359-uf1ao1x1 41 4 and and CC cord-266359-uf1ao1x1 41 5 proven prove VBN cord-266359-uf1ao1x1 41 6 LRTD LRTD NNP cord-266359-uf1ao1x1 41 7 were be VBD cord-266359-uf1ao1x1 41 8 identification identification NN cord-266359-uf1ao1x1 41 9 of of IN cord-266359-uf1ao1x1 41 10 a a DT cord-266359-uf1ao1x1 41 11 respiratory respiratory JJ cord-266359-uf1ao1x1 41 12 virus virus NN cord-266359-uf1ao1x1 41 13 in in IN cord-266359-uf1ao1x1 41 14 an an DT cord-266359-uf1ao1x1 41 15 NP NP NNP cord-266359-uf1ao1x1 41 16 sample sample NN cord-266359-uf1ao1x1 41 17 ( ( -LRB- cord-266359-uf1ao1x1 41 18 possible possible JJ cord-266359-uf1ao1x1 41 19 LRTD LRTD NNP cord-266359-uf1ao1x1 41 20 ) ) -RRB- cord-266359-uf1ao1x1 41 21 or or CC cord-266359-uf1ao1x1 41 22 BAL BAL NNP cord-266359-uf1ao1x1 41 23 sample sample NN cord-266359-uf1ao1x1 41 24 ( ( -LRB- cord-266359-uf1ao1x1 41 25 proven prove VBN cord-266359-uf1ao1x1 41 26 LRTD LRTD NNP cord-266359-uf1ao1x1 41 27 ) ) -RRB- cord-266359-uf1ao1x1 41 28 , , , cord-266359-uf1ao1x1 41 29 along along IN cord-266359-uf1ao1x1 41 30 with with IN cord-266359-uf1ao1x1 41 31 new new JJ cord-266359-uf1ao1x1 41 32 pulmonary pulmonary NN cord-266359-uf1ao1x1 41 33 infiltrates infiltrate VBZ cord-266359-uf1ao1x1 41 34 on on IN cord-266359-uf1ao1x1 41 35 thoracic thoracic JJ cord-266359-uf1ao1x1 41 36 imaging imaging NN cord-266359-uf1ao1x1 41 37 [ [ -LRB- cord-266359-uf1ao1x1 41 38 24 24 CD cord-266359-uf1ao1x1 41 39 ] ] -RRB- cord-266359-uf1ao1x1 41 40 . . . cord-266359-uf1ao1x1 42 1 Comparison comparison NN cord-266359-uf1ao1x1 42 2 of of IN cord-266359-uf1ao1x1 42 3 categorical categorical JJ cord-266359-uf1ao1x1 42 4 variables variable NNS cord-266359-uf1ao1x1 42 5 between between IN cord-266359-uf1ao1x1 42 6 viral viral JJ cord-266359-uf1ao1x1 42 7 groups group NNS cord-266359-uf1ao1x1 42 8 was be VBD cord-266359-uf1ao1x1 42 9 performed perform VBN cord-266359-uf1ao1x1 42 10 using use VBG cord-266359-uf1ao1x1 42 11 two two CD cord-266359-uf1ao1x1 42 12 - - HYPH cord-266359-uf1ao1x1 42 13 tailed tailed JJ cord-266359-uf1ao1x1 42 14 Fisher Fisher NNP cord-266359-uf1ao1x1 42 15 's 's POS cord-266359-uf1ao1x1 42 16 exact exact JJ cord-266359-uf1ao1x1 42 17 test test NN cord-266359-uf1ao1x1 42 18 . . . cord-266359-uf1ao1x1 42 19 _SP cord-266359-uf1ao1x1 43 1 A a DT cord-266359-uf1ao1x1 43 2 total total NN cord-266359-uf1ao1x1 43 3 of of IN cord-266359-uf1ao1x1 43 4 1661 1661 CD cord-266359-uf1ao1x1 43 5 NP NP NNP cord-266359-uf1ao1x1 43 6 and and CC cord-266359-uf1ao1x1 43 7 BAL bal NN cord-266359-uf1ao1x1 43 8 samples sample NNS cord-266359-uf1ao1x1 43 9 obtained obtain VBN cord-266359-uf1ao1x1 43 10 from from IN cord-266359-uf1ao1x1 43 11 the the DT cord-266359-uf1ao1x1 43 12 general general JJ cord-266359-uf1ao1x1 43 13 hospital hospital NN cord-266359-uf1ao1x1 43 14 inpatient inpatient NN cord-266359-uf1ao1x1 43 15 and and CC cord-266359-uf1ao1x1 43 16 outpatient outpatient NN cord-266359-uf1ao1x1 43 17 populations population NNS cord-266359-uf1ao1x1 43 18 -inclusive -inclusive RB cord-266359-uf1ao1x1 43 19 of of IN cord-266359-uf1ao1x1 43 20 , , , cord-266359-uf1ao1x1 43 21 but but CC cord-266359-uf1ao1x1 43 22 not not RB cord-266359-uf1ao1x1 43 23 limited limit VBN cord-266359-uf1ao1x1 43 24 , , , cord-266359-uf1ao1x1 43 25 to to IN cord-266359-uf1ao1x1 43 26 HSCT HSCT NNP cord-266359-uf1ao1x1 43 27 recipients recipient NNS cord-266359-uf1ao1x1 43 28 and and CC cord-266359-uf1ao1x1 43 29 hematologic hematologic JJ cord-266359-uf1ao1x1 43 30 malignancy malignancy NN cord-266359-uf1ao1x1 43 31 patientswere patientswere NN cord-266359-uf1ao1x1 43 32 analyzed analyze VBN cord-266359-uf1ao1x1 43 33 . . . cord-266359-uf1ao1x1 44 1 Of of IN cord-266359-uf1ao1x1 44 2 these these DT cord-266359-uf1ao1x1 44 3 , , , cord-266359-uf1ao1x1 44 4 631 631 CD cord-266359-uf1ao1x1 44 5 samples sample NNS cord-266359-uf1ao1x1 44 6 ( ( -LRB- cord-266359-uf1ao1x1 44 7 38 38 CD cord-266359-uf1ao1x1 44 8 % % NN cord-266359-uf1ao1x1 44 9 ) ) -RRB- cord-266359-uf1ao1x1 44 10 submitted submit VBN cord-266359-uf1ao1x1 44 11 during during IN cord-266359-uf1ao1x1 44 12 461 461 CD cord-266359-uf1ao1x1 44 13 unique unique JJ cord-266359-uf1ao1x1 44 14 episodes episode NNS cord-266359-uf1ao1x1 44 15 of of IN cord-266359-uf1ao1x1 44 16 infection infection NN cord-266359-uf1ao1x1 44 17 tested test VBD cord-266359-uf1ao1x1 44 18 positive positive JJ cord-266359-uf1ao1x1 44 19 for for IN cord-266359-uf1ao1x1 44 20 a a DT cord-266359-uf1ao1x1 44 21 respiratory respiratory JJ cord-266359-uf1ao1x1 44 22 virus virus NN cord-266359-uf1ao1x1 44 23 ( ( -LRB- cord-266359-uf1ao1x1 44 24 Table table NN cord-266359-uf1ao1x1 44 25 1 1 CD cord-266359-uf1ao1x1 44 26 ) ) -RRB- cord-266359-uf1ao1x1 44 27 . . . cord-266359-uf1ao1x1 45 1 CoV CoV NNP cord-266359-uf1ao1x1 45 2 was be VBD cord-266359-uf1ao1x1 45 3 the the DT cord-266359-uf1ao1x1 45 4 third third JJ cord-266359-uf1ao1x1 45 5 most most RBS cord-266359-uf1ao1x1 45 6 - - HYPH cord-266359-uf1ao1x1 45 7 common common JJ cord-266359-uf1ao1x1 45 8 virus virus NN cord-266359-uf1ao1x1 45 9 identified identify VBN cord-266359-uf1ao1x1 45 10 after after IN cord-266359-uf1ao1x1 45 11 RhV rhv NN cord-266359-uf1ao1x1 45 12 / / SYM cord-266359-uf1ao1x1 45 13 EnV env NN cord-266359-uf1ao1x1 45 14 and and CC cord-266359-uf1ao1x1 45 15 PIV3 PIV3 NNP cord-266359-uf1ao1x1 45 16 , , , cord-266359-uf1ao1x1 45 17 accounting account VBG cord-266359-uf1ao1x1 45 18 for for IN cord-266359-uf1ao1x1 45 19 43 43 CD cord-266359-uf1ao1x1 45 20 ( ( -LRB- cord-266359-uf1ao1x1 45 21 6.8 6.8 CD cord-266359-uf1ao1x1 45 22 % % NN cord-266359-uf1ao1x1 45 23 ) ) -RRB- cord-266359-uf1ao1x1 45 24 positive positive JJ cord-266359-uf1ao1x1 45 25 samples sample NNS cord-266359-uf1ao1x1 45 26 . . . cord-266359-uf1ao1x1 46 1 Three three CD cord-266359-uf1ao1x1 46 2 BAL bal NN cord-266359-uf1ao1x1 46 3 specimens specimen NNS cord-266359-uf1ao1x1 46 4 were be VBD cord-266359-uf1ao1x1 46 5 positive positive JJ cord-266359-uf1ao1x1 46 6 for for IN cord-266359-uf1ao1x1 46 7 CoV CoV NNP cord-266359-uf1ao1x1 46 8 ( ( -LRB- cord-266359-uf1ao1x1 46 9 see see VB cord-266359-uf1ao1x1 46 10 below below RB cord-266359-uf1ao1x1 46 11 ) ) -RRB- cord-266359-uf1ao1x1 46 12 , , , cord-266359-uf1ao1x1 46 13 representing represent VBG cord-266359-uf1ao1x1 46 14 7 7 CD cord-266359-uf1ao1x1 46 15 % % NN cord-266359-uf1ao1x1 46 16 of of IN cord-266359-uf1ao1x1 46 17 all all DT cord-266359-uf1ao1x1 46 18 CoV cov NN cord-266359-uf1ao1x1 46 19 - - HYPH cord-266359-uf1ao1x1 46 20 positive positive JJ cord-266359-uf1ao1x1 46 21 samples sample NNS cord-266359-uf1ao1x1 46 22 . . . cord-266359-uf1ao1x1 47 1 Of of IN cord-266359-uf1ao1x1 47 2 the the DT cord-266359-uf1ao1x1 47 3 461 461 CD cord-266359-uf1ao1x1 47 4 unique unique JJ cord-266359-uf1ao1x1 47 5 episodes episode NNS cord-266359-uf1ao1x1 47 6 of of IN cord-266359-uf1ao1x1 47 7 infection infection NN cord-266359-uf1ao1x1 47 8 , , , cord-266359-uf1ao1x1 47 9 339 339 CD cord-266359-uf1ao1x1 47 10 ( ( -LRB- cord-266359-uf1ao1x1 47 11 73.5 73.5 CD cord-266359-uf1ao1x1 47 12 % % NN cord-266359-uf1ao1x1 47 13 ) ) -RRB- cord-266359-uf1ao1x1 47 14 were be VBD cord-266359-uf1ao1x1 47 15 in in IN cord-266359-uf1ao1x1 47 16 the the DT cord-266359-uf1ao1x1 47 17 hematologic hematologic JJ cord-266359-uf1ao1x1 47 18 malignancy malignancy NN cord-266359-uf1ao1x1 47 19 and and CC cord-266359-uf1ao1x1 47 20 HSCT HSCT NNP cord-266359-uf1ao1x1 47 21 patient patient NN cord-266359-uf1ao1x1 47 22 populations population NNS cord-266359-uf1ao1x1 47 23 ( ( -LRB- cord-266359-uf1ao1x1 47 24 Table table NN cord-266359-uf1ao1x1 47 25 1 1 CD cord-266359-uf1ao1x1 47 26 ) ) -RRB- cord-266359-uf1ao1x1 47 27 . . . cord-266359-uf1ao1x1 48 1 CoV CoV NNP cord-266359-uf1ao1x1 48 2 was be VBD cord-266359-uf1ao1x1 48 3 identified identify VBN cord-266359-uf1ao1x1 48 4 in in IN cord-266359-uf1ao1x1 48 5 38 38 CD cord-266359-uf1ao1x1 48 6 ( ( -LRB- cord-266359-uf1ao1x1 48 7 8.2 8.2 CD cord-266359-uf1ao1x1 48 8 % % NN cord-266359-uf1ao1x1 48 9 ) ) -RRB- cord-266359-uf1ao1x1 48 10 episodes episode NNS cord-266359-uf1ao1x1 48 11 among among IN cord-266359-uf1ao1x1 48 12 all all DT cord-266359-uf1ao1x1 48 13 patients patient NNS cord-266359-uf1ao1x1 48 14 , , , cord-266359-uf1ao1x1 48 15 and and CC cord-266359-uf1ao1x1 48 16 33 33 CD cord-266359-uf1ao1x1 48 17 ( ( -LRB- cord-266359-uf1ao1x1 48 18 9.7 9.7 CD cord-266359-uf1ao1x1 48 19 % % NN cord-266359-uf1ao1x1 48 20 ) ) -RRB- cord-266359-uf1ao1x1 48 21 of of IN cord-266359-uf1ao1x1 48 22 episodes episode NNS cord-266359-uf1ao1x1 48 23 among among IN cord-266359-uf1ao1x1 48 24 hematologic hematologic JJ cord-266359-uf1ao1x1 48 25 malignancy malignancy NN cord-266359-uf1ao1x1 48 26 and and CC cord-266359-uf1ao1x1 48 27 HSCT HSCT NNP cord-266359-uf1ao1x1 48 28 patients patient NNS cord-266359-uf1ao1x1 48 29 . . . cord-266359-uf1ao1x1 49 1 19 19 CD cord-266359-uf1ao1x1 49 2 ( ( -LRB- cord-266359-uf1ao1x1 49 3 57.5 57.5 CD cord-266359-uf1ao1x1 49 4 % % NN cord-266359-uf1ao1x1 49 5 ) ) -RRB- cord-266359-uf1ao1x1 49 6 of of IN cord-266359-uf1ao1x1 49 7 the the DT cord-266359-uf1ao1x1 49 8 33 33 CD cord-266359-uf1ao1x1 49 9 episodes episode NNS cord-266359-uf1ao1x1 49 10 of of IN cord-266359-uf1ao1x1 49 11 CoV cov NN cord-266359-uf1ao1x1 49 12 infection infection NN cord-266359-uf1ao1x1 49 13 in in IN cord-266359-uf1ao1x1 49 14 the the DT cord-266359-uf1ao1x1 49 15 HSCT HSCT NNP cord-266359-uf1ao1x1 49 16 and and CC cord-266359-uf1ao1x1 49 17 hematologic hematologic JJ cord-266359-uf1ao1x1 49 18 malignancy malignancy NN cord-266359-uf1ao1x1 49 19 population population NN cord-266359-uf1ao1x1 49 20 were be VBD cord-266359-uf1ao1x1 49 21 diagnosed diagnose VBN cord-266359-uf1ao1x1 49 22 during during IN cord-266359-uf1ao1x1 49 23 the the DT cord-266359-uf1ao1x1 49 24 winter winter NN cord-266359-uf1ao1x1 49 25 months month NNS cord-266359-uf1ao1x1 49 26 of of IN cord-266359-uf1ao1x1 49 27 December December NNP cord-266359-uf1ao1x1 49 28 - - HYPH cord-266359-uf1ao1x1 49 29 March March NNP cord-266359-uf1ao1x1 49 30 ( ( -LRB- cord-266359-uf1ao1x1 49 31 Fig Fig NNP cord-266359-uf1ao1x1 49 32 . . . cord-266359-uf1ao1x1 49 33 1 1 CD cord-266359-uf1ao1x1 49 34 ) ) -RRB- cord-266359-uf1ao1x1 49 35 . . . cord-266359-uf1ao1x1 50 1 38 38 CD cord-266359-uf1ao1x1 50 2 samples sample NNS cord-266359-uf1ao1x1 50 3 from from IN cord-266359-uf1ao1x1 50 4 the the DT cord-266359-uf1ao1x1 50 5 33 33 CD cord-266359-uf1ao1x1 50 6 hematologic hematologic JJ cord-266359-uf1ao1x1 50 7 malignancy malignancy NN cord-266359-uf1ao1x1 50 8 and and CC cord-266359-uf1ao1x1 50 9 HSCT HSCT NNP cord-266359-uf1ao1x1 50 10 patients patient NNS cord-266359-uf1ao1x1 50 11 tested test VBD cord-266359-uf1ao1x1 50 12 positive positive JJ cord-266359-uf1ao1x1 50 13 for for IN cord-266359-uf1ao1x1 50 14 CoV cov NN cord-266359-uf1ao1x1 50 15 , , , cord-266359-uf1ao1x1 50 16 with with IN cord-266359-uf1ao1x1 50 17 the the DT cord-266359-uf1ao1x1 50 18 majority majority NN cord-266359-uf1ao1x1 50 19 ( ( -LRB- cord-266359-uf1ao1x1 50 20 76.3 76.3 CD cord-266359-uf1ao1x1 50 21 % % NN cord-266359-uf1ao1x1 50 22 ) ) -RRB- cord-266359-uf1ao1x1 50 23 being be VBG cord-266359-uf1ao1x1 50 24 Group group NN cord-266359-uf1ao1x1 51 1 I -PRON- PRP cord-266359-uf1ao1x1 51 2 subtypes subtype NNS cord-266359-uf1ao1x1 51 3 ( ( -LRB- cord-266359-uf1ao1x1 51 4 NL63 NL63 NNP cord-266359-uf1ao1x1 51 5 ( ( -LRB- cord-266359-uf1ao1x1 51 6 n n NN cord-266359-uf1ao1x1 51 7 = = SYM cord-266359-uf1ao1x1 51 8 15 15 CD cord-266359-uf1ao1x1 51 9 ) ) -RRB- cord-266359-uf1ao1x1 51 10 and and CC cord-266359-uf1ao1x1 51 11 229E 229e CD cord-266359-uf1ao1x1 51 12 ( ( -LRB- cord-266359-uf1ao1x1 51 13 n n NN cord-266359-uf1ao1x1 51 14 = = SYM cord-266359-uf1ao1x1 51 15 14 14 CD cord-266359-uf1ao1x1 51 16 ) ) -RRB- cord-266359-uf1ao1x1 51 17 ) ) -RRB- cord-266359-uf1ao1x1 51 18 , , , cord-266359-uf1ao1x1 51 19 as as IN cord-266359-uf1ao1x1 51 20 compared compare VBN cord-266359-uf1ao1x1 51 21 to to IN cord-266359-uf1ao1x1 51 22 Group Group NNP cord-266359-uf1ao1x1 51 23 II II NNP cord-266359-uf1ao1x1 51 24 subtypes subtype NNS cord-266359-uf1ao1x1 51 25 ( ( -LRB- cord-266359-uf1ao1x1 51 26 OC43 OC43 NNP cord-266359-uf1ao1x1 51 27 ( ( -LRB- cord-266359-uf1ao1x1 51 28 n n NN cord-266359-uf1ao1x1 51 29 = = SYM cord-266359-uf1ao1x1 51 30 5 5 CD cord-266359-uf1ao1x1 51 31 ) ) -RRB- cord-266359-uf1ao1x1 51 32 and and CC cord-266359-uf1ao1x1 51 33 HKU1 HKU1 NNP cord-266359-uf1ao1x1 51 34 ( ( -LRB- cord-266359-uf1ao1x1 51 35 n n NN cord-266359-uf1ao1x1 51 36 = = SYM cord-266359-uf1ao1x1 51 37 4 4 CD cord-266359-uf1ao1x1 51 38 ) ) -RRB- cord-266359-uf1ao1x1 51 39 ) ) -RRB- cord-266359-uf1ao1x1 51 40 . . . cord-266359-uf1ao1x1 52 1 30 30 CD cord-266359-uf1ao1x1 52 2 of of IN cord-266359-uf1ao1x1 52 3 the the DT cord-266359-uf1ao1x1 52 4 38 38 CD cord-266359-uf1ao1x1 52 5 ( ( -LRB- cord-266359-uf1ao1x1 52 6 78.9 78.9 CD cord-266359-uf1ao1x1 52 7 % % NN cord-266359-uf1ao1x1 53 1 ) ) -RRB- cord-266359-uf1ao1x1 53 2 CoV cov NN cord-266359-uf1ao1x1 53 3 positive positive JJ cord-266359-uf1ao1x1 53 4 samples sample NNS cord-266359-uf1ao1x1 53 5 were be VBD cord-266359-uf1ao1x1 53 6 positive positive JJ cord-266359-uf1ao1x1 53 7 only only RB cord-266359-uf1ao1x1 53 8 for for IN cord-266359-uf1ao1x1 53 9 CoV CoV NNP cord-266359-uf1ao1x1 53 10 , , , cord-266359-uf1ao1x1 53 11 and and CC cord-266359-uf1ao1x1 53 12 the the DT cord-266359-uf1ao1x1 53 13 other other JJ cord-266359-uf1ao1x1 53 14 8 8 CD cord-266359-uf1ao1x1 53 15 samples sample NNS cord-266359-uf1ao1x1 53 16 were be VBD cord-266359-uf1ao1x1 53 17 co co JJ cord-266359-uf1ao1x1 53 18 - - JJ cord-266359-uf1ao1x1 53 19 infected infect VBN cord-266359-uf1ao1x1 53 20 with with IN cord-266359-uf1ao1x1 53 21 RhV rhv JJ cord-266359-uf1ao1x1 53 22 [ [ -LRB- cord-266359-uf1ao1x1 53 23 4 4 CD cord-266359-uf1ao1x1 53 24 ] ] -RRB- cord-266359-uf1ao1x1 53 25 , , . cord-266359-uf1ao1x1 54 1 RSV RSV NNP cord-266359-uf1ao1x1 54 2 A A NNP cord-266359-uf1ao1x1 54 3 [ [ -LRB- cord-266359-uf1ao1x1 54 4 2 2 CD cord-266359-uf1ao1x1 54 5 ] ] -RRB- cord-266359-uf1ao1x1 54 6 , , , cord-266359-uf1ao1x1 54 7 hMPV hmpv ADD cord-266359-uf1ao1x1 54 8 [ [ -LRB- cord-266359-uf1ao1x1 54 9 1 1 CD cord-266359-uf1ao1x1 54 10 ] ] -RRB- cord-266359-uf1ao1x1 54 11 , , , cord-266359-uf1ao1x1 54 12 and and CC cord-266359-uf1ao1x1 54 13 both both CC cord-266359-uf1ao1x1 54 14 RSV RSV NNP cord-266359-uf1ao1x1 54 15 A A NNP cord-266359-uf1ao1x1 54 16 and and CC cord-266359-uf1ao1x1 54 17 AdV adv NN cord-266359-uf1ao1x1 54 18 [ [ -LRB- cord-266359-uf1ao1x1 54 19 1 1 CD cord-266359-uf1ao1x1 54 20 ] ] -RRB- cord-266359-uf1ao1x1 54 21 . . . cord-266359-uf1ao1x1 55 1 In in IN cord-266359-uf1ao1x1 55 2 order order NN cord-266359-uf1ao1x1 55 3 to to TO cord-266359-uf1ao1x1 55 4 better better RB cord-266359-uf1ao1x1 55 5 define define VB cord-266359-uf1ao1x1 55 6 the the DT cord-266359-uf1ao1x1 55 7 role role NN cord-266359-uf1ao1x1 55 8 of of IN cord-266359-uf1ao1x1 55 9 CoV cov NN cord-266359-uf1ao1x1 55 10 in in IN cord-266359-uf1ao1x1 55 11 respiratory respiratory JJ cord-266359-uf1ao1x1 55 12 tract tract NN cord-266359-uf1ao1x1 55 13 syndromes syndrome NNS cord-266359-uf1ao1x1 55 14 among among IN cord-266359-uf1ao1x1 55 15 patients patient NNS cord-266359-uf1ao1x1 55 16 with with IN cord-266359-uf1ao1x1 55 17 hematologic hematologic JJ cord-266359-uf1ao1x1 55 18 malignancies malignancy NNS cord-266359-uf1ao1x1 55 19 and and CC cord-266359-uf1ao1x1 55 20 HSCT HSCT NNP cord-266359-uf1ao1x1 55 21 recipients recipient NNS cord-266359-uf1ao1x1 55 22 , , , cord-266359-uf1ao1x1 55 23 we -PRON- PRP cord-266359-uf1ao1x1 55 24 limited limit VBD cord-266359-uf1ao1x1 55 25 our -PRON- PRP$ cord-266359-uf1ao1x1 55 26 clinical clinical JJ cord-266359-uf1ao1x1 55 27 analysis analysis NN cord-266359-uf1ao1x1 55 28 to to IN cord-266359-uf1ao1x1 55 29 patients patient NNS cord-266359-uf1ao1x1 55 30 infected infect VBN cord-266359-uf1ao1x1 55 31 only only RB cord-266359-uf1ao1x1 55 32 with with IN cord-266359-uf1ao1x1 55 33 CoV cov NN cord-266359-uf1ao1x1 55 34 , , , cord-266359-uf1ao1x1 55 35 excluding exclude VBG cord-266359-uf1ao1x1 55 36 those those DT cord-266359-uf1ao1x1 55 37 co co NNS cord-266359-uf1ao1x1 55 38 - - VBN cord-266359-uf1ao1x1 55 39 infected infect VBN cord-266359-uf1ao1x1 55 40 with with IN cord-266359-uf1ao1x1 55 41 other other JJ cord-266359-uf1ao1x1 55 42 respiratory respiratory JJ cord-266359-uf1ao1x1 55 43 viruses virus NNS cord-266359-uf1ao1x1 55 44 ( ( -LRB- cord-266359-uf1ao1x1 55 45 Table table NN cord-266359-uf1ao1x1 55 46 2 2 CD cord-266359-uf1ao1x1 55 47 ) ) -RRB- cord-266359-uf1ao1x1 55 48 . . . cord-266359-uf1ao1x1 56 1 29 29 CD cord-266359-uf1ao1x1 56 2 patients patient NNS cord-266359-uf1ao1x1 56 3 were be VBD cord-266359-uf1ao1x1 56 4 infected infect VBN cord-266359-uf1ao1x1 56 5 only only RB cord-266359-uf1ao1x1 56 6 with with IN cord-266359-uf1ao1x1 56 7 CoV cov NN cord-266359-uf1ao1x1 56 8 , , , cord-266359-uf1ao1x1 56 9 and and CC cord-266359-uf1ao1x1 56 10 of of IN cord-266359-uf1ao1x1 56 11 those those DT cord-266359-uf1ao1x1 56 12 28 28 CD cord-266359-uf1ao1x1 56 13 ( ( -LRB- cord-266359-uf1ao1x1 56 14 96.5 96.5 CD cord-266359-uf1ao1x1 56 15 % % NN cord-266359-uf1ao1x1 56 16 ) ) -RRB- cord-266359-uf1ao1x1 56 17 had have VBD cord-266359-uf1ao1x1 56 18 an an DT cord-266359-uf1ao1x1 56 19 underlying underlying JJ cord-266359-uf1ao1x1 56 20 hematologic hematologic JJ cord-266359-uf1ao1x1 56 21 malignancy malignancy NN cord-266359-uf1ao1x1 56 22 ( ( -LRB- cord-266359-uf1ao1x1 56 23 n n NN cord-266359-uf1ao1x1 56 24 = = SYM cord-266359-uf1ao1x1 56 25 8) 8) NN cord-266359-uf1ao1x1 56 26 or or CC cord-266359-uf1ao1x1 56 27 had have VBD cord-266359-uf1ao1x1 56 28 undergone undergo VBN cord-266359-uf1ao1x1 56 29 allogeneic allogeneic NN cord-266359-uf1ao1x1 56 30 ( ( -LRB- cord-266359-uf1ao1x1 56 31 n n NN cord-266359-uf1ao1x1 56 32 = = SYM cord-266359-uf1ao1x1 56 33 15 15 CD cord-266359-uf1ao1x1 56 34 ) ) -RRB- cord-266359-uf1ao1x1 56 35 or or CC cord-266359-uf1ao1x1 56 36 autologous autologous JJ cord-266359-uf1ao1x1 56 37 ( ( -LRB- cord-266359-uf1ao1x1 56 38 n n NN cord-266359-uf1ao1x1 56 39 = = SYM cord-266359-uf1ao1x1 56 40 5 5 CD cord-266359-uf1ao1x1 56 41 ) ) -RRB- cord-266359-uf1ao1x1 56 42 HSCT HSCT NNP cord-266359-uf1ao1x1 56 43 . . . cord-266359-uf1ao1x1 57 1 The the DT cord-266359-uf1ao1x1 57 2 clinical clinical JJ cord-266359-uf1ao1x1 57 3 characteristics characteristic NNS cord-266359-uf1ao1x1 57 4 of of IN cord-266359-uf1ao1x1 57 5 CoV cov NN cord-266359-uf1ao1x1 57 6 infection infection NN cord-266359-uf1ao1x1 57 7 in in IN cord-266359-uf1ao1x1 57 8 these these DT cord-266359-uf1ao1x1 57 9 28 28 CD cord-266359-uf1ao1x1 57 10 patients patient NNS cord-266359-uf1ao1x1 57 11 were be VBD cord-266359-uf1ao1x1 57 12 examined examine VBN cord-266359-uf1ao1x1 57 13 and and CC cord-266359-uf1ao1x1 57 14 compared compare VBN cord-266359-uf1ao1x1 57 15 to to IN cord-266359-uf1ao1x1 57 16 episodes episode NNS cord-266359-uf1ao1x1 57 17 of of IN cord-266359-uf1ao1x1 57 18 mono mono NN cord-266359-uf1ao1x1 57 19 - - HYPH cord-266359-uf1ao1x1 57 20 infection infection NN cord-266359-uf1ao1x1 57 21 with with IN cord-266359-uf1ao1x1 57 22 other other JJ cord-266359-uf1ao1x1 57 23 respiratory respiratory JJ cord-266359-uf1ao1x1 57 24 viruses virus NNS cord-266359-uf1ao1x1 58 1 ( ( -LRB- cord-266359-uf1ao1x1 58 2 PIV1 PIV1 NNP cord-266359-uf1ao1x1 58 3 - - HYPH cord-266359-uf1ao1x1 58 4 4 4 CD cord-266359-uf1ao1x1 58 5 , , , cord-266359-uf1ao1x1 58 6 hMPV hmpv NN cord-266359-uf1ao1x1 58 7 , , , cord-266359-uf1ao1x1 58 8 RSV RSV NNP cord-266359-uf1ao1x1 58 9 , , , cord-266359-uf1ao1x1 58 10 and and CC cord-266359-uf1ao1x1 58 11 RhV rhv JJ cord-266359-uf1ao1x1 58 12 / / SYM cord-266359-uf1ao1x1 58 13 EnV env NN cord-266359-uf1ao1x1 58 14 ) ) -RRB- cord-266359-uf1ao1x1 58 15 in in IN cord-266359-uf1ao1x1 58 16 the the DT cord-266359-uf1ao1x1 58 17 same same JJ cord-266359-uf1ao1x1 58 18 patient patient JJ cord-266359-uf1ao1x1 58 19 population population NN cord-266359-uf1ao1x1 58 20 . . . cord-266359-uf1ao1x1 59 1 The the DT cord-266359-uf1ao1x1 59 2 median median JJ cord-266359-uf1ao1x1 59 3 age age NN cord-266359-uf1ao1x1 59 4 of of IN cord-266359-uf1ao1x1 59 5 those those DT cord-266359-uf1ao1x1 59 6 infected infect VBN cord-266359-uf1ao1x1 59 7 with with IN cord-266359-uf1ao1x1 59 8 CoV CoV NNP cord-266359-uf1ao1x1 59 9 was be VBD cord-266359-uf1ao1x1 59 10 similar similar JJ cord-266359-uf1ao1x1 59 11 to to IN cord-266359-uf1ao1x1 59 12 the the DT cord-266359-uf1ao1x1 59 13 other other JJ cord-266359-uf1ao1x1 59 14 respiratory respiratory JJ cord-266359-uf1ao1x1 59 15 viruses virus NNS cord-266359-uf1ao1x1 59 16 analyzed analyze VBN cord-266359-uf1ao1x1 59 17 . . . cord-266359-uf1ao1x1 60 1 Surprisingly surprisingly RB cord-266359-uf1ao1x1 60 2 , , , cord-266359-uf1ao1x1 60 3 CoV CoV NNP cord-266359-uf1ao1x1 60 4 was be VBD cord-266359-uf1ao1x1 60 5 identified identify VBN cord-266359-uf1ao1x1 60 6 significantly significantly RB cord-266359-uf1ao1x1 60 7 more more RBR cord-266359-uf1ao1x1 60 8 often often RB cord-266359-uf1ao1x1 60 9 in in IN cord-266359-uf1ao1x1 60 10 females female NNS cord-266359-uf1ao1x1 60 11 ( ( -LRB- cord-266359-uf1ao1x1 60 12 64 64 CD cord-266359-uf1ao1x1 60 13 % % NN cord-266359-uf1ao1x1 60 14 ) ) -RRB- cord-266359-uf1ao1x1 60 15 than than IN cord-266359-uf1ao1x1 60 16 males male NNS cord-266359-uf1ao1x1 60 17 compared compare VBN cord-266359-uf1ao1x1 60 18 to to IN cord-266359-uf1ao1x1 60 19 hMPV hmpv NN cord-266359-uf1ao1x1 60 20 , , , cord-266359-uf1ao1x1 60 21 PIV1 PIV1 NNP cord-266359-uf1ao1x1 60 22 - - HYPH cord-266359-uf1ao1x1 60 23 4 4 CD cord-266359-uf1ao1x1 60 24 , , , cord-266359-uf1ao1x1 60 25 and and CC cord-266359-uf1ao1x1 60 26 RhV rhv JJ cord-266359-uf1ao1x1 60 27 / / SYM cord-266359-uf1ao1x1 60 28 EnV env NN cord-266359-uf1ao1x1 60 29 , , , cord-266359-uf1ao1x1 60 30 with with IN cord-266359-uf1ao1x1 60 31 a a DT cord-266359-uf1ao1x1 60 32 trend trend NN cord-266359-uf1ao1x1 60 33 toward toward IN cord-266359-uf1ao1x1 60 34 the the DT cord-266359-uf1ao1x1 60 35 same same JJ cord-266359-uf1ao1x1 60 36 finding finding NN cord-266359-uf1ao1x1 60 37 for for IN cord-266359-uf1ao1x1 60 38 RSV RSV NNP cord-266359-uf1ao1x1 60 39 . . . cord-266359-uf1ao1x1 61 1 Five five CD cord-266359-uf1ao1x1 61 2 episodes episode NNS cord-266359-uf1ao1x1 61 3 of of IN cord-266359-uf1ao1x1 61 4 CoV cov NN cord-266359-uf1ao1x1 61 5 infection infection NN cord-266359-uf1ao1x1 61 6 ( ( -LRB- cord-266359-uf1ao1x1 61 7 17.8 17.8 CD cord-266359-uf1ao1x1 61 8 % % NN cord-266359-uf1ao1x1 61 9 ) ) -RRB- cord-266359-uf1ao1x1 61 10 were be VBD cord-266359-uf1ao1x1 61 11 hospital hospital NN cord-266359-uf1ao1x1 61 12 - - HYPH cord-266359-uf1ao1x1 61 13 acquired acquire VBN cord-266359-uf1ao1x1 61 14 . . . cord-266359-uf1ao1x1 62 1 Four four CD cord-266359-uf1ao1x1 62 2 of of IN cord-266359-uf1ao1x1 62 3 these these DT cord-266359-uf1ao1x1 62 4 cases case NNS cord-266359-uf1ao1x1 62 5 , , , cord-266359-uf1ao1x1 62 6 all all DT cord-266359-uf1ao1x1 62 7 subtype subtype NN cord-266359-uf1ao1x1 63 1 NL63 NL63 NNP cord-266359-uf1ao1x1 63 2 , , , cord-266359-uf1ao1x1 63 3 occurred occur VBD cord-266359-uf1ao1x1 63 4 on on IN cord-266359-uf1ao1x1 63 5 the the DT cord-266359-uf1ao1x1 63 6 same same JJ cord-266359-uf1ao1x1 63 7 inpatient inpatient JJ cord-266359-uf1ao1x1 63 8 HSCT HSCT NNP cord-266359-uf1ao1x1 63 9 / / SYM cord-266359-uf1ao1x1 63 10 oncology oncology NNP cord-266359-uf1ao1x1 63 11 ward ward NN cord-266359-uf1ao1x1 63 12 within within IN cord-266359-uf1ao1x1 63 13 a a DT cord-266359-uf1ao1x1 63 14 60 60 CD cord-266359-uf1ao1x1 63 15 day day NN cord-266359-uf1ao1x1 63 16 period period NN cord-266359-uf1ao1x1 63 17 between between IN cord-266359-uf1ao1x1 63 18 January January NNP cord-266359-uf1ao1x1 63 19 27 27 CD cord-266359-uf1ao1x1 63 20 and and CC cord-266359-uf1ao1x1 63 21 March March NNP cord-266359-uf1ao1x1 63 22 24 24 CD cord-266359-uf1ao1x1 63 23 , , , cord-266359-uf1ao1x1 63 24 2012 2012 CD cord-266359-uf1ao1x1 63 25 . . . cord-266359-uf1ao1x1 64 1 While while IN cord-266359-uf1ao1x1 64 2 indicative indicative JJ cord-266359-uf1ao1x1 64 3 of of IN cord-266359-uf1ao1x1 64 4 an an DT cord-266359-uf1ao1x1 64 5 epidemiological epidemiological JJ cord-266359-uf1ao1x1 64 6 link link NN cord-266359-uf1ao1x1 64 7 , , , cord-266359-uf1ao1x1 64 8 we -PRON- PRP cord-266359-uf1ao1x1 64 9 were be VBD cord-266359-uf1ao1x1 64 10 unable unable JJ cord-266359-uf1ao1x1 64 11 to to TO cord-266359-uf1ao1x1 64 12 conclusively conclusively RB cord-266359-uf1ao1x1 64 13 prove prove VB cord-266359-uf1ao1x1 64 14 this this DT cord-266359-uf1ao1x1 64 15 . . . cord-266359-uf1ao1x1 65 1 According accord VBG cord-266359-uf1ao1x1 65 2 to to IN cord-266359-uf1ao1x1 65 3 surveillance surveillance NN cord-266359-uf1ao1x1 65 4 performed perform VBN cord-266359-uf1ao1x1 65 5 as as IN cord-266359-uf1ao1x1 65 6 part part NN cord-266359-uf1ao1x1 65 7 of of IN cord-266359-uf1ao1x1 65 8 OHSU OHSU NNP cord-266359-uf1ao1x1 65 9 's 's POS cord-266359-uf1ao1x1 65 10 Infection Infection NNP cord-266359-uf1ao1x1 65 11 Control Control NNP cord-266359-uf1ao1x1 65 12 program program NN cord-266359-uf1ao1x1 65 13 , , , cord-266359-uf1ao1x1 65 14 during during IN cord-266359-uf1ao1x1 65 15 this this DT cord-266359-uf1ao1x1 65 16 time time NN cord-266359-uf1ao1x1 65 17 period period NN cord-266359-uf1ao1x1 65 18 , , , cord-266359-uf1ao1x1 65 19 only only RB cord-266359-uf1ao1x1 65 20 two two CD cord-266359-uf1ao1x1 65 21 other other JJ cord-266359-uf1ao1x1 65 22 cases case NNS cord-266359-uf1ao1x1 65 23 of of IN cord-266359-uf1ao1x1 65 24 nosocomial nosocomial JJ cord-266359-uf1ao1x1 65 25 acquisition acquisition NN cord-266359-uf1ao1x1 65 26 of of IN cord-266359-uf1ao1x1 65 27 a a DT cord-266359-uf1ao1x1 65 28 respiratory respiratory JJ cord-266359-uf1ao1x1 65 29 virus virus NN cord-266359-uf1ao1x1 65 30 occurred occur VBD cord-266359-uf1ao1x1 65 31 on on IN cord-266359-uf1ao1x1 65 32 this this DT cord-266359-uf1ao1x1 65 33 ward ward NN cord-266359-uf1ao1x1 65 34 -one -one CD cord-266359-uf1ao1x1 65 35 RhV RhV NNP cord-266359-uf1ao1x1 65 36 / / SYM cord-266359-uf1ao1x1 65 37 EnV env NN cord-266359-uf1ao1x1 65 38 and and CC cord-266359-uf1ao1x1 65 39 one one CD cord-266359-uf1ao1x1 65 40 influenza influenza NN cord-266359-uf1ao1x1 65 41 A a DT cord-266359-uf1ao1x1 65 42 ( ( -LRB- cord-266359-uf1ao1x1 65 43 personal personal JJ cord-266359-uf1ao1x1 65 44 communication communication NN cord-266359-uf1ao1x1 65 45 , , , cord-266359-uf1ao1x1 65 46 Dr. Dr. NNP cord-266359-uf1ao1x1 65 47 Lynne Lynne NNP cord-266359-uf1ao1x1 65 48 Strasfeld Strasfeld NNP cord-266359-uf1ao1x1 65 49 ) ) -RRB- cord-266359-uf1ao1x1 65 50 . . . cord-266359-uf1ao1x1 66 1 Of of IN cord-266359-uf1ao1x1 66 2 cases case NNS cord-266359-uf1ao1x1 66 3 acquired acquire VBN cord-266359-uf1ao1x1 66 4 as as IN cord-266359-uf1ao1x1 66 5 an an DT cord-266359-uf1ao1x1 66 6 outpatient outpatient NN cord-266359-uf1ao1x1 66 7 , , , cord-266359-uf1ao1x1 66 8 7 7 CD cord-266359-uf1ao1x1 66 9 ( ( -LRB- cord-266359-uf1ao1x1 66 10 30.4 30.4 CD cord-266359-uf1ao1x1 66 11 % % NN cord-266359-uf1ao1x1 66 12 ) ) -RRB- cord-266359-uf1ao1x1 66 13 required require VBN cord-266359-uf1ao1x1 66 14 admission admission NN cord-266359-uf1ao1x1 66 15 to to IN cord-266359-uf1ao1x1 66 16 the the DT cord-266359-uf1ao1x1 66 17 hospital hospital NN cord-266359-uf1ao1x1 66 18 , , , cord-266359-uf1ao1x1 66 19 typically typically RB cord-266359-uf1ao1x1 66 20 for for IN cord-266359-uf1ao1x1 66 21 evaluation evaluation NN cord-266359-uf1ao1x1 66 22 of of IN cord-266359-uf1ao1x1 66 23 fevers fever NNS cord-266359-uf1ao1x1 66 24 or or CC cord-266359-uf1ao1x1 66 25 new new JJ cord-266359-uf1ao1x1 66 26 pulmonary pulmonary NN cord-266359-uf1ao1x1 66 27 infiltrates infiltrate VBZ cord-266359-uf1ao1x1 66 28 . . . cord-266359-uf1ao1x1 67 1 The the DT cord-266359-uf1ao1x1 67 2 requirement requirement NN cord-266359-uf1ao1x1 67 3 for for IN cord-266359-uf1ao1x1 67 4 hospitalization hospitalization NN cord-266359-uf1ao1x1 67 5 during during IN cord-266359-uf1ao1x1 67 6 CoV cov NN cord-266359-uf1ao1x1 67 7 infection infection NN cord-266359-uf1ao1x1 67 8 was be VBD cord-266359-uf1ao1x1 67 9 not not RB cord-266359-uf1ao1x1 67 10 significantly significantly RB cord-266359-uf1ao1x1 67 11 different different JJ cord-266359-uf1ao1x1 67 12 from from IN cord-266359-uf1ao1x1 67 13 those those DT cord-266359-uf1ao1x1 67 14 during during IN cord-266359-uf1ao1x1 67 15 infection infection NN cord-266359-uf1ao1x1 67 16 with with IN cord-266359-uf1ao1x1 67 17 other other JJ cord-266359-uf1ao1x1 67 18 respiratory respiratory JJ cord-266359-uf1ao1x1 67 19 viruses virus NNS cord-266359-uf1ao1x1 67 20 . . . cord-266359-uf1ao1x1 68 1 Similar similar JJ cord-266359-uf1ao1x1 68 2 to to IN cord-266359-uf1ao1x1 68 3 most most JJS cord-266359-uf1ao1x1 68 4 other other JJ cord-266359-uf1ao1x1 68 5 respiratory respiratory JJ cord-266359-uf1ao1x1 68 6 viruses virus NNS cord-266359-uf1ao1x1 68 7 , , , cord-266359-uf1ao1x1 68 8 the the DT cord-266359-uf1ao1x1 68 9 majority majority NN cord-266359-uf1ao1x1 68 10 of of IN cord-266359-uf1ao1x1 68 11 patients patient NNS cord-266359-uf1ao1x1 68 12 ( ( -LRB- cord-266359-uf1ao1x1 68 13 85.7 85.7 CD cord-266359-uf1ao1x1 68 14 % % NN cord-266359-uf1ao1x1 68 15 ) ) -RRB- cord-266359-uf1ao1x1 68 16 in in IN cord-266359-uf1ao1x1 68 17 whom whom WP cord-266359-uf1ao1x1 68 18 CoV CoV NNP cord-266359-uf1ao1x1 68 19 was be VBD cord-266359-uf1ao1x1 68 20 detected detect VBN cord-266359-uf1ao1x1 68 21 had have VBD cord-266359-uf1ao1x1 68 22 URI URI NNP cord-266359-uf1ao1x1 68 23 symptoms symptom NNS cord-266359-uf1ao1x1 68 24 ( ( -LRB- cord-266359-uf1ao1x1 68 25 rhinorrhea rhinorrhea NN cord-266359-uf1ao1x1 68 26 , , , cord-266359-uf1ao1x1 68 27 congestion congestion NN cord-266359-uf1ao1x1 68 28 , , , cord-266359-uf1ao1x1 68 29 or or CC cord-266359-uf1ao1x1 68 30 sore sore JJ cord-266359-uf1ao1x1 68 31 throat throat NN cord-266359-uf1ao1x1 68 32 ) ) -RRB- cord-266359-uf1ao1x1 68 33 . . . cord-266359-uf1ao1x1 69 1 However however RB cord-266359-uf1ao1x1 69 2 , , , cord-266359-uf1ao1x1 69 3 evidence evidence NN cord-266359-uf1ao1x1 69 4 of of IN cord-266359-uf1ao1x1 69 5 LRTD LRTD NNP cord-266359-uf1ao1x1 69 6 such such JJ cord-266359-uf1ao1x1 69 7 as as IN cord-266359-uf1ao1x1 69 8 cough cough NN cord-266359-uf1ao1x1 69 9 and and CC cord-266359-uf1ao1x1 69 10 new new JJ cord-266359-uf1ao1x1 69 11 radiographic radiographic JJ cord-266359-uf1ao1x1 69 12 abnormalities abnormality NNS cord-266359-uf1ao1x1 69 13 was be VBD cord-266359-uf1ao1x1 69 14 observed observe VBN cord-266359-uf1ao1x1 69 15 less less RBR cord-266359-uf1ao1x1 69 16 frequently frequently RB cord-266359-uf1ao1x1 69 17 during during IN cord-266359-uf1ao1x1 69 18 CoV cov NN cord-266359-uf1ao1x1 69 19 infection infection NN cord-266359-uf1ao1x1 69 20 , , , cord-266359-uf1ao1x1 69 21 with with IN cord-266359-uf1ao1x1 69 22 a a DT cord-266359-uf1ao1x1 69 23 trend trend NN cord-266359-uf1ao1x1 69 24 toward toward IN cord-266359-uf1ao1x1 69 25 less less JJR cord-266359-uf1ao1x1 69 26 hypoxemia hypoxemia NN cord-266359-uf1ao1x1 69 27 as as RB cord-266359-uf1ao1x1 69 28 well well RB cord-266359-uf1ao1x1 69 29 . . . cord-266359-uf1ao1x1 70 1 Three three CD cord-266359-uf1ao1x1 70 2 patients patient NNS cord-266359-uf1ao1x1 70 3 ( ( -LRB- cord-266359-uf1ao1x1 70 4 10.7 10.7 CD cord-266359-uf1ao1x1 70 5 % % NN cord-266359-uf1ao1x1 70 6 ) ) -RRB- cord-266359-uf1ao1x1 70 7 , , , cord-266359-uf1ao1x1 70 8 all all DT cord-266359-uf1ao1x1 70 9 allogeneic allogeneic JJ cord-266359-uf1ao1x1 70 10 HSCT HSCT NNP cord-266359-uf1ao1x1 70 11 recipients recipient NNS cord-266359-uf1ao1x1 70 12 , , , cord-266359-uf1ao1x1 70 13 met meet VBD cord-266359-uf1ao1x1 70 14 criteria criterion NNS cord-266359-uf1ao1x1 70 15 for for IN cord-266359-uf1ao1x1 70 16 possible possible JJ cord-266359-uf1ao1x1 70 17 CoV cov NN cord-266359-uf1ao1x1 70 18 LRTD LRTD NNP cord-266359-uf1ao1x1 71 1 ( ( -LRB- cord-266359-uf1ao1x1 71 2 Tables table NNS cord-266359-uf1ao1x1 71 3 2 2 CD cord-266359-uf1ao1x1 71 4 and and CC cord-266359-uf1ao1x1 71 5 3 3 CD cord-266359-uf1ao1x1 71 6 ) ) -RRB- cord-266359-uf1ao1x1 71 7 based base VBN cord-266359-uf1ao1x1 71 8 on on IN cord-266359-uf1ao1x1 71 9 the the DT cord-266359-uf1ao1x1 71 10 identification identification NN cord-266359-uf1ao1x1 71 11 of of IN cord-266359-uf1ao1x1 71 12 CoV cov NN cord-266359-uf1ao1x1 71 13 from from IN cord-266359-uf1ao1x1 71 14 an an DT cord-266359-uf1ao1x1 71 15 NP NP NNP cord-266359-uf1ao1x1 71 16 specimen specimen NN cord-266359-uf1ao1x1 71 17 and and CC cord-266359-uf1ao1x1 71 18 new new JJ cord-266359-uf1ao1x1 71 19 radiographic radiographic JJ cord-266359-uf1ao1x1 71 20 abnormalities abnormality NNS cord-266359-uf1ao1x1 71 21 [ [ -LRB- cord-266359-uf1ao1x1 71 22 24 24 CD cord-266359-uf1ao1x1 71 23 ] ] -RRB- cord-266359-uf1ao1x1 71 24 , , , cord-266359-uf1ao1x1 71 25 significantly significantly RB cord-266359-uf1ao1x1 71 26 less less JJR cord-266359-uf1ao1x1 71 27 than than IN cord-266359-uf1ao1x1 71 28 during during IN cord-266359-uf1ao1x1 71 29 infection infection NN cord-266359-uf1ao1x1 71 30 with with IN cord-266359-uf1ao1x1 71 31 the the DT cord-266359-uf1ao1x1 71 32 other other JJ cord-266359-uf1ao1x1 71 33 respiratory respiratory JJ cord-266359-uf1ao1x1 71 34 viruses virus NNS cord-266359-uf1ao1x1 71 35 except except IN cord-266359-uf1ao1x1 71 36 RhV RhV VBN cord-266359-uf1ao1x1 72 1 / / NFP cord-266359-uf1ao1x1 73 1 EnV. EnV. NNP cord-266359-uf1ao1x1 74 1 None none NN cord-266359-uf1ao1x1 74 2 of of IN cord-266359-uf1ao1x1 74 3 these these DT cord-266359-uf1ao1x1 74 4 patients patient NNS cord-266359-uf1ao1x1 74 5 underwent undergo VBD cord-266359-uf1ao1x1 74 6 bronchoscopy bronchoscopy RB cord-266359-uf1ao1x1 74 7 . . . cord-266359-uf1ao1x1 75 1 Two two CD cord-266359-uf1ao1x1 75 2 patients patient NNS cord-266359-uf1ao1x1 75 3 , , , cord-266359-uf1ao1x1 75 4 both both DT cord-266359-uf1ao1x1 75 5 allogeneic allogeneic VBD cord-266359-uf1ao1x1 75 6 HSCT HSCT NNP cord-266359-uf1ao1x1 75 7 recipients recipient NNS cord-266359-uf1ao1x1 75 8 , , , cord-266359-uf1ao1x1 75 9 met meet VBD cord-266359-uf1ao1x1 75 10 criteria criterion NNS cord-266359-uf1ao1x1 75 11 for for IN cord-266359-uf1ao1x1 75 12 proven prove VBN cord-266359-uf1ao1x1 75 13 LRTD LRTD NNP cord-266359-uf1ao1x1 75 14 based base VBN cord-266359-uf1ao1x1 75 15 on on IN cord-266359-uf1ao1x1 75 16 identification identification NN cord-266359-uf1ao1x1 75 17 of of IN cord-266359-uf1ao1x1 75 18 CoV cov NN cord-266359-uf1ao1x1 75 19 in in IN cord-266359-uf1ao1x1 75 20 a a DT cord-266359-uf1ao1x1 75 21 BAL bal NN cord-266359-uf1ao1x1 75 22 sample sample NN cord-266359-uf1ao1x1 75 23 along along IN cord-266359-uf1ao1x1 75 24 with with IN cord-266359-uf1ao1x1 75 25 new new JJ cord-266359-uf1ao1x1 75 26 radiographic radiographic JJ cord-266359-uf1ao1x1 75 27 abnormalities abnormality NNS cord-266359-uf1ao1x1 75 28 ( ( -LRB- cord-266359-uf1ao1x1 75 29 Tables table NNS cord-266359-uf1ao1x1 75 30 2 2 CD cord-266359-uf1ao1x1 75 31 and and CC cord-266359-uf1ao1x1 75 32 3 3 CD cord-266359-uf1ao1x1 75 33 ) ) -RRB- cord-266359-uf1ao1x1 75 34 [ [ -LRB- cord-266359-uf1ao1x1 75 35 24 24 CD cord-266359-uf1ao1x1 75 36 ] ] -RRB- cord-266359-uf1ao1x1 75 37 . . . cord-266359-uf1ao1x1 76 1 However however RB cord-266359-uf1ao1x1 76 2 , , , cord-266359-uf1ao1x1 76 3 one one CD cord-266359-uf1ao1x1 76 4 of of IN cord-266359-uf1ao1x1 76 5 these these DT cord-266359-uf1ao1x1 76 6 patients patient NNS cord-266359-uf1ao1x1 76 7 also also RB cord-266359-uf1ao1x1 76 8 had have VBD cord-266359-uf1ao1x1 76 9 RSV RSV NNP cord-266359-uf1ao1x1 76 10 , , , cord-266359-uf1ao1x1 76 11 AdV adv NN cord-266359-uf1ao1x1 76 12 , , , cord-266359-uf1ao1x1 76 13 and and CC cord-266359-uf1ao1x1 76 14 methicillin methicillin NN cord-266359-uf1ao1x1 76 15 - - HYPH cord-266359-uf1ao1x1 76 16 resistant resistant JJ cord-266359-uf1ao1x1 76 17 Staphylococcus Staphylococcus NNP cord-266359-uf1ao1x1 76 18 aureus aureus NN cord-266359-uf1ao1x1 76 19 identified identify VBN cord-266359-uf1ao1x1 76 20 in in IN cord-266359-uf1ao1x1 76 21 the the DT cord-266359-uf1ao1x1 76 22 BAL bal NN cord-266359-uf1ao1x1 76 23 specimen specimen NN cord-266359-uf1ao1x1 76 24 , , , cord-266359-uf1ao1x1 76 25 making make VBG cord-266359-uf1ao1x1 76 26 the the DT cord-266359-uf1ao1x1 76 27 contribution contribution NN cord-266359-uf1ao1x1 76 28 of of IN cord-266359-uf1ao1x1 76 29 CoV CoV NNP cord-266359-uf1ao1x1 76 30 to to IN cord-266359-uf1ao1x1 76 31 LRTD LRTD NNP cord-266359-uf1ao1x1 76 32 unclear unclear JJ cord-266359-uf1ao1x1 76 33 . . . cord-266359-uf1ao1x1 77 1 The the DT cord-266359-uf1ao1x1 77 2 combined combined JJ cord-266359-uf1ao1x1 77 3 incidence incidence NN cord-266359-uf1ao1x1 77 4 of of IN cord-266359-uf1ao1x1 77 5 possible possible JJ cord-266359-uf1ao1x1 77 6 and and CC cord-266359-uf1ao1x1 77 7 proven proven JJ cord-266359-uf1ao1x1 77 8 LRTD LRTD NNP cord-266359-uf1ao1x1 77 9 was be VBD cord-266359-uf1ao1x1 77 10 significantly significantly RB cord-266359-uf1ao1x1 77 11 lower low JJR cord-266359-uf1ao1x1 77 12 during during IN cord-266359-uf1ao1x1 77 13 CoV cov NN cord-266359-uf1ao1x1 77 14 infection infection NN cord-266359-uf1ao1x1 77 15 compared compare VBN cord-266359-uf1ao1x1 77 16 to to IN cord-266359-uf1ao1x1 77 17 all all DT cord-266359-uf1ao1x1 77 18 of of IN cord-266359-uf1ao1x1 77 19 the the DT cord-266359-uf1ao1x1 77 20 other other JJ cord-266359-uf1ao1x1 77 21 respiratory respiratory JJ cord-266359-uf1ao1x1 77 22 viruses virus NNS cord-266359-uf1ao1x1 77 23 analyzed analyze VBN cord-266359-uf1ao1x1 77 24 except except IN cord-266359-uf1ao1x1 77 25 RhV rhv NN cord-266359-uf1ao1x1 77 26 / / SYM cord-266359-uf1ao1x1 77 27 EnV. EnV. NNP cord-266359-uf1ao1x1 77 28 Four Four NNP cord-266359-uf1ao1x1 77 29 of of IN cord-266359-uf1ao1x1 77 30 the the DT cord-266359-uf1ao1x1 77 31 five five CD cord-266359-uf1ao1x1 77 32 cases case NNS cord-266359-uf1ao1x1 77 33 of of IN cord-266359-uf1ao1x1 77 34 possible possible JJ cord-266359-uf1ao1x1 77 35 or or CC cord-266359-uf1ao1x1 77 36 proven proven JJ cord-266359-uf1ao1x1 77 37 LRTD LRTD NNP cord-266359-uf1ao1x1 77 38 occurred occur VBD cord-266359-uf1ao1x1 77 39 after after IN cord-266359-uf1ao1x1 77 40 day day NN cord-266359-uf1ao1x1 77 41 +100 +100 NNS cord-266359-uf1ao1x1 77 42 following follow VBG cord-266359-uf1ao1x1 77 43 HSCT HSCT NNP cord-266359-uf1ao1x1 77 44 , , , cord-266359-uf1ao1x1 77 45 and and CC cord-266359-uf1ao1x1 77 46 all all DT cord-266359-uf1ao1x1 77 47 five five CD cord-266359-uf1ao1x1 77 48 were be VBD cord-266359-uf1ao1x1 77 49 associated associate VBN cord-266359-uf1ao1x1 77 50 with with IN cord-266359-uf1ao1x1 77 51 acute acute JJ cord-266359-uf1ao1x1 77 52 or or CC cord-266359-uf1ao1x1 77 53 chronic chronic JJ cord-266359-uf1ao1x1 77 54 graft graft NN cord-266359-uf1ao1x1 77 55 - - HYPH cord-266359-uf1ao1x1 77 56 versus versus IN cord-266359-uf1ao1x1 77 57 - - HYPH cord-266359-uf1ao1x1 77 58 host host NN cord-266359-uf1ao1x1 77 59 disease disease NN cord-266359-uf1ao1x1 77 60 ( ( -LRB- cord-266359-uf1ao1x1 77 61 GVHD GVHD NNP cord-266359-uf1ao1x1 77 62 ) ) -RRB- cord-266359-uf1ao1x1 77 63 . . . cord-266359-uf1ao1x1 78 1 A a DT cord-266359-uf1ao1x1 78 2 third third JJ cord-266359-uf1ao1x1 78 3 episode episode NN cord-266359-uf1ao1x1 78 4 of of IN cord-266359-uf1ao1x1 78 5 proven prove VBN cord-266359-uf1ao1x1 78 6 LRTD LRTD NNP cord-266359-uf1ao1x1 78 7 , , , cord-266359-uf1ao1x1 78 8 accounting account VBG cord-266359-uf1ao1x1 78 9 for for IN cord-266359-uf1ao1x1 78 10 the the DT cord-266359-uf1ao1x1 78 11 third third JJ cord-266359-uf1ao1x1 78 12 CoV cov NN cord-266359-uf1ao1x1 78 13 - - HYPH cord-266359-uf1ao1x1 78 14 positive positive JJ cord-266359-uf1ao1x1 78 15 BAL bal NN cord-266359-uf1ao1x1 78 16 ( ( -LRB- cord-266359-uf1ao1x1 78 17 Table table NN cord-266359-uf1ao1x1 78 18 1 1 CD cord-266359-uf1ao1x1 78 19 ) ) -RRB- cord-266359-uf1ao1x1 78 20 , , , cord-266359-uf1ao1x1 78 21 occurred occur VBD cord-266359-uf1ao1x1 78 22 in in IN cord-266359-uf1ao1x1 78 23 a a DT cord-266359-uf1ao1x1 78 24 patient patient NN cord-266359-uf1ao1x1 78 25 who who WP cord-266359-uf1ao1x1 78 26 had have VBD cord-266359-uf1ao1x1 78 27 not not RB cord-266359-uf1ao1x1 78 28 undergone undergo VBN cord-266359-uf1ao1x1 78 29 HSCT HSCT NNP cord-266359-uf1ao1x1 78 30 and and CC cord-266359-uf1ao1x1 78 31 did do VBD cord-266359-uf1ao1x1 78 32 not not RB cord-266359-uf1ao1x1 78 33 have have VB cord-266359-uf1ao1x1 78 34 an an DT cord-266359-uf1ao1x1 78 35 underlying underlying JJ cord-266359-uf1ao1x1 78 36 hematologic hematologic JJ cord-266359-uf1ao1x1 78 37 malignancy malignancy NN cord-266359-uf1ao1x1 78 38 ; ; : cord-266359-uf1ao1x1 78 39 characteristics characteristic NNS cord-266359-uf1ao1x1 78 40 of of IN cord-266359-uf1ao1x1 78 41 that that DT cord-266359-uf1ao1x1 78 42 case case NN cord-266359-uf1ao1x1 78 43 were be VBD cord-266359-uf1ao1x1 78 44 therefore therefore RB cord-266359-uf1ao1x1 78 45 not not RB cord-266359-uf1ao1x1 78 46 further further RB cord-266359-uf1ao1x1 78 47 analyzed analyze VBN cord-266359-uf1ao1x1 78 48 . . . cord-266359-uf1ao1x1 79 1 There there EX cord-266359-uf1ao1x1 79 2 were be VBD cord-266359-uf1ao1x1 79 3 no no DT cord-266359-uf1ao1x1 79 4 cases case NNS cord-266359-uf1ao1x1 79 5 in in IN cord-266359-uf1ao1x1 79 6 which which WDT cord-266359-uf1ao1x1 79 7 mortality mortality NN cord-266359-uf1ao1x1 79 8 was be VBD cord-266359-uf1ao1x1 79 9 directly directly RB cord-266359-uf1ao1x1 79 10 attributable attributable JJ cord-266359-uf1ao1x1 79 11 to to IN cord-266359-uf1ao1x1 79 12 CoV cov NN cord-266359-uf1ao1x1 79 13 infection infection NN cord-266359-uf1ao1x1 79 14 . . . cord-266359-uf1ao1x1 80 1 The the DT cord-266359-uf1ao1x1 80 2 results result NNS cord-266359-uf1ao1x1 80 3 presented present VBN cord-266359-uf1ao1x1 80 4 here here RB cord-266359-uf1ao1x1 80 5 complement complement VBP cord-266359-uf1ao1x1 80 6 and and CC cord-266359-uf1ao1x1 80 7 expand expand VB cord-266359-uf1ao1x1 80 8 upon upon IN cord-266359-uf1ao1x1 80 9 the the DT cord-266359-uf1ao1x1 80 10 few few JJ cord-266359-uf1ao1x1 80 11 existing exist VBG cord-266359-uf1ao1x1 80 12 studies study NNS cord-266359-uf1ao1x1 80 13 evaluating evaluate VBG cord-266359-uf1ao1x1 80 14 the the DT cord-266359-uf1ao1x1 80 15 role role NN cord-266359-uf1ao1x1 80 16 of of IN cord-266359-uf1ao1x1 80 17 CoV cov NN cord-266359-uf1ao1x1 80 18 infection infection NN cord-266359-uf1ao1x1 80 19 in in IN cord-266359-uf1ao1x1 80 20 the the DT cord-266359-uf1ao1x1 80 21 immunocompromised immunocompromised JJ cord-266359-uf1ao1x1 80 22 host host NN cord-266359-uf1ao1x1 80 23 [ [ -LRB- cord-266359-uf1ao1x1 80 24 15 15 CD cord-266359-uf1ao1x1 80 25 ] ] -RRB- cord-266359-uf1ao1x1 80 26 [ [ -LRB- cord-266359-uf1ao1x1 80 27 16 16 CD cord-266359-uf1ao1x1 80 28 ] ] -RRB- cord-266359-uf1ao1x1 80 29 [ [ -LRB- cord-266359-uf1ao1x1 80 30 17 17 CD cord-266359-uf1ao1x1 80 31 ] ] -RRB- cord-266359-uf1ao1x1 80 32 25 25 CD cord-266359-uf1ao1x1 80 33 ] ] -RRB- cord-266359-uf1ao1x1 80 34 . . . cord-266359-uf1ao1x1 81 1 CoV CoV NNP cord-266359-uf1ao1x1 81 2 , , , cord-266359-uf1ao1x1 81 3 primarily primarily RB cord-266359-uf1ao1x1 81 4 Group Group NNP cord-266359-uf1ao1x1 81 5 I i CD cord-266359-uf1ao1x1 81 6 subtypes subtype NNS cord-266359-uf1ao1x1 81 7 , , , cord-266359-uf1ao1x1 81 8 was be VBD cord-266359-uf1ao1x1 81 9 frequently frequently RB cord-266359-uf1ao1x1 81 10 identified identify VBN cord-266359-uf1ao1x1 81 11 in in IN cord-266359-uf1ao1x1 81 12 the the DT cord-266359-uf1ao1x1 81 13 HSCT HSCT NNP cord-266359-uf1ao1x1 81 14 and and CC cord-266359-uf1ao1x1 81 15 hematologic hematologic JJ cord-266359-uf1ao1x1 81 16 malignancy malignancy NN cord-266359-uf1ao1x1 81 17 populations population NNS cord-266359-uf1ao1x1 81 18 when when WRB cord-266359-uf1ao1x1 81 19 suspicion suspicion NN cord-266359-uf1ao1x1 81 20 for for IN cord-266359-uf1ao1x1 81 21 a a DT cord-266359-uf1ao1x1 81 22 respiratory respiratory JJ cord-266359-uf1ao1x1 81 23 viral viral JJ cord-266359-uf1ao1x1 81 24 infection infection NN cord-266359-uf1ao1x1 81 25 prompted prompt VBD cord-266359-uf1ao1x1 81 26 diagnostic diagnostic JJ cord-266359-uf1ao1x1 81 27 testing testing NN cord-266359-uf1ao1x1 81 28 . . . cord-266359-uf1ao1x1 82 1 In in IN cord-266359-uf1ao1x1 82 2 this this DT cord-266359-uf1ao1x1 82 3 population population NN cord-266359-uf1ao1x1 82 4 , , , cord-266359-uf1ao1x1 82 5 CoV cov NN cord-266359-uf1ao1x1 82 6 infection infection NN cord-266359-uf1ao1x1 82 7 was be VBD cord-266359-uf1ao1x1 82 8 associated associate VBN cord-266359-uf1ao1x1 82 9 with with IN cord-266359-uf1ao1x1 82 10 similar similar JJ cord-266359-uf1ao1x1 82 11 rates rate NNS cord-266359-uf1ao1x1 82 12 of of IN cord-266359-uf1ao1x1 82 13 URI uri NN cord-266359-uf1ao1x1 82 14 symptoms symptom NNS cord-266359-uf1ao1x1 82 15 , , , cord-266359-uf1ao1x1 82 16 nosocomial nosocomial JJ cord-266359-uf1ao1x1 82 17 acquisition acquisition NN cord-266359-uf1ao1x1 82 18 , , , cord-266359-uf1ao1x1 82 19 and and CC cord-266359-uf1ao1x1 82 20 requirement requirement NN cord-266359-uf1ao1x1 82 21 for for IN cord-266359-uf1ao1x1 82 22 hospital hospital NN cord-266359-uf1ao1x1 82 23 admission admission NN cord-266359-uf1ao1x1 82 24 compared compare VBN cord-266359-uf1ao1x1 82 25 to to IN cord-266359-uf1ao1x1 82 26 most most JJS cord-266359-uf1ao1x1 82 27 other other JJ cord-266359-uf1ao1x1 82 28 respiratory respiratory JJ cord-266359-uf1ao1x1 82 29 viruses virus NNS cord-266359-uf1ao1x1 82 30 . . . cord-266359-uf1ao1x1 83 1 However however RB cord-266359-uf1ao1x1 83 2 , , , cord-266359-uf1ao1x1 83 3 CoV cov NN cord-266359-uf1ao1x1 83 4 infection infection NN cord-266359-uf1ao1x1 83 5 resulted result VBD cord-266359-uf1ao1x1 83 6 in in IN cord-266359-uf1ao1x1 83 7 less less RBR cord-266359-uf1ao1x1 83 8 possible possible JJ cord-266359-uf1ao1x1 83 9 and and CC cord-266359-uf1ao1x1 83 10 proven prove VBN cord-266359-uf1ao1x1 83 11 LRTD LRTD NNP cord-266359-uf1ao1x1 83 12 than than IN cord-266359-uf1ao1x1 83 13 other other JJ cord-266359-uf1ao1x1 83 14 respiratory respiratory JJ cord-266359-uf1ao1x1 83 15 viruses virus NNS cord-266359-uf1ao1x1 83 16 with with IN cord-266359-uf1ao1x1 83 17 the the DT cord-266359-uf1ao1x1 83 18 exception exception NN cord-266359-uf1ao1x1 83 19 of of IN cord-266359-uf1ao1x1 83 20 RhV/ rhv/ CD cord-266359-uf1ao1x1 84 1 EnV. EnV. NNP cord-266359-uf1ao1x1 85 1 The the DT cord-266359-uf1ao1x1 85 2 frequency frequency NN cord-266359-uf1ao1x1 85 3 of of IN cord-266359-uf1ao1x1 85 4 detection detection NN cord-266359-uf1ao1x1 85 5 of of IN cord-266359-uf1ao1x1 85 6 CoV cov NN cord-266359-uf1ao1x1 85 7 among among IN cord-266359-uf1ao1x1 85 8 all all DT cord-266359-uf1ao1x1 85 9 samples sample NNS cord-266359-uf1ao1x1 85 10 tested test VBN cord-266359-uf1ao1x1 85 11 in in IN cord-266359-uf1ao1x1 85 12 this this DT cord-266359-uf1ao1x1 85 13 study study NN cord-266359-uf1ao1x1 85 14 is be VBZ cord-266359-uf1ao1x1 85 15 consistent consistent JJ cord-266359-uf1ao1x1 85 16 with with IN cord-266359-uf1ao1x1 85 17 previous previous JJ cord-266359-uf1ao1x1 85 18 reports report NNS cord-266359-uf1ao1x1 85 19 of of IN cord-266359-uf1ao1x1 85 20 CoV cov NN cord-266359-uf1ao1x1 85 21 detection detection NN cord-266359-uf1ao1x1 85 22 in in IN cord-266359-uf1ao1x1 85 23 patients patient NNS cord-266359-uf1ao1x1 85 24 hospitalized hospitalize VBN cord-266359-uf1ao1x1 85 25 with with IN cord-266359-uf1ao1x1 85 26 respiratory respiratory JJ cord-266359-uf1ao1x1 85 27 syndromes syndrome NNS cord-266359-uf1ao1x1 85 28 [ [ -LRB- cord-266359-uf1ao1x1 85 29 15 15 CD cord-266359-uf1ao1x1 85 30 ] ] -RRB- cord-266359-uf1ao1x1 85 31 [ [ -LRB- cord-266359-uf1ao1x1 85 32 16 16 CD cord-266359-uf1ao1x1 85 33 ] ] -RRB- cord-266359-uf1ao1x1 85 34 [ [ -LRB- cord-266359-uf1ao1x1 85 35 17 17 CD cord-266359-uf1ao1x1 85 36 ] ] -RRB- cord-266359-uf1ao1x1 85 37 . . . cord-266359-uf1ao1x1 86 1 However however RB cord-266359-uf1ao1x1 86 2 , , , cord-266359-uf1ao1x1 86 3 our -PRON- PRP$ cord-266359-uf1ao1x1 86 4 results result NNS cord-266359-uf1ao1x1 86 5 may may MD cord-266359-uf1ao1x1 86 6 not not RB cord-266359-uf1ao1x1 86 7 reflect reflect VB cord-266359-uf1ao1x1 86 8 the the DT cord-266359-uf1ao1x1 86 9 true true JJ cord-266359-uf1ao1x1 86 10 prevalence prevalence NN cord-266359-uf1ao1x1 86 11 of of IN cord-266359-uf1ao1x1 86 12 CoV cov NN cord-266359-uf1ao1x1 86 13 infection infection NN cord-266359-uf1ao1x1 86 14 in in IN cord-266359-uf1ao1x1 86 15 our -PRON- PRP$ cord-266359-uf1ao1x1 86 16 patients patient NNS cord-266359-uf1ao1x1 86 17 as as IN cord-266359-uf1ao1x1 86 18 we -PRON- PRP cord-266359-uf1ao1x1 86 19 do do VBP cord-266359-uf1ao1x1 86 20 not not RB cord-266359-uf1ao1x1 86 21 routinely routinely RB cord-266359-uf1ao1x1 86 22 screen screen VB cord-266359-uf1ao1x1 86 23 asymptomatic asymptomatic JJ cord-266359-uf1ao1x1 86 24 patients patient NNS cord-266359-uf1ao1x1 86 25 ; ; : cord-266359-uf1ao1x1 86 26 doing do VBG cord-266359-uf1ao1x1 86 27 so so RB cord-266359-uf1ao1x1 86 28 would would MD cord-266359-uf1ao1x1 86 29 most most RBS cord-266359-uf1ao1x1 86 30 likely likely RB cord-266359-uf1ao1x1 86 31 increase increase VB cord-266359-uf1ao1x1 86 32 the the DT cord-266359-uf1ao1x1 86 33 prevalence prevalence NN cord-266359-uf1ao1x1 86 34 of of IN cord-266359-uf1ao1x1 86 35 infection infection NN cord-266359-uf1ao1x1 86 36 due due IN cord-266359-uf1ao1x1 86 37 to to IN cord-266359-uf1ao1x1 86 38 detection detection NN cord-266359-uf1ao1x1 86 39 in in IN cord-266359-uf1ao1x1 86 40 asymptomatic asymptomatic JJ cord-266359-uf1ao1x1 86 41 shedders shedder NNS cord-266359-uf1ao1x1 86 42 [ [ -LRB- cord-266359-uf1ao1x1 86 43 15 15 CD cord-266359-uf1ao1x1 86 44 ] ] -RRB- cord-266359-uf1ao1x1 86 45 . . . cord-266359-uf1ao1x1 87 1 It -PRON- PRP cord-266359-uf1ao1x1 87 2 is be VBZ cord-266359-uf1ao1x1 87 3 also also RB cord-266359-uf1ao1x1 87 4 important important JJ cord-266359-uf1ao1x1 87 5 to to TO cord-266359-uf1ao1x1 87 6 note note VB cord-266359-uf1ao1x1 87 7 that that IN cord-266359-uf1ao1x1 87 8 the the DT cord-266359-uf1ao1x1 87 9 true true JJ cord-266359-uf1ao1x1 87 10 rate rate NN cord-266359-uf1ao1x1 87 11 of of IN cord-266359-uf1ao1x1 87 12 influenza influenza NN cord-266359-uf1ao1x1 87 13 A a NN cord-266359-uf1ao1x1 87 14 and and CC cord-266359-uf1ao1x1 87 15 B b NN cord-266359-uf1ao1x1 87 16 infection infection NN cord-266359-uf1ao1x1 87 17 is be VBZ cord-266359-uf1ao1x1 87 18 under under RB cord-266359-uf1ao1x1 87 19 - - HYPH cord-266359-uf1ao1x1 87 20 represented represent VBN cord-266359-uf1ao1x1 87 21 in in IN cord-266359-uf1ao1x1 87 22 our -PRON- PRP$ cord-266359-uf1ao1x1 87 23 results result NNS cord-266359-uf1ao1x1 87 24 since since IN cord-266359-uf1ao1x1 87 25 the the DT cord-266359-uf1ao1x1 87 26 initial initial JJ cord-266359-uf1ao1x1 87 27 test test NN cord-266359-uf1ao1x1 87 28 of of IN cord-266359-uf1ao1x1 87 29 choice choice NN cord-266359-uf1ao1x1 87 30 for for IN cord-266359-uf1ao1x1 87 31 these these DT cord-266359-uf1ao1x1 87 32 pathogens pathogen NNS cord-266359-uf1ao1x1 87 33 at at IN cord-266359-uf1ao1x1 87 34 our -PRON- PRP$ cord-266359-uf1ao1x1 87 35 institution institution NN cord-266359-uf1ao1x1 87 36 is be VBZ cord-266359-uf1ao1x1 87 37 an an DT cord-266359-uf1ao1x1 87 38 influenza influenza NN cord-266359-uf1ao1x1 87 39 - - HYPH cord-266359-uf1ao1x1 87 40 specific specific JJ cord-266359-uf1ao1x1 87 41 PCR PCR NNP cord-266359-uf1ao1x1 87 42 assay assay NN cord-266359-uf1ao1x1 87 43 , , , cord-266359-uf1ao1x1 87 44 not not RB cord-266359-uf1ao1x1 87 45 the the DT cord-266359-uf1ao1x1 87 46 respiratory respiratory JJ cord-266359-uf1ao1x1 87 47 virus virus NN cord-266359-uf1ao1x1 87 48 panel panel NN cord-266359-uf1ao1x1 87 49 used use VBN cord-266359-uf1ao1x1 87 50 in in IN cord-266359-uf1ao1x1 87 51 this this DT cord-266359-uf1ao1x1 87 52 study study NN cord-266359-uf1ao1x1 87 53 . . . cord-266359-uf1ao1x1 88 1 Accounting account VBG cord-266359-uf1ao1x1 88 2 for for IN cord-266359-uf1ao1x1 88 3 this this DT cord-266359-uf1ao1x1 88 4 would would MD cord-266359-uf1ao1x1 88 5 reduce reduce VB cord-266359-uf1ao1x1 88 6 the the DT cord-266359-uf1ao1x1 88 7 relative relative JJ cord-266359-uf1ao1x1 88 8 frequency frequency NN cord-266359-uf1ao1x1 88 9 of of IN cord-266359-uf1ao1x1 88 10 CoV cov NN cord-266359-uf1ao1x1 88 11 as as RB cord-266359-uf1ao1x1 88 12 well well RB cord-266359-uf1ao1x1 88 13 as as IN cord-266359-uf1ao1x1 88 14 that that DT cord-266359-uf1ao1x1 88 15 of of IN cord-266359-uf1ao1x1 88 16 all all DT cord-266359-uf1ao1x1 88 17 other other JJ cord-266359-uf1ao1x1 88 18 non non JJ cord-266359-uf1ao1x1 88 19 - - JJ cord-266359-uf1ao1x1 88 20 influenza influenza JJ cord-266359-uf1ao1x1 88 21 respiratory respiratory JJ cord-266359-uf1ao1x1 88 22 viruses virus NNS cord-266359-uf1ao1x1 88 23 . . . cord-266359-uf1ao1x1 89 1 We -PRON- PRP cord-266359-uf1ao1x1 89 2 found find VBD cord-266359-uf1ao1x1 89 3 that that IN cord-266359-uf1ao1x1 89 4 the the DT cord-266359-uf1ao1x1 89 5 hematologic hematologic JJ cord-266359-uf1ao1x1 89 6 malignancy malignancy NN cord-266359-uf1ao1x1 89 7 and and CC cord-266359-uf1ao1x1 89 8 HSCT HSCT NNP cord-266359-uf1ao1x1 89 9 populations population NNS cord-266359-uf1ao1x1 89 10 accounted account VBD cord-266359-uf1ao1x1 89 11 for for IN cord-266359-uf1ao1x1 89 12 the the DT cord-266359-uf1ao1x1 89 13 majority majority NN cord-266359-uf1ao1x1 89 14 of of IN cord-266359-uf1ao1x1 89 15 patients patient NNS cord-266359-uf1ao1x1 89 16 testing test VBG cord-266359-uf1ao1x1 89 17 positive positive JJ cord-266359-uf1ao1x1 89 18 for for IN cord-266359-uf1ao1x1 89 19 CoV cov NN cord-266359-uf1ao1x1 89 20 and and CC cord-266359-uf1ao1x1 89 21 the the DT cord-266359-uf1ao1x1 89 22 other other JJ cord-266359-uf1ao1x1 89 23 respiratory respiratory JJ cord-266359-uf1ao1x1 89 24 viruses virus NNS cord-266359-uf1ao1x1 89 25 . . . cord-266359-uf1ao1x1 90 1 This this DT cord-266359-uf1ao1x1 90 2 finding finding NN cord-266359-uf1ao1x1 90 3 almost almost RB cord-266359-uf1ao1x1 90 4 certainly certainly RB cord-266359-uf1ao1x1 90 5 reflects reflect VBZ cord-266359-uf1ao1x1 90 6 testing test VBG cord-266359-uf1ao1x1 90 7 bias bias NN cord-266359-uf1ao1x1 90 8 in in IN cord-266359-uf1ao1x1 90 9 that that IN cord-266359-uf1ao1x1 90 10 these these DT cord-266359-uf1ao1x1 90 11 patients patient NNS cord-266359-uf1ao1x1 90 12 are be VBP cord-266359-uf1ao1x1 90 13 more more RBR cord-266359-uf1ao1x1 90 14 likely likely JJ cord-266359-uf1ao1x1 90 15 to to TO cord-266359-uf1ao1x1 90 16 be be VB cord-266359-uf1ao1x1 90 17 tested test VBN cord-266359-uf1ao1x1 90 18 for for IN cord-266359-uf1ao1x1 90 19 respiratory respiratory JJ cord-266359-uf1ao1x1 90 20 viruses virus NNS cord-266359-uf1ao1x1 90 21 when when WRB cord-266359-uf1ao1x1 90 22 symptomatic symptomatic JJ cord-266359-uf1ao1x1 90 23 given give VBN cord-266359-uf1ao1x1 90 24 the the DT cord-266359-uf1ao1x1 90 25 importance importance NN cord-266359-uf1ao1x1 90 26 placed place VBN cord-266359-uf1ao1x1 90 27 on on IN cord-266359-uf1ao1x1 90 28 these these DT cord-266359-uf1ao1x1 90 29 pathogens pathogen NNS cord-266359-uf1ao1x1 90 30 [ [ -LRB- cord-266359-uf1ao1x1 90 31 9 9 CD cord-266359-uf1ao1x1 90 32 ] ] -RRB- cord-266359-uf1ao1x1 90 33 . . . cord-266359-uf1ao1x1 91 1 Interestingly interestingly RB cord-266359-uf1ao1x1 91 2 , , , cord-266359-uf1ao1x1 91 3 we -PRON- PRP cord-266359-uf1ao1x1 91 4 also also RB cord-266359-uf1ao1x1 91 5 found find VBD cord-266359-uf1ao1x1 91 6 a a DT cord-266359-uf1ao1x1 91 7 female female JJ cord-266359-uf1ao1x1 91 8 - - HYPH cord-266359-uf1ao1x1 91 9 predominant predominant JJ cord-266359-uf1ao1x1 91 10 gender gender NN cord-266359-uf1ao1x1 91 11 distribution distribution NN cord-266359-uf1ao1x1 91 12 among among IN cord-266359-uf1ao1x1 91 13 those those DT cord-266359-uf1ao1x1 91 14 infected infect VBN cord-266359-uf1ao1x1 91 15 with with IN cord-266359-uf1ao1x1 91 16 CoV cov NN cord-266359-uf1ao1x1 91 17 , , , cord-266359-uf1ao1x1 91 18 which which WDT cord-266359-uf1ao1x1 91 19 to to IN cord-266359-uf1ao1x1 91 20 the the DT cord-266359-uf1ao1x1 91 21 best good JJS cord-266359-uf1ao1x1 91 22 of of IN cord-266359-uf1ao1x1 91 23 our -PRON- PRP$ cord-266359-uf1ao1x1 91 24 knowledge knowledge NN cord-266359-uf1ao1x1 91 25 , , , cord-266359-uf1ao1x1 91 26 has have VBZ cord-266359-uf1ao1x1 91 27 not not RB cord-266359-uf1ao1x1 91 28 been be VBN cord-266359-uf1ao1x1 91 29 reported report VBN cord-266359-uf1ao1x1 91 30 before before IN cord-266359-uf1ao1x1 91 31 [ [ -LRB- cord-266359-uf1ao1x1 91 32 15 15 CD cord-266359-uf1ao1x1 91 33 ] ] -RRB- cord-266359-uf1ao1x1 91 34 [ [ -LRB- cord-266359-uf1ao1x1 91 35 16 16 CD cord-266359-uf1ao1x1 91 36 ] ] -RRB- cord-266359-uf1ao1x1 91 37 [ [ -LRB- cord-266359-uf1ao1x1 91 38 17 17 CD cord-266359-uf1ao1x1 91 39 ] ] -RRB- cord-266359-uf1ao1x1 91 40 25 25 CD cord-266359-uf1ao1x1 91 41 , , , cord-266359-uf1ao1x1 91 42 26 26 CD cord-266359-uf1ao1x1 91 43 ] ] -RRB- cord-266359-uf1ao1x1 91 44 . . . cord-266359-uf1ao1x1 92 1 While while IN cord-266359-uf1ao1x1 92 2 the the DT cord-266359-uf1ao1x1 92 3 frequency frequency NN cord-266359-uf1ao1x1 92 4 of of IN cord-266359-uf1ao1x1 92 5 respiratory respiratory JJ cord-266359-uf1ao1x1 92 6 illnesses illness NNS cord-266359-uf1ao1x1 92 7 in in IN cord-266359-uf1ao1x1 92 8 the the DT cord-266359-uf1ao1x1 92 9 general general JJ cord-266359-uf1ao1x1 92 10 population population NN cord-266359-uf1ao1x1 92 11 has have VBZ cord-266359-uf1ao1x1 92 12 been be VBN cord-266359-uf1ao1x1 92 13 described describe VBN cord-266359-uf1ao1x1 92 14 to to TO cord-266359-uf1ao1x1 92 15 be be VB cord-266359-uf1ao1x1 92 16 higher high JJR cord-266359-uf1ao1x1 92 17 among among IN cord-266359-uf1ao1x1 92 18 females female NNS cord-266359-uf1ao1x1 92 19 , , , cord-266359-uf1ao1x1 92 20 perhaps perhaps RB cord-266359-uf1ao1x1 92 21 due due JJ cord-266359-uf1ao1x1 92 22 to to IN cord-266359-uf1ao1x1 92 23 increased increase VBN cord-266359-uf1ao1x1 92 24 exposure exposure NN cord-266359-uf1ao1x1 92 25 [ [ -LRB- cord-266359-uf1ao1x1 92 26 27 27 CD cord-266359-uf1ao1x1 92 27 ] ] -RRB- cord-266359-uf1ao1x1 92 28 , , , cord-266359-uf1ao1x1 92 29 if if IN cord-266359-uf1ao1x1 92 30 this this DT cord-266359-uf1ao1x1 92 31 was be VBD cord-266359-uf1ao1x1 92 32 responsible responsible JJ cord-266359-uf1ao1x1 92 33 for for IN cord-266359-uf1ao1x1 92 34 the the DT cord-266359-uf1ao1x1 92 35 higher high JJR cord-266359-uf1ao1x1 92 36 burden burden NN cord-266359-uf1ao1x1 92 37 of of IN cord-266359-uf1ao1x1 92 38 CoV cov NN cord-266359-uf1ao1x1 92 39 infection infection NN cord-266359-uf1ao1x1 92 40 among among IN cord-266359-uf1ao1x1 92 41 women woman NNS cord-266359-uf1ao1x1 92 42 compared compare VBN cord-266359-uf1ao1x1 92 43 to to IN cord-266359-uf1ao1x1 92 44 men man NNS cord-266359-uf1ao1x1 92 45 , , , cord-266359-uf1ao1x1 92 46 then then RB cord-266359-uf1ao1x1 92 47 a a DT cord-266359-uf1ao1x1 92 48 similar similar JJ cord-266359-uf1ao1x1 92 49 pattern pattern NN cord-266359-uf1ao1x1 92 50 might may MD cord-266359-uf1ao1x1 92 51 be be VB cord-266359-uf1ao1x1 92 52 expected expect VBN cord-266359-uf1ao1x1 92 53 for for IN cord-266359-uf1ao1x1 92 54 the the DT cord-266359-uf1ao1x1 92 55 other other JJ cord-266359-uf1ao1x1 92 56 respiratory respiratory JJ cord-266359-uf1ao1x1 92 57 viruses virus NNS cord-266359-uf1ao1x1 92 58 as as RB cord-266359-uf1ao1x1 92 59 well well RB cord-266359-uf1ao1x1 92 60 . . . cord-266359-uf1ao1x1 93 1 This this DT cord-266359-uf1ao1x1 93 2 finding finding NN cord-266359-uf1ao1x1 93 3 requires require VBZ cord-266359-uf1ao1x1 93 4 confirmation confirmation NN cord-266359-uf1ao1x1 93 5 by by IN cord-266359-uf1ao1x1 93 6 additional additional JJ cord-266359-uf1ao1x1 93 7 studies study NNS cord-266359-uf1ao1x1 93 8 . . . cord-266359-uf1ao1x1 94 1 The the DT cord-266359-uf1ao1x1 94 2 majority majority NN cord-266359-uf1ao1x1 94 3 ( ( -LRB- cord-266359-uf1ao1x1 94 4 76.3 76.3 CD cord-266359-uf1ao1x1 94 5 % % NN cord-266359-uf1ao1x1 94 6 ) ) -RRB- cord-266359-uf1ao1x1 94 7 of of IN cord-266359-uf1ao1x1 94 8 CoV CoV NNP cord-266359-uf1ao1x1 94 9 identified identify VBN cord-266359-uf1ao1x1 94 10 in in IN cord-266359-uf1ao1x1 94 11 the the DT cord-266359-uf1ao1x1 94 12 hematologic hematologic JJ cord-266359-uf1ao1x1 94 13 malignancy malignancy NN cord-266359-uf1ao1x1 94 14 and and CC cord-266359-uf1ao1x1 94 15 HSCT HSCT NNP cord-266359-uf1ao1x1 94 16 patients patient NNS cord-266359-uf1ao1x1 94 17 in in IN cord-266359-uf1ao1x1 94 18 this this DT cord-266359-uf1ao1x1 94 19 study study NN cord-266359-uf1ao1x1 94 20 belongs belong VBZ cord-266359-uf1ao1x1 94 21 to to IN cord-266359-uf1ao1x1 95 1 Group group NN cord-266359-uf1ao1x1 95 2 I. I. NNP cord-266359-uf1ao1x1 95 3 Similarly similarly RB cord-266359-uf1ao1x1 95 4 , , , cord-266359-uf1ao1x1 95 5 Group Group NNP cord-266359-uf1ao1x1 95 6 I -PRON- PRP cord-266359-uf1ao1x1 95 7 CoVs CoVs NNP cord-266359-uf1ao1x1 95 8 have have VBP cord-266359-uf1ao1x1 95 9 been be VBN cord-266359-uf1ao1x1 95 10 associated associate VBN cord-266359-uf1ao1x1 95 11 with with IN cord-266359-uf1ao1x1 95 12 infection infection NN cord-266359-uf1ao1x1 95 13 in in IN cord-266359-uf1ao1x1 95 14 the the DT cord-266359-uf1ao1x1 95 15 immunocompromised immunocompromised JJ cord-266359-uf1ao1x1 95 16 host host NN cord-266359-uf1ao1x1 95 17 more more JJR cord-266359-uf1ao1x1 95 18 than than IN cord-266359-uf1ao1x1 95 19 Group Group NNP cord-266359-uf1ao1x1 95 20 II II NNP cord-266359-uf1ao1x1 95 21 CoVs CoVs NNP cord-266359-uf1ao1x1 95 22 in in IN cord-266359-uf1ao1x1 95 23 several several JJ cord-266359-uf1ao1x1 95 24 series series NN cord-266359-uf1ao1x1 95 25 and and CC cord-266359-uf1ao1x1 95 26 case case NN cord-266359-uf1ao1x1 95 27 reports report NNS cord-266359-uf1ao1x1 95 28 [ [ -LRB- cord-266359-uf1ao1x1 95 29 12 12 CD cord-266359-uf1ao1x1 95 30 , , , cord-266359-uf1ao1x1 95 31 13 13 CD cord-266359-uf1ao1x1 95 32 , , , cord-266359-uf1ao1x1 95 33 15 15 CD cord-266359-uf1ao1x1 95 34 , , , cord-266359-uf1ao1x1 95 35 26 26 CD cord-266359-uf1ao1x1 95 36 , , , cord-266359-uf1ao1x1 95 37 28 28 CD cord-266359-uf1ao1x1 95 38 ] ] -RRB- cord-266359-uf1ao1x1 95 39 . . . cord-266359-uf1ao1x1 96 1 In in IN cord-266359-uf1ao1x1 96 2 contrast contrast NN cord-266359-uf1ao1x1 96 3 , , , cord-266359-uf1ao1x1 96 4 studies study NNS cord-266359-uf1ao1x1 96 5 involving involve VBG cord-266359-uf1ao1x1 96 6 general general JJ cord-266359-uf1ao1x1 96 7 or or CC cord-266359-uf1ao1x1 96 8 pediatric pediatric JJ cord-266359-uf1ao1x1 96 9 patient patient JJ cord-266359-uf1ao1x1 96 10 populations population NNS cord-266359-uf1ao1x1 96 11 have have VBP cord-266359-uf1ao1x1 96 12 reported report VBN cord-266359-uf1ao1x1 96 13 a a DT cord-266359-uf1ao1x1 96 14 majority majority NN cord-266359-uf1ao1x1 96 15 of of IN cord-266359-uf1ao1x1 96 16 CoV cov NN cord-266359-uf1ao1x1 96 17 belonging belong VBG cord-266359-uf1ao1x1 96 18 to to IN cord-266359-uf1ao1x1 96 19 Group Group NNP cord-266359-uf1ao1x1 96 20 II II NNP cord-266359-uf1ao1x1 96 21 [ [ -LRB- cord-266359-uf1ao1x1 96 22 16 16 CD cord-266359-uf1ao1x1 96 23 , , , cord-266359-uf1ao1x1 96 24 17 17 CD cord-266359-uf1ao1x1 96 25 , , , cord-266359-uf1ao1x1 96 26 25 25 CD cord-266359-uf1ao1x1 96 27 , , , cord-266359-uf1ao1x1 96 28 26 26 CD cord-266359-uf1ao1x1 96 29 , , , cord-266359-uf1ao1x1 96 30 [ [ -LRB- cord-266359-uf1ao1x1 96 31 29 29 CD cord-266359-uf1ao1x1 96 32 ] ] -RRB- cord-266359-uf1ao1x1 96 33 [ [ -LRB- cord-266359-uf1ao1x1 96 34 30 30 CD cord-266359-uf1ao1x1 96 35 ] ] -RRB- cord-266359-uf1ao1x1 96 36 [ [ -LRB- cord-266359-uf1ao1x1 96 37 31 31 CD cord-266359-uf1ao1x1 96 38 ] ] -RRB- cord-266359-uf1ao1x1 96 39 [ [ -LRB- cord-266359-uf1ao1x1 96 40 32 32 CD cord-266359-uf1ao1x1 96 41 ] ] -RRB- cord-266359-uf1ao1x1 96 42 . . . cord-266359-uf1ao1x1 97 1 Group group NN cord-266359-uf1ao1x1 97 2 I I NNP cord-266359-uf1ao1x1 97 3 and and CC cord-266359-uf1ao1x1 97 4 II II NNP cord-266359-uf1ao1x1 97 5 CoVs CoVs NNP cord-266359-uf1ao1x1 97 6 differ differ VBP cord-266359-uf1ao1x1 97 7 in in IN cord-266359-uf1ao1x1 97 8 the the DT cord-266359-uf1ao1x1 97 9 mechanism mechanism NN cord-266359-uf1ao1x1 97 10 of of IN cord-266359-uf1ao1x1 97 11 virus virus NN cord-266359-uf1ao1x1 97 12 entry entry NN cord-266359-uf1ao1x1 97 13 into into IN cord-266359-uf1ao1x1 97 14 the the DT cord-266359-uf1ao1x1 97 15 host host NN cord-266359-uf1ao1x1 97 16 cell cell NN cord-266359-uf1ao1x1 97 17 and and CC cord-266359-uf1ao1x1 97 18 the the DT cord-266359-uf1ao1x1 97 19 degree degree NN cord-266359-uf1ao1x1 97 20 of of IN cord-266359-uf1ao1x1 97 21 genetic genetic JJ cord-266359-uf1ao1x1 97 22 variability variability NN cord-266359-uf1ao1x1 97 23 , , , cord-266359-uf1ao1x1 97 24 but but CC cord-266359-uf1ao1x1 97 25 whether whether IN cord-266359-uf1ao1x1 97 26 these these DT cord-266359-uf1ao1x1 97 27 differences difference NNS cord-266359-uf1ao1x1 97 28 affect affect VBP cord-266359-uf1ao1x1 97 29 pathogenicity pathogenicity NN cord-266359-uf1ao1x1 97 30 is be VBZ cord-266359-uf1ao1x1 97 31 not not RB cord-266359-uf1ao1x1 97 32 known know VBN cord-266359-uf1ao1x1 97 33 [ [ -LRB- cord-266359-uf1ao1x1 97 34 33 33 CD cord-266359-uf1ao1x1 97 35 ] ] -RRB- cord-266359-uf1ao1x1 97 36 . . . cord-266359-uf1ao1x1 98 1 Indeed indeed RB cord-266359-uf1ao1x1 98 2 , , , cord-266359-uf1ao1x1 98 3 reports report VBZ cord-266359-uf1ao1x1 98 4 associating associate VBG cord-266359-uf1ao1x1 98 5 CoV cov NN cord-266359-uf1ao1x1 98 6 subtypes subtype NNS cord-266359-uf1ao1x1 98 7 with with IN cord-266359-uf1ao1x1 98 8 disease disease NN cord-266359-uf1ao1x1 98 9 manifestations manifestation NNS cord-266359-uf1ao1x1 98 10 are be VBP cord-266359-uf1ao1x1 98 11 conflicting conflict VBG cord-266359-uf1ao1x1 98 12 [ [ -LRB- cord-266359-uf1ao1x1 98 13 17 17 CD cord-266359-uf1ao1x1 98 14 , , , cord-266359-uf1ao1x1 98 15 26 26 CD cord-266359-uf1ao1x1 98 16 , , , cord-266359-uf1ao1x1 98 17 31 31 CD cord-266359-uf1ao1x1 98 18 ] ] -RRB- cord-266359-uf1ao1x1 98 19 . . . cord-266359-uf1ao1x1 99 1 Further further JJ cord-266359-uf1ao1x1 99 2 studies study NNS cord-266359-uf1ao1x1 99 3 into into IN cord-266359-uf1ao1x1 99 4 the the DT cord-266359-uf1ao1x1 99 5 relative relative JJ cord-266359-uf1ao1x1 99 6 incidence incidence NN cord-266359-uf1ao1x1 99 7 of of IN cord-266359-uf1ao1x1 99 8 CoV cov NN cord-266359-uf1ao1x1 99 9 subtypes subtype NNS cord-266359-uf1ao1x1 99 10 among among IN cord-266359-uf1ao1x1 99 11 various various JJ cord-266359-uf1ao1x1 99 12 patient patient JJ cord-266359-uf1ao1x1 99 13 populations population NNS cord-266359-uf1ao1x1 99 14 are be VBP cord-266359-uf1ao1x1 99 15 necessary necessary JJ cord-266359-uf1ao1x1 99 16 and and CC cord-266359-uf1ao1x1 99 17 may may MD cord-266359-uf1ao1x1 99 18 provide provide VB cord-266359-uf1ao1x1 99 19 insight insight NN cord-266359-uf1ao1x1 99 20 into into IN cord-266359-uf1ao1x1 99 21 fundamental fundamental JJ cord-266359-uf1ao1x1 99 22 biological biological JJ cord-266359-uf1ao1x1 99 23 differences difference NNS cord-266359-uf1ao1x1 99 24 between between IN cord-266359-uf1ao1x1 99 25 Group Group NNP cord-266359-uf1ao1x1 99 26 I I NNP cord-266359-uf1ao1x1 99 27 and and CC cord-266359-uf1ao1x1 99 28 II II NNP cord-266359-uf1ao1x1 99 29 subtypes subtype NNS cord-266359-uf1ao1x1 99 30 . . . cord-266359-uf1ao1x1 100 1 Similar similar JJ cord-266359-uf1ao1x1 100 2 to to IN cord-266359-uf1ao1x1 100 3 previous previous JJ cord-266359-uf1ao1x1 100 4 reports report NNS cord-266359-uf1ao1x1 100 5 [ [ -LRB- cord-266359-uf1ao1x1 100 6 3 3 CD cord-266359-uf1ao1x1 100 7 , , , cord-266359-uf1ao1x1 100 8 15 15 CD cord-266359-uf1ao1x1 100 9 ] ] -RRB- cord-266359-uf1ao1x1 100 10 , , , cord-266359-uf1ao1x1 100 11 the the DT cord-266359-uf1ao1x1 100 12 rate rate NN cord-266359-uf1ao1x1 100 13 of of IN cord-266359-uf1ao1x1 100 14 CoV cov NN cord-266359-uf1ao1x1 100 15 - - HYPH cord-266359-uf1ao1x1 100 16 proven prove VBN cord-266359-uf1ao1x1 100 17 LRTD LRTD NNP cord-266359-uf1ao1x1 100 18 was be VBD cord-266359-uf1ao1x1 100 19 low low JJ cord-266359-uf1ao1x1 100 20 but but CC cord-266359-uf1ao1x1 100 21 was be VBD cord-266359-uf1ao1x1 100 22 not not RB cord-266359-uf1ao1x1 100 23 significantly significantly RB cord-266359-uf1ao1x1 100 24 different different JJ cord-266359-uf1ao1x1 100 25 from from IN cord-266359-uf1ao1x1 100 26 other other JJ cord-266359-uf1ao1x1 100 27 respiratory respiratory JJ cord-266359-uf1ao1x1 100 28 viruses virus NNS cord-266359-uf1ao1x1 100 29 . . . cord-266359-uf1ao1x1 101 1 However however RB cord-266359-uf1ao1x1 101 2 , , , cord-266359-uf1ao1x1 101 3 these these DT cord-266359-uf1ao1x1 101 4 results result NNS cord-266359-uf1ao1x1 101 5 must must MD cord-266359-uf1ao1x1 101 6 be be VB cord-266359-uf1ao1x1 101 7 interpreted interpret VBN cord-266359-uf1ao1x1 101 8 with with IN cord-266359-uf1ao1x1 101 9 caution caution NN cord-266359-uf1ao1x1 101 10 since since IN cord-266359-uf1ao1x1 101 11 bronchoscopy bronchoscopy NN cord-266359-uf1ao1x1 101 12 , , , cord-266359-uf1ao1x1 101 13 which which WDT cord-266359-uf1ao1x1 101 14 we -PRON- PRP cord-266359-uf1ao1x1 101 15 used use VBD cord-266359-uf1ao1x1 101 16 as as IN cord-266359-uf1ao1x1 101 17 a a DT cord-266359-uf1ao1x1 101 18 criteria criterion NNS cord-266359-uf1ao1x1 101 19 for for IN cord-266359-uf1ao1x1 101 20 defining define VBG cord-266359-uf1ao1x1 101 21 " " `` cord-266359-uf1ao1x1 101 22 proven prove VBN cord-266359-uf1ao1x1 101 23 LRTD LRTD NNP cord-266359-uf1ao1x1 101 24 " " '' cord-266359-uf1ao1x1 101 25 , , , cord-266359-uf1ao1x1 101 26 is be VBZ cord-266359-uf1ao1x1 101 27 no no DT cord-266359-uf1ao1x1 101 28 longer long RBR cord-266359-uf1ao1x1 101 29 done do VBN cord-266359-uf1ao1x1 101 30 in in IN cord-266359-uf1ao1x1 101 31 many many JJ cord-266359-uf1ao1x1 101 32 cases case NNS cord-266359-uf1ao1x1 101 33 when when WRB cord-266359-uf1ao1x1 101 34 a a DT cord-266359-uf1ao1x1 101 35 respiratory respiratory JJ cord-266359-uf1ao1x1 101 36 virus virus NN cord-266359-uf1ao1x1 101 37 is be VBZ cord-266359-uf1ao1x1 101 38 identified identify VBN cord-266359-uf1ao1x1 101 39 in in IN cord-266359-uf1ao1x1 101 40 an an DT cord-266359-uf1ao1x1 101 41 upper upper JJ cord-266359-uf1ao1x1 101 42 airway airway NN cord-266359-uf1ao1x1 101 43 sample sample NN cord-266359-uf1ao1x1 101 44 at at IN cord-266359-uf1ao1x1 101 45 this this DT cord-266359-uf1ao1x1 101 46 institution institution NN cord-266359-uf1ao1x1 101 47 or or CC cord-266359-uf1ao1x1 101 48 others other NNS cord-266359-uf1ao1x1 101 49 [ [ -LRB- cord-266359-uf1ao1x1 101 50 24 24 CD cord-266359-uf1ao1x1 101 51 ] ] -RRB- cord-266359-uf1ao1x1 101 52 . . . cord-266359-uf1ao1x1 102 1 Analyzing analyze VBG cord-266359-uf1ao1x1 102 2 " " `` cord-266359-uf1ao1x1 102 3 possible possible JJ cord-266359-uf1ao1x1 102 4 LRTD LRTD NNP cord-266359-uf1ao1x1 102 5 " " '' cord-266359-uf1ao1x1 102 6 instead instead RB cord-266359-uf1ao1x1 102 7 , , , cord-266359-uf1ao1x1 102 8 CoV CoV NNP cord-266359-uf1ao1x1 102 9 was be VBD cord-266359-uf1ao1x1 102 10 indeed indeed RB cord-266359-uf1ao1x1 102 11 associated associate VBN cord-266359-uf1ao1x1 102 12 with with IN cord-266359-uf1ao1x1 102 13 significantly significantly RB cord-266359-uf1ao1x1 102 14 less less JJR cord-266359-uf1ao1x1 102 15 disease disease NN cord-266359-uf1ao1x1 102 16 compared compare VBN cord-266359-uf1ao1x1 102 17 to to IN cord-266359-uf1ao1x1 102 18 all all PDT cord-266359-uf1ao1x1 102 19 the the DT cord-266359-uf1ao1x1 102 20 other other JJ cord-266359-uf1ao1x1 102 21 respiratory respiratory JJ cord-266359-uf1ao1x1 102 22 viruses virus NNS cord-266359-uf1ao1x1 102 23 analyzed analyze VBN cord-266359-uf1ao1x1 102 24 except except IN cord-266359-uf1ao1x1 102 25 RhV rhv NN cord-266359-uf1ao1x1 102 26 / / SYM cord-266359-uf1ao1x1 102 27 EnV env NN cord-266359-uf1ao1x1 102 28 , , , cord-266359-uf1ao1x1 102 29 with with IN cord-266359-uf1ao1x1 102 30 the the DT cord-266359-uf1ao1x1 102 31 rate rate NN cord-266359-uf1ao1x1 102 32 of of IN cord-266359-uf1ao1x1 102 33 possible possible JJ cord-266359-uf1ao1x1 102 34 LRTD LRTD NNP cord-266359-uf1ao1x1 102 35 due due IN cord-266359-uf1ao1x1 102 36 to to IN cord-266359-uf1ao1x1 102 37 the the DT cord-266359-uf1ao1x1 102 38 other other JJ cord-266359-uf1ao1x1 102 39 respiratory respiratory JJ cord-266359-uf1ao1x1 102 40 viruses virus NNS cord-266359-uf1ao1x1 102 41 in in IN cord-266359-uf1ao1x1 102 42 this this DT cord-266359-uf1ao1x1 102 43 report report NN cord-266359-uf1ao1x1 102 44 being be VBG cord-266359-uf1ao1x1 102 45 generally generally RB cord-266359-uf1ao1x1 102 46 consistent consistent JJ cord-266359-uf1ao1x1 102 47 with with IN cord-266359-uf1ao1x1 102 48 the the DT cord-266359-uf1ao1x1 102 49 published publish VBN cord-266359-uf1ao1x1 102 50 literature literature NN cord-266359-uf1ao1x1 102 51 [ [ -LRB- cord-266359-uf1ao1x1 102 52 9 9 CD cord-266359-uf1ao1x1 102 53 , , , cord-266359-uf1ao1x1 102 54 24 24 CD cord-266359-uf1ao1x1 102 55 ] ] -RRB- cord-266359-uf1ao1x1 102 56 . . . cord-266359-uf1ao1x1 103 1 However however RB cord-266359-uf1ao1x1 103 2 , , , cord-266359-uf1ao1x1 103 3 not not RB cord-266359-uf1ao1x1 103 4 all all DT cord-266359-uf1ao1x1 103 5 patients patient NNS cord-266359-uf1ao1x1 103 6 had have VBD cord-266359-uf1ao1x1 103 7 radiography radiography NN cord-266359-uf1ao1x1 103 8 performed perform VBN cord-266359-uf1ao1x1 103 9 at at IN cord-266359-uf1ao1x1 103 10 the the DT cord-266359-uf1ao1x1 103 11 time time NN cord-266359-uf1ao1x1 103 12 of of IN cord-266359-uf1ao1x1 103 13 diagnosis diagnosis NN cord-266359-uf1ao1x1 103 14 of of IN cord-266359-uf1ao1x1 103 15 respiratory respiratory JJ cord-266359-uf1ao1x1 103 16 viral viral JJ cord-266359-uf1ao1x1 103 17 infection infection NN cord-266359-uf1ao1x1 103 18 , , , cord-266359-uf1ao1x1 103 19 which which WDT cord-266359-uf1ao1x1 103 20 may may MD cord-266359-uf1ao1x1 103 21 bias bias VB cord-266359-uf1ao1x1 103 22 the the DT cord-266359-uf1ao1x1 103 23 results result NNS cord-266359-uf1ao1x1 103 24 toward toward IN cord-266359-uf1ao1x1 103 25 those those DT cord-266359-uf1ao1x1 103 26 more more RBR cord-266359-uf1ao1x1 103 27 likely likely JJ cord-266359-uf1ao1x1 103 28 to to TO cord-266359-uf1ao1x1 103 29 have have VB cord-266359-uf1ao1x1 103 30 evidence evidence NN cord-266359-uf1ao1x1 103 31 of of IN cord-266359-uf1ao1x1 103 32 lower low JJR cord-266359-uf1ao1x1 103 33 respiratory respiratory JJ cord-266359-uf1ao1x1 103 34 tract tract NN cord-266359-uf1ao1x1 103 35 illness illness NN cord-266359-uf1ao1x1 103 36 . . . cord-266359-uf1ao1x1 104 1 Interestingly interestingly RB cord-266359-uf1ao1x1 104 2 , , , cord-266359-uf1ao1x1 104 3 all all DT cord-266359-uf1ao1x1 104 4 cases case NNS cord-266359-uf1ao1x1 104 5 of of IN cord-266359-uf1ao1x1 104 6 possible possible JJ cord-266359-uf1ao1x1 104 7 and and CC cord-266359-uf1ao1x1 104 8 proven prove VBN cord-266359-uf1ao1x1 104 9 CoV cov NN cord-266359-uf1ao1x1 104 10 - - HYPH cord-266359-uf1ao1x1 104 11 associated associate VBN cord-266359-uf1ao1x1 104 12 LRTD LRTD NNP cord-266359-uf1ao1x1 104 13 occurred occur VBD cord-266359-uf1ao1x1 104 14 in in IN cord-266359-uf1ao1x1 104 15 HSCT HSCT NNP cord-266359-uf1ao1x1 104 16 recipients recipient NNS cord-266359-uf1ao1x1 104 17 , , , cord-266359-uf1ao1x1 104 18 whereas whereas IN cord-266359-uf1ao1x1 104 19 the the DT cord-266359-uf1ao1x1 104 20 cases case NNS cord-266359-uf1ao1x1 104 21 of of IN cord-266359-uf1ao1x1 104 22 possible possible JJ cord-266359-uf1ao1x1 104 23 and and CC cord-266359-uf1ao1x1 104 24 proven prove VBN cord-266359-uf1ao1x1 104 25 LRTD LRTD NNP cord-266359-uf1ao1x1 104 26 during during IN cord-266359-uf1ao1x1 104 27 infection infection NN cord-266359-uf1ao1x1 104 28 with with IN cord-266359-uf1ao1x1 104 29 the the DT cord-266359-uf1ao1x1 104 30 other other JJ cord-266359-uf1ao1x1 104 31 respiratory respiratory JJ cord-266359-uf1ao1x1 104 32 viruses virus NNS cord-266359-uf1ao1x1 104 33 were be VBD cord-266359-uf1ao1x1 104 34 divided divide VBN cord-266359-uf1ao1x1 104 35 more more RBR cord-266359-uf1ao1x1 104 36 evenly evenly RB cord-266359-uf1ao1x1 104 37 among among IN cord-266359-uf1ao1x1 104 38 HSCT HSCT NNP cord-266359-uf1ao1x1 104 39 recipients recipient NNS cord-266359-uf1ao1x1 104 40 and and CC cord-266359-uf1ao1x1 104 41 hematologic hematologic JJ cord-266359-uf1ao1x1 104 42 malignancy malignancy NN cord-266359-uf1ao1x1 104 43 patients patient NNS cord-266359-uf1ao1x1 104 44 . . . cord-266359-uf1ao1x1 105 1 Additionally additionally RB cord-266359-uf1ao1x1 105 2 , , , cord-266359-uf1ao1x1 105 3 all all DT cord-266359-uf1ao1x1 105 4 cases case NNS cord-266359-uf1ao1x1 105 5 occurred occur VBD cord-266359-uf1ao1x1 105 6 in in IN cord-266359-uf1ao1x1 105 7 the the DT cord-266359-uf1ao1x1 105 8 setting setting NN cord-266359-uf1ao1x1 105 9 of of IN cord-266359-uf1ao1x1 105 10 acute acute JJ cord-266359-uf1ao1x1 105 11 or or CC cord-266359-uf1ao1x1 105 12 chronic chronic JJ cord-266359-uf1ao1x1 105 13 GVHD GVHD NNP cord-266359-uf1ao1x1 105 14 . . . cord-266359-uf1ao1x1 106 1 Taken take VBN cord-266359-uf1ao1x1 106 2 together together RB cord-266359-uf1ao1x1 106 3 , , , cord-266359-uf1ao1x1 106 4 these these DT cord-266359-uf1ao1x1 106 5 findings finding NNS cord-266359-uf1ao1x1 106 6 suggest suggest VBP cord-266359-uf1ao1x1 106 7 that that IN cord-266359-uf1ao1x1 106 8 CoV cov NN cord-266359-uf1ao1x1 106 9 may may MD cord-266359-uf1ao1x1 106 10 be be VB cord-266359-uf1ao1x1 106 11 inherently inherently RB cord-266359-uf1ao1x1 106 12 less less RBR cord-266359-uf1ao1x1 106 13 virulent virulent JJ cord-266359-uf1ao1x1 106 14 compared compare VBN cord-266359-uf1ao1x1 106 15 to to IN cord-266359-uf1ao1x1 106 16 other other JJ cord-266359-uf1ao1x1 106 17 respiratory respiratory JJ cord-266359-uf1ao1x1 106 18 viruses virus NNS cord-266359-uf1ao1x1 106 19 , , , cord-266359-uf1ao1x1 106 20 and and CC cord-266359-uf1ao1x1 106 21 therefore therefore RB cord-266359-uf1ao1x1 106 22 , , , cord-266359-uf1ao1x1 106 23 requires require VBZ cord-266359-uf1ao1x1 106 24 augmented augment VBN cord-266359-uf1ao1x1 106 25 immune immune JJ cord-266359-uf1ao1x1 106 26 suppression suppression NN cord-266359-uf1ao1x1 106 27 after after IN cord-266359-uf1ao1x1 106 28 HSCT HSCT NNP cord-266359-uf1ao1x1 106 29 in in IN cord-266359-uf1ao1x1 106 30 order order NN cord-266359-uf1ao1x1 106 31 to to TO cord-266359-uf1ao1x1 106 32 progress progress VB cord-266359-uf1ao1x1 106 33 to to IN cord-266359-uf1ao1x1 106 34 LRTD LRTD NNP cord-266359-uf1ao1x1 106 35 . . . cord-266359-uf1ao1x1 107 1 The the DT cord-266359-uf1ao1x1 107 2 low low JJ cord-266359-uf1ao1x1 107 3 number number NN cord-266359-uf1ao1x1 107 4 of of IN cord-266359-uf1ao1x1 107 5 CoV cov NN cord-266359-uf1ao1x1 107 6 - - HYPH cord-266359-uf1ao1x1 107 7 associated associate VBN cord-266359-uf1ao1x1 107 8 LRTD LRTD NNP cord-266359-uf1ao1x1 107 9 in in IN cord-266359-uf1ao1x1 107 10 this this DT cord-266359-uf1ao1x1 107 11 study study NN cord-266359-uf1ao1x1 107 12 precludes preclude VBZ cord-266359-uf1ao1x1 107 13 meaningful meaningful JJ cord-266359-uf1ao1x1 107 14 risk risk NN cord-266359-uf1ao1x1 107 15 factor factor NN cord-266359-uf1ao1x1 107 16 assessment assessment NN cord-266359-uf1ao1x1 107 17 but but CC cord-266359-uf1ao1x1 107 18 additional additional JJ cord-266359-uf1ao1x1 107 19 studies study NNS cord-266359-uf1ao1x1 107 20 may may MD cord-266359-uf1ao1x1 107 21 make make VB cord-266359-uf1ao1x1 107 22 this this DT cord-266359-uf1ao1x1 107 23 more more RBR cord-266359-uf1ao1x1 107 24 feasible feasible JJ cord-266359-uf1ao1x1 107 25 . . . cord-266359-uf1ao1x1 108 1 Aside aside RB cord-266359-uf1ao1x1 108 2 from from IN cord-266359-uf1ao1x1 108 3 LRTD LRTD NNP cord-266359-uf1ao1x1 108 4 , , , cord-266359-uf1ao1x1 108 5 CoV cov NN cord-266359-uf1ao1x1 108 6 infection infection NN cord-266359-uf1ao1x1 108 7 was be VBD cord-266359-uf1ao1x1 108 8 associated associate VBN cord-266359-uf1ao1x1 108 9 with with IN cord-266359-uf1ao1x1 108 10 other other JJ cord-266359-uf1ao1x1 108 11 clinically clinically RB cord-266359-uf1ao1x1 108 12 - - HYPH cord-266359-uf1ao1x1 108 13 relevant relevant JJ cord-266359-uf1ao1x1 108 14 consequences consequence NNS cord-266359-uf1ao1x1 108 15 . . . cord-266359-uf1ao1x1 109 1 Namely namely RB cord-266359-uf1ao1x1 109 2 , , , cord-266359-uf1ao1x1 109 3 30 30 CD cord-266359-uf1ao1x1 109 4 % % NN cord-266359-uf1ao1x1 109 5 of of IN cord-266359-uf1ao1x1 109 6 outpatients outpatient NNS cord-266359-uf1ao1x1 109 7 were be VBD cord-266359-uf1ao1x1 109 8 admitted admit VBN cord-266359-uf1ao1x1 109 9 to to IN cord-266359-uf1ao1x1 109 10 the the DT cord-266359-uf1ao1x1 109 11 hospital hospital NN cord-266359-uf1ao1x1 109 12 based base VBN cord-266359-uf1ao1x1 109 13 on on IN cord-266359-uf1ao1x1 109 14 manifestations manifestation NNS cord-266359-uf1ao1x1 109 15 of of IN cord-266359-uf1ao1x1 109 16 CoV cov NN cord-266359-uf1ao1x1 109 17 infection infection NN cord-266359-uf1ao1x1 109 18 , , , cord-266359-uf1ao1x1 109 19 and and CC cord-266359-uf1ao1x1 109 20 hospital hospital NN cord-266359-uf1ao1x1 109 21 acquisition acquisition NN cord-266359-uf1ao1x1 109 22 occurred occur VBD cord-266359-uf1ao1x1 109 23 in in IN cord-266359-uf1ao1x1 109 24 5 5 CD cord-266359-uf1ao1x1 109 25 cases case NNS cord-266359-uf1ao1x1 109 26 , , , cord-266359-uf1ao1x1 109 27 with with IN cord-266359-uf1ao1x1 109 28 a a DT cord-266359-uf1ao1x1 109 29 cluster cluster NN cord-266359-uf1ao1x1 109 30 of of IN cord-266359-uf1ao1x1 109 31 4 4 CD cord-266359-uf1ao1x1 109 32 nosocomially nosocomially RB cord-266359-uf1ao1x1 109 33 - - HYPH cord-266359-uf1ao1x1 109 34 acquired acquire VBN cord-266359-uf1ao1x1 109 35 cases case NNS cord-266359-uf1ao1x1 109 36 occurring occur VBG cord-266359-uf1ao1x1 109 37 within within IN cord-266359-uf1ao1x1 109 38 a a DT cord-266359-uf1ao1x1 109 39 2 2 CD cord-266359-uf1ao1x1 109 40 month month NN cord-266359-uf1ao1x1 109 41 span span NN cord-266359-uf1ao1x1 109 42 . . . cord-266359-uf1ao1x1 110 1 Additionally additionally RB cord-266359-uf1ao1x1 110 2 , , , cord-266359-uf1ao1x1 110 3 50 50 CD cord-266359-uf1ao1x1 110 4 % % NN cord-266359-uf1ao1x1 110 5 of of IN cord-266359-uf1ao1x1 110 6 CoV cov NN cord-266359-uf1ao1x1 110 7 - - HYPH cord-266359-uf1ao1x1 110 8 infected infect VBN cord-266359-uf1ao1x1 110 9 patients patient NNS cord-266359-uf1ao1x1 110 10 received receive VBD cord-266359-uf1ao1x1 110 11 an an DT cord-266359-uf1ao1x1 110 12 empiric empiric JJ cord-266359-uf1ao1x1 110 13 course course NN cord-266359-uf1ao1x1 110 14 of of IN cord-266359-uf1ao1x1 110 15 antibacterial antibacterial JJ cord-266359-uf1ao1x1 110 16 therapy therapy NN cord-266359-uf1ao1x1 110 17 ( ( -LRB- cord-266359-uf1ao1x1 110 18 data datum NNS cord-266359-uf1ao1x1 110 19 not not RB cord-266359-uf1ao1x1 110 20 shown show VBN cord-266359-uf1ao1x1 110 21 ) ) -RRB- cord-266359-uf1ao1x1 110 22 . . . cord-266359-uf1ao1x1 111 1 Notably notably RB cord-266359-uf1ao1x1 111 2 , , , cord-266359-uf1ao1x1 111 3 while while IN cord-266359-uf1ao1x1 111 4 CoV CoV NNP cord-266359-uf1ao1x1 111 5 is be VBZ cord-266359-uf1ao1x1 111 6 detected detect VBN cord-266359-uf1ao1x1 111 7 as as IN cord-266359-uf1ao1x1 111 8 part part NN cord-266359-uf1ao1x1 111 9 of of IN cord-266359-uf1ao1x1 111 10 the the DT cord-266359-uf1ao1x1 111 11 respiratory respiratory JJ cord-266359-uf1ao1x1 111 12 virus virus NN cord-266359-uf1ao1x1 111 13 panel panel NN cord-266359-uf1ao1x1 111 14 used use VBN cord-266359-uf1ao1x1 111 15 at at IN cord-266359-uf1ao1x1 111 16 our -PRON- PRP$ cord-266359-uf1ao1x1 111 17 institution institution NN cord-266359-uf1ao1x1 111 18 during during IN cord-266359-uf1ao1x1 111 19 the the DT cord-266359-uf1ao1x1 111 20 study study NN cord-266359-uf1ao1x1 111 21 period period NN cord-266359-uf1ao1x1 111 22 , , , cord-266359-uf1ao1x1 111 23 the the DT cord-266359-uf1ao1x1 111 24 CoV cov NN cord-266359-uf1ao1x1 111 25 results result NNS cord-266359-uf1ao1x1 111 26 were be VBD cord-266359-uf1ao1x1 111 27 not not RB cord-266359-uf1ao1x1 111 28 reported report VBN cord-266359-uf1ao1x1 111 29 in in IN cord-266359-uf1ao1x1 111 30 the the DT cord-266359-uf1ao1x1 111 31 medical medical JJ cord-266359-uf1ao1x1 111 32 record record NN cord-266359-uf1ao1x1 111 33 since since IN cord-266359-uf1ao1x1 111 34 the the DT cord-266359-uf1ao1x1 111 35 assay assay NN cord-266359-uf1ao1x1 111 36 was be VBD cord-266359-uf1ao1x1 111 37 not not RB cord-266359-uf1ao1x1 111 38 approved approve VBN cord-266359-uf1ao1x1 111 39 by by IN cord-266359-uf1ao1x1 111 40 the the DT cord-266359-uf1ao1x1 111 41 Food Food NNP cord-266359-uf1ao1x1 111 42 and and CC cord-266359-uf1ao1x1 111 43 Drug Drug NNP cord-266359-uf1ao1x1 111 44 Administration Administration NNP cord-266359-uf1ao1x1 111 45 for for IN cord-266359-uf1ao1x1 111 46 this this DT cord-266359-uf1ao1x1 111 47 purpose purpose NN cord-266359-uf1ao1x1 111 48 . . . cord-266359-uf1ao1x1 112 1 In in IN cord-266359-uf1ao1x1 112 2 theory theory NN cord-266359-uf1ao1x1 112 3 , , , cord-266359-uf1ao1x1 112 4 a a DT cord-266359-uf1ao1x1 112 5 " " `` cord-266359-uf1ao1x1 112 6 negative negative JJ cord-266359-uf1ao1x1 112 7 " " '' cord-266359-uf1ao1x1 112 8 respiratory respiratory JJ cord-266359-uf1ao1x1 112 9 virus virus NN cord-266359-uf1ao1x1 112 10 panel panel NN cord-266359-uf1ao1x1 112 11 result result NN cord-266359-uf1ao1x1 112 12 may may MD cord-266359-uf1ao1x1 112 13 lead lead VB cord-266359-uf1ao1x1 112 14 to to IN cord-266359-uf1ao1x1 112 15 more more RBR cord-266359-uf1ao1x1 112 16 frequent frequent JJ cord-266359-uf1ao1x1 112 17 admission admission NN cord-266359-uf1ao1x1 112 18 to to IN cord-266359-uf1ao1x1 112 19 the the DT cord-266359-uf1ao1x1 112 20 hospital hospital NN cord-266359-uf1ao1x1 112 21 for for IN cord-266359-uf1ao1x1 112 22 further further JJ cord-266359-uf1ao1x1 112 23 medical medical JJ cord-266359-uf1ao1x1 112 24 evaluation evaluation NN cord-266359-uf1ao1x1 112 25 , , , cord-266359-uf1ao1x1 112 26 antibacterial antibacterial JJ cord-266359-uf1ao1x1 112 27 use use NN cord-266359-uf1ao1x1 112 28 , , , cord-266359-uf1ao1x1 112 29 or or CC cord-266359-uf1ao1x1 112 30 nosocomial nosocomial JJ cord-266359-uf1ao1x1 112 31 transmission transmission NN cord-266359-uf1ao1x1 112 32 . . . cord-266359-uf1ao1x1 113 1 However however RB cord-266359-uf1ao1x1 113 2 , , , cord-266359-uf1ao1x1 113 3 we -PRON- PRP cord-266359-uf1ao1x1 113 4 found find VBD cord-266359-uf1ao1x1 113 5 the the DT cord-266359-uf1ao1x1 113 6 rates rate NNS cord-266359-uf1ao1x1 113 7 of of IN cord-266359-uf1ao1x1 113 8 these these DT cord-266359-uf1ao1x1 113 9 events event NNS cord-266359-uf1ao1x1 113 10 during during IN cord-266359-uf1ao1x1 113 11 CoV cov NN cord-266359-uf1ao1x1 113 12 infection infection NN cord-266359-uf1ao1x1 113 13 to to TO cord-266359-uf1ao1x1 113 14 be be VB cord-266359-uf1ao1x1 113 15 similar similar JJ cord-266359-uf1ao1x1 113 16 to to IN cord-266359-uf1ao1x1 113 17 those those DT cord-266359-uf1ao1x1 113 18 during during IN cord-266359-uf1ao1x1 113 19 infection infection NN cord-266359-uf1ao1x1 113 20 with with IN cord-266359-uf1ao1x1 113 21 other other JJ cord-266359-uf1ao1x1 113 22 respiratory respiratory JJ cord-266359-uf1ao1x1 113 23 viruses virus NNS cord-266359-uf1ao1x1 113 24 ( ( -LRB- cord-266359-uf1ao1x1 113 25 Table table NN cord-266359-uf1ao1x1 113 26 2 2 CD cord-266359-uf1ao1x1 113 27 and and CC cord-266359-uf1ao1x1 113 28 data datum NNS cord-266359-uf1ao1x1 113 29 not not RB cord-266359-uf1ao1x1 113 30 shown show VBN cord-266359-uf1ao1x1 113 31 ) ) -RRB- cord-266359-uf1ao1x1 113 32 , , , cord-266359-uf1ao1x1 113 33 highlighting highlight VBG cord-266359-uf1ao1x1 113 34 the the DT cord-266359-uf1ao1x1 113 35 overall overall JJ cord-266359-uf1ao1x1 113 36 impact impact NN cord-266359-uf1ao1x1 113 37 of of IN cord-266359-uf1ao1x1 113 38 respiratory respiratory JJ cord-266359-uf1ao1x1 113 39 viral viral JJ cord-266359-uf1ao1x1 113 40 infections infection NNS cord-266359-uf1ao1x1 113 41 in in IN cord-266359-uf1ao1x1 113 42 these these DT cord-266359-uf1ao1x1 113 43 patients patient NNS cord-266359-uf1ao1x1 113 44 in in IN cord-266359-uf1ao1x1 113 45 terms term NNS cord-266359-uf1ao1x1 113 46 of of IN cord-266359-uf1ao1x1 113 47 utilization utilization NN cord-266359-uf1ao1x1 113 48 of of IN cord-266359-uf1ao1x1 113 49 medical medical JJ cord-266359-uf1ao1x1 113 50 resources resource NNS cord-266359-uf1ao1x1 113 51 . . . cord-266359-uf1ao1x1 114 1 In in IN cord-266359-uf1ao1x1 114 2 conclusion conclusion NN cord-266359-uf1ao1x1 114 3 , , , cord-266359-uf1ao1x1 114 4 we -PRON- PRP cord-266359-uf1ao1x1 114 5 found find VBD cord-266359-uf1ao1x1 114 6 that that IN cord-266359-uf1ao1x1 114 7 CoV cov NN cord-266359-uf1ao1x1 114 8 is be VBZ cord-266359-uf1ao1x1 114 9 detected detect VBN cord-266359-uf1ao1x1 114 10 frequently frequently RB cord-266359-uf1ao1x1 114 11 in in IN cord-266359-uf1ao1x1 114 12 patients patient NNS cord-266359-uf1ao1x1 114 13 with with IN cord-266359-uf1ao1x1 114 14 hematologic hematologic JJ cord-266359-uf1ao1x1 114 15 malignancies malignancy NNS cord-266359-uf1ao1x1 114 16 and and CC cord-266359-uf1ao1x1 114 17 HSCT HSCT NNP cord-266359-uf1ao1x1 114 18 recipients recipient NNS cord-266359-uf1ao1x1 114 19 in in IN cord-266359-uf1ao1x1 114 20 whom whom WP cord-266359-uf1ao1x1 114 21 suspicion suspicion NN cord-266359-uf1ao1x1 114 22 for for IN cord-266359-uf1ao1x1 114 23 a a DT cord-266359-uf1ao1x1 114 24 respiratory respiratory JJ cord-266359-uf1ao1x1 114 25 viral viral JJ cord-266359-uf1ao1x1 114 26 infection infection NN cord-266359-uf1ao1x1 114 27 exists exist VBZ cord-266359-uf1ao1x1 114 28 , , , cord-266359-uf1ao1x1 114 29 but but CC cord-266359-uf1ao1x1 114 30 is be VBZ cord-266359-uf1ao1x1 114 31 associated associate VBN cord-266359-uf1ao1x1 114 32 with with IN cord-266359-uf1ao1x1 114 33 less less JJR cord-266359-uf1ao1x1 114 34 LRTD LRTD NNP cord-266359-uf1ao1x1 114 35 than than IN cord-266359-uf1ao1x1 114 36 other other JJ cord-266359-uf1ao1x1 114 37 respiratory respiratory JJ cord-266359-uf1ao1x1 114 38 viruses virus NNS cord-266359-uf1ao1x1 114 39 except except IN cord-266359-uf1ao1x1 114 40 RhV/ rhv/ CD cord-266359-uf1ao1x1 115 1 EnV. EnV. NNP cord-266359-uf1ao1x1 116 1 The the DT cord-266359-uf1ao1x1 116 2 retrospective retrospective JJ cord-266359-uf1ao1x1 116 3 nature nature NN cord-266359-uf1ao1x1 116 4 of of IN cord-266359-uf1ao1x1 116 5 this this DT cord-266359-uf1ao1x1 116 6 work work NN cord-266359-uf1ao1x1 116 7 mandates mandate VBZ cord-266359-uf1ao1x1 116 8 confirmation confirmation NN cord-266359-uf1ao1x1 116 9 of of IN cord-266359-uf1ao1x1 116 10 our -PRON- PRP$ cord-266359-uf1ao1x1 116 11 findings finding NNS cord-266359-uf1ao1x1 116 12 by by IN cord-266359-uf1ao1x1 116 13 additional additional JJ cord-266359-uf1ao1x1 116 14 , , , cord-266359-uf1ao1x1 116 15 prospective prospective JJ cord-266359-uf1ao1x1 116 16 studies study NNS cord-266359-uf1ao1x1 116 17 . . . cord-266359-uf1ao1x1 117 1 Human human JJ cord-266359-uf1ao1x1 117 2 metapneumovirus metapneumovirus JJ cord-266359-uf1ao1x1 117 3 infection infection NN cord-266359-uf1ao1x1 117 4 in in IN cord-266359-uf1ao1x1 117 5 hematopoietic hematopoietic JJ cord-266359-uf1ao1x1 117 6 stem stem NN cord-266359-uf1ao1x1 117 7 cell cell NN cord-266359-uf1ao1x1 117 8 transplant transplant NN cord-266359-uf1ao1x1 117 9 recipients recipient NNS cord-266359-uf1ao1x1 117 10 Rhinovirus Rhinovirus NNP cord-266359-uf1ao1x1 117 11 infections infection NNS cord-266359-uf1ao1x1 117 12 in in IN cord-266359-uf1ao1x1 117 13 myelosuppressed myelosuppressed JJ cord-266359-uf1ao1x1 117 14 adult adult NN cord-266359-uf1ao1x1 117 15 blood blood NN cord-266359-uf1ao1x1 117 16 and and CC cord-266359-uf1ao1x1 117 17 marrow marrow NN cord-266359-uf1ao1x1 117 18 transplant transplant NN cord-266359-uf1ao1x1 117 19 recipients recipient NNS cord-266359-uf1ao1x1 117 20 Rhinovirus Rhinovirus NNP cord-266359-uf1ao1x1 117 21 infections infection NNS cord-266359-uf1ao1x1 117 22 in in IN cord-266359-uf1ao1x1 117 23 hematopoietic hematopoietic JJ cord-266359-uf1ao1x1 117 24 stem stem NN cord-266359-uf1ao1x1 117 25 cell cell NN cord-266359-uf1ao1x1 117 26 transplant transplant NN cord-266359-uf1ao1x1 117 27 recipients recipient NNS cord-266359-uf1ao1x1 117 28 with with IN cord-266359-uf1ao1x1 117 29 pneumonia pneumonia NN cord-266359-uf1ao1x1 117 30 Clinical clinical JJ cord-266359-uf1ao1x1 117 31 characterization characterization NN cord-266359-uf1ao1x1 117 32 of of IN cord-266359-uf1ao1x1 117 33 human human JJ cord-266359-uf1ao1x1 117 34 metapneumovirus metapneumovirus JJ cord-266359-uf1ao1x1 117 35 infection infection NN cord-266359-uf1ao1x1 117 36 among among IN cord-266359-uf1ao1x1 117 37 patients patient NNS cord-266359-uf1ao1x1 117 38 with with IN cord-266359-uf1ao1x1 117 39 cancer cancer NN cord-266359-uf1ao1x1 117 40 Adenovirus Adenovirus NNP cord-266359-uf1ao1x1 117 41 infections infection NNS cord-266359-uf1ao1x1 117 42 in in IN cord-266359-uf1ao1x1 117 43 adult adult NN cord-266359-uf1ao1x1 117 44 recipients recipient NNS cord-266359-uf1ao1x1 117 45 of of IN cord-266359-uf1ao1x1 117 46 blood blood NN cord-266359-uf1ao1x1 117 47 and and CC cord-266359-uf1ao1x1 117 48 marrow marrow NN cord-266359-uf1ao1x1 117 49 transplants transplant NNS cord-266359-uf1ao1x1 118 1 Parainfluenza Parainfluenza NNP cord-266359-uf1ao1x1 118 2 virus virus NN cord-266359-uf1ao1x1 118 3 infections infection NNS cord-266359-uf1ao1x1 118 4 after after IN cord-266359-uf1ao1x1 118 5 hematopoietic hematopoietic JJ cord-266359-uf1ao1x1 118 6 stem stem NN cord-266359-uf1ao1x1 118 7 cell cell NN cord-266359-uf1ao1x1 118 8 transplantation transplantation NN cord-266359-uf1ao1x1 118 9 : : : cord-266359-uf1ao1x1 118 10 risk risk NN cord-266359-uf1ao1x1 118 11 factors factor NNS cord-266359-uf1ao1x1 118 12 , , , cord-266359-uf1ao1x1 118 13 response response NN cord-266359-uf1ao1x1 118 14 to to IN cord-266359-uf1ao1x1 118 15 antiviral antiviral JJ cord-266359-uf1ao1x1 118 16 therapy therapy NN cord-266359-uf1ao1x1 118 17 , , , cord-266359-uf1ao1x1 118 18 and and CC cord-266359-uf1ao1x1 118 19 effect effect NN cord-266359-uf1ao1x1 118 20 on on IN cord-266359-uf1ao1x1 118 21 transplant transplant NN cord-266359-uf1ao1x1 118 22 outcome outcome NN cord-266359-uf1ao1x1 118 23 Influenza influenza NN cord-266359-uf1ao1x1 118 24 infections infection NNS cord-266359-uf1ao1x1 118 25 after after IN cord-266359-uf1ao1x1 118 26 hematopoietic hematopoietic JJ cord-266359-uf1ao1x1 118 27 stem stem NN cord-266359-uf1ao1x1 118 28 cell cell NN cord-266359-uf1ao1x1 118 29 transplantation transplantation NN cord-266359-uf1ao1x1 118 30 : : : cord-266359-uf1ao1x1 118 31 risk risk NN cord-266359-uf1ao1x1 118 32 factors factor NNS cord-266359-uf1ao1x1 118 33 , , , cord-266359-uf1ao1x1 118 34 mortality mortality NN cord-266359-uf1ao1x1 118 35 , , , cord-266359-uf1ao1x1 118 36 and and CC cord-266359-uf1ao1x1 118 37 the the DT cord-266359-uf1ao1x1 118 38 effect effect NN cord-266359-uf1ao1x1 118 39 of of IN cord-266359-uf1ao1x1 118 40 antiviral antiviral JJ cord-266359-uf1ao1x1 118 41 therapy therapy NN cord-266359-uf1ao1x1 118 42 Parainfluenza Parainfluenza NNP cord-266359-uf1ao1x1 118 43 virus virus NN cord-266359-uf1ao1x1 118 44 infections infection NNS cord-266359-uf1ao1x1 118 45 in in IN cord-266359-uf1ao1x1 118 46 children child NNS cord-266359-uf1ao1x1 118 47 with with IN cord-266359-uf1ao1x1 118 48 hematologic hematologic JJ cord-266359-uf1ao1x1 118 49 malignancies malignancy NNS cord-266359-uf1ao1x1 118 50 Changing change VBG cord-266359-uf1ao1x1 118 51 epidemiology epidemiology NN cord-266359-uf1ao1x1 118 52 of of IN cord-266359-uf1ao1x1 118 53 respiratory respiratory JJ cord-266359-uf1ao1x1 118 54 viral viral JJ cord-266359-uf1ao1x1 118 55 infections infection NNS cord-266359-uf1ao1x1 118 56 in in IN cord-266359-uf1ao1x1 118 57 hematopoietic hematopoietic JJ cord-266359-uf1ao1x1 118 58 cell cell NN cord-266359-uf1ao1x1 118 59 transplant transplant NN cord-266359-uf1ao1x1 118 60 recipients recipient NNS cord-266359-uf1ao1x1 118 61 and and CC cord-266359-uf1ao1x1 118 62 solid solid JJ cord-266359-uf1ao1x1 118 63 organ organ NN cord-266359-uf1ao1x1 118 64 transplant transplant NN cord-266359-uf1ao1x1 118 65 recipients recipient NNS cord-266359-uf1ao1x1 118 66 Coronavirus Coronavirus NNP cord-266359-uf1ao1x1 118 67 pneumonia pneumonia NN cord-266359-uf1ao1x1 118 68 following follow VBG cord-266359-uf1ao1x1 118 69 autologous autologous JJ cord-266359-uf1ao1x1 118 70 bone bone NN cord-266359-uf1ao1x1 118 71 marrow marrow NN cord-266359-uf1ao1x1 118 72 transplantation transplantation NN cord-266359-uf1ao1x1 118 73 for for IN cord-266359-uf1ao1x1 118 74 breast breast NN cord-266359-uf1ao1x1 118 75 cancer cancer NN cord-266359-uf1ao1x1 118 76 Coronavirus Coronavirus NNP cord-266359-uf1ao1x1 118 77 - - HYPH cord-266359-uf1ao1x1 118 78 associated associate VBN cord-266359-uf1ao1x1 118 79 pneumonia pneumonia NN cord-266359-uf1ao1x1 118 80 in in IN cord-266359-uf1ao1x1 118 81 previously previously RB cord-266359-uf1ao1x1 118 82 healthy healthy JJ cord-266359-uf1ao1x1 118 83 children child NNS cord-266359-uf1ao1x1 118 84 Fatal fatal JJ cord-266359-uf1ao1x1 118 85 lower low JJR cord-266359-uf1ao1x1 118 86 respiratory respiratory JJ cord-266359-uf1ao1x1 118 87 tract tract NN cord-266359-uf1ao1x1 118 88 disease disease NN cord-266359-uf1ao1x1 118 89 with with IN cord-266359-uf1ao1x1 118 90 human human JJ cord-266359-uf1ao1x1 118 91 corona corona NN cord-266359-uf1ao1x1 118 92 virus virus NN cord-266359-uf1ao1x1 118 93 NL63 NL63 NNP cord-266359-uf1ao1x1 118 94 in in IN cord-266359-uf1ao1x1 118 95 an an DT cord-266359-uf1ao1x1 118 96 adult adult JJ cord-266359-uf1ao1x1 118 97 haematopoietic haematopoietic JJ cord-266359-uf1ao1x1 118 98 cell cell NN cord-266359-uf1ao1x1 118 99 transplant transplant NN cord-266359-uf1ao1x1 118 100 recipient recipient NN cord-266359-uf1ao1x1 119 1 Coronavirus Coronavirus NNP cord-266359-uf1ao1x1 119 2 229E 229e CD cord-266359-uf1ao1x1 119 3 - - HYPH cord-266359-uf1ao1x1 119 4 related relate VBN cord-266359-uf1ao1x1 119 5 pneumonia pneumonia NN cord-266359-uf1ao1x1 119 6 in in IN cord-266359-uf1ao1x1 119 7 immunocompromised immunocompromised JJ cord-266359-uf1ao1x1 119 8 patients patient NNS cord-266359-uf1ao1x1 119 9 Use Use NNP cord-266359-uf1ao1x1 119 10 of of IN cord-266359-uf1ao1x1 119 11 a a DT cord-266359-uf1ao1x1 119 12 novel novel JJ cord-266359-uf1ao1x1 119 13 virus virus NN cord-266359-uf1ao1x1 119 14 detection detection NN cord-266359-uf1ao1x1 119 15 assay assay NN cord-266359-uf1ao1x1 119 16 to to TO cord-266359-uf1ao1x1 119 17 identify identify VB cord-266359-uf1ao1x1 119 18 coronavirus coronavirus NN cord-266359-uf1ao1x1 119 19 HKU1 HKU1 NNP cord-266359-uf1ao1x1 119 20 in in IN cord-266359-uf1ao1x1 119 21 the the DT cord-266359-uf1ao1x1 119 22 lungs lung NNS cord-266359-uf1ao1x1 119 23 of of IN cord-266359-uf1ao1x1 119 24 a a DT cord-266359-uf1ao1x1 119 25 hematopoietic hematopoietic JJ cord-266359-uf1ao1x1 119 26 stem stem NN cord-266359-uf1ao1x1 119 27 cell cell NN cord-266359-uf1ao1x1 119 28 transplant transplant NN cord-266359-uf1ao1x1 119 29 recipient recipient NN cord-266359-uf1ao1x1 119 30 with with IN cord-266359-uf1ao1x1 119 31 fatal fatal JJ cord-266359-uf1ao1x1 119 32 pneumonia pneumonia NN cord-266359-uf1ao1x1 119 33 Human human JJ cord-266359-uf1ao1x1 119 34 rhinovirus rhinovirus NN cord-266359-uf1ao1x1 119 35 and and CC cord-266359-uf1ao1x1 119 36 coronavirus coronavirus NN cord-266359-uf1ao1x1 119 37 detection detection NN cord-266359-uf1ao1x1 119 38 among among IN cord-266359-uf1ao1x1 119 39 allogeneic allogeneic IN cord-266359-uf1ao1x1 119 40 hematopoietic hematopoietic JJ cord-266359-uf1ao1x1 119 41 stem stem NN cord-266359-uf1ao1x1 119 42 cell cell NN cord-266359-uf1ao1x1 119 43 transplantation transplantation NN cord-266359-uf1ao1x1 119 44 recipients recipient NNS cord-266359-uf1ao1x1 120 1 A a DT cord-266359-uf1ao1x1 120 2 prospective prospective JJ cord-266359-uf1ao1x1 120 3 hospital hospital NN cord-266359-uf1ao1x1 120 4 - - HYPH cord-266359-uf1ao1x1 120 5 based base VBN cord-266359-uf1ao1x1 120 6 study study NN cord-266359-uf1ao1x1 120 7 of of IN cord-266359-uf1ao1x1 120 8 the the DT cord-266359-uf1ao1x1 120 9 clinical clinical JJ cord-266359-uf1ao1x1 120 10 impact impact NN cord-266359-uf1ao1x1 120 11 of of IN cord-266359-uf1ao1x1 120 12 non non JJ cord-266359-uf1ao1x1 120 13 - - JJ cord-266359-uf1ao1x1 120 14 severe severe JJ cord-266359-uf1ao1x1 120 15 acute acute JJ cord-266359-uf1ao1x1 120 16 respiratory respiratory JJ cord-266359-uf1ao1x1 120 17 syndrome syndrome NN cord-266359-uf1ao1x1 120 18 ( ( -LRB- cord-266359-uf1ao1x1 120 19 Non Non NNP cord-266359-uf1ao1x1 120 20 - - JJ cord-266359-uf1ao1x1 120 21 SARS)-related sars)-related JJ cord-266359-uf1ao1x1 120 22 human human JJ cord-266359-uf1ao1x1 120 23 coronavirus coronavirus NN cord-266359-uf1ao1x1 120 24 infection infection NN cord-266359-uf1ao1x1 120 25 Genetic genetic JJ cord-266359-uf1ao1x1 120 26 variability variability NN cord-266359-uf1ao1x1 120 27 of of IN cord-266359-uf1ao1x1 120 28 human human JJ cord-266359-uf1ao1x1 120 29 coronavirus coronavirus NN cord-266359-uf1ao1x1 120 30 OC43- oc43- NN cord-266359-uf1ao1x1 120 31 , , , cord-266359-uf1ao1x1 120 32 229E- 229e- CD cord-266359-uf1ao1x1 120 33 , , , cord-266359-uf1ao1x1 120 34 and and CC cord-266359-uf1ao1x1 120 35 NL63-like nl63-like JJ cord-266359-uf1ao1x1 120 36 strains strain NNS cord-266359-uf1ao1x1 120 37 and and CC cord-266359-uf1ao1x1 120 38 their -PRON- PRP$ cord-266359-uf1ao1x1 120 39 association association NN cord-266359-uf1ao1x1 120 40 with with IN cord-266359-uf1ao1x1 120 41 lower low JJR cord-266359-uf1ao1x1 120 42 respiratory respiratory JJ cord-266359-uf1ao1x1 120 43 tract tract NN cord-266359-uf1ao1x1 120 44 infections infection NNS cord-266359-uf1ao1x1 120 45 of of IN cord-266359-uf1ao1x1 120 46 hospitalized hospitalize VBN cord-266359-uf1ao1x1 120 47 infants infant NNS cord-266359-uf1ao1x1 120 48 and and CC cord-266359-uf1ao1x1 120 49 immunocompromised immunocompromised JJ cord-266359-uf1ao1x1 120 50 patients patient NNS cord-266359-uf1ao1x1 120 51 Respiratory respiratory JJ cord-266359-uf1ao1x1 120 52 viral viral JJ cord-266359-uf1ao1x1 120 53 infections infection NNS cord-266359-uf1ao1x1 120 54 after after IN cord-266359-uf1ao1x1 120 55 bone bone NN cord-266359-uf1ao1x1 120 56 marrow marrow NN cord-266359-uf1ao1x1 120 57 / / SYM cord-266359-uf1ao1x1 120 58 peripheral peripheral JJ cord-266359-uf1ao1x1 120 59 stem stem NN cord-266359-uf1ao1x1 120 60 - - HYPH cord-266359-uf1ao1x1 120 61 cell cell NN cord-266359-uf1ao1x1 120 62 transplantation transplantation NN cord-266359-uf1ao1x1 120 63 : : : cord-266359-uf1ao1x1 120 64 the the DT cord-266359-uf1ao1x1 120 65 Christie Christie NNP cord-266359-uf1ao1x1 120 66 hospital hospital NN cord-266359-uf1ao1x1 120 67 experience experience NN cord-266359-uf1ao1x1 120 68 Respiratory respiratory JJ cord-266359-uf1ao1x1 120 69 virus virus NN cord-266359-uf1ao1x1 120 70 infections infection NNS cord-266359-uf1ao1x1 120 71 after after IN cord-266359-uf1ao1x1 120 72 stem stem NN cord-266359-uf1ao1x1 120 73 cell cell NN cord-266359-uf1ao1x1 120 74 transplantation transplantation NN cord-266359-uf1ao1x1 120 75 : : : cord-266359-uf1ao1x1 120 76 a a DT cord-266359-uf1ao1x1 120 77 prospective prospective JJ cord-266359-uf1ao1x1 120 78 study study NN cord-266359-uf1ao1x1 120 79 from from IN cord-266359-uf1ao1x1 120 80 the the DT cord-266359-uf1ao1x1 120 81 Infectious Infectious NNP cord-266359-uf1ao1x1 120 82 Diseases Diseases NNPS cord-266359-uf1ao1x1 120 83 Working Working NNP cord-266359-uf1ao1x1 120 84 Party Party NNP cord-266359-uf1ao1x1 120 85 of of IN cord-266359-uf1ao1x1 120 86 the the DT cord-266359-uf1ao1x1 120 87 European European NNP cord-266359-uf1ao1x1 120 88 Group Group NNP cord-266359-uf1ao1x1 120 89 for for IN cord-266359-uf1ao1x1 120 90 Blood Blood NNP cord-266359-uf1ao1x1 120 91 and and CC cord-266359-uf1ao1x1 120 92 Marrow Marrow NNP cord-266359-uf1ao1x1 120 93 Transplantation Transplantation NNP cord-266359-uf1ao1x1 120 94 Prospective prospective JJ cord-266359-uf1ao1x1 120 95 study study NN cord-266359-uf1ao1x1 120 96 of of IN cord-266359-uf1ao1x1 120 97 the the DT cord-266359-uf1ao1x1 120 98 incidence incidence NN cord-266359-uf1ao1x1 120 99 , , , cord-266359-uf1ao1x1 120 100 clinical clinical JJ cord-266359-uf1ao1x1 120 101 features feature NNS cord-266359-uf1ao1x1 120 102 , , , cord-266359-uf1ao1x1 120 103 and and CC cord-266359-uf1ao1x1 120 104 outcome outcome NN cord-266359-uf1ao1x1 120 105 of of IN cord-266359-uf1ao1x1 120 106 symptomatic symptomatic JJ cord-266359-uf1ao1x1 120 107 upper upper JJ cord-266359-uf1ao1x1 120 108 and and CC cord-266359-uf1ao1x1 120 109 lower low JJR cord-266359-uf1ao1x1 120 110 respiratory respiratory JJ cord-266359-uf1ao1x1 120 111 tract tract NN cord-266359-uf1ao1x1 120 112 infections infection NNS cord-266359-uf1ao1x1 120 113 by by IN cord-266359-uf1ao1x1 120 114 respiratory respiratory JJ cord-266359-uf1ao1x1 120 115 viruses virus NNS cord-266359-uf1ao1x1 120 116 in in IN cord-266359-uf1ao1x1 120 117 adult adult NN cord-266359-uf1ao1x1 120 118 recipients recipient NNS cord-266359-uf1ao1x1 120 119 of of IN cord-266359-uf1ao1x1 120 120 hematopoietic hematopoietic JJ cord-266359-uf1ao1x1 120 121 stem stem NN cord-266359-uf1ao1x1 120 122 cell cell NN cord-266359-uf1ao1x1 120 123 transplants transplant NNS cord-266359-uf1ao1x1 120 124 for for IN cord-266359-uf1ao1x1 120 125 hematologic hematologic JJ cord-266359-uf1ao1x1 120 126 malignancies malignancy NNS cord-266359-uf1ao1x1 120 127 Epidemiology epidemiology NN cord-266359-uf1ao1x1 120 128 of of IN cord-266359-uf1ao1x1 120 129 viral viral JJ cord-266359-uf1ao1x1 120 130 respiratory respiratory JJ cord-266359-uf1ao1x1 120 131 tract tract NN cord-266359-uf1ao1x1 120 132 infections infection NNS cord-266359-uf1ao1x1 120 133 in in IN cord-266359-uf1ao1x1 120 134 an an DT cord-266359-uf1ao1x1 120 135 outpatient outpatient NN cord-266359-uf1ao1x1 120 136 haematology haematology NN cord-266359-uf1ao1x1 120 137 facility facility NN cord-266359-uf1ao1x1 120 138 Viral viral JJ cord-266359-uf1ao1x1 120 139 respiratory respiratory JJ cord-266359-uf1ao1x1 120 140 infections infection NNS cord-266359-uf1ao1x1 120 141 diagnosed diagnose VBN cord-266359-uf1ao1x1 120 142 by by IN cord-266359-uf1ao1x1 120 143 multiplex multiplex NN cord-266359-uf1ao1x1 120 144 PCR pcr NN cord-266359-uf1ao1x1 120 145 after after IN cord-266359-uf1ao1x1 120 146 allogeneic allogeneic JJ cord-266359-uf1ao1x1 120 147 hematopoietic hematopoietic JJ cord-266359-uf1ao1x1 120 148 stem stem NN cord-266359-uf1ao1x1 120 149 cell cell NN cord-266359-uf1ao1x1 120 150 transplantation transplantation NN cord-266359-uf1ao1x1 120 151 : : : cord-266359-uf1ao1x1 120 152 long long JJ cord-266359-uf1ao1x1 120 153 - - HYPH cord-266359-uf1ao1x1 120 154 term term NN cord-266359-uf1ao1x1 120 155 incidence incidence NN cord-266359-uf1ao1x1 120 156 and and CC cord-266359-uf1ao1x1 120 157 outcome outcome NN cord-266359-uf1ao1x1 120 158 xTAG xTAG VBN cord-266359-uf1ao1x1 120 159 RVP RVP NNP cord-266359-uf1ao1x1 120 160 assay assay NN cord-266359-uf1ao1x1 120 161 : : : cord-266359-uf1ao1x1 120 162 analytical analytical JJ cord-266359-uf1ao1x1 120 163 and and CC cord-266359-uf1ao1x1 120 164 clinical clinical JJ cord-266359-uf1ao1x1 120 165 performance performance NN cord-266359-uf1ao1x1 121 1 Parainfluenza Parainfluenza NNP cord-266359-uf1ao1x1 121 2 virus virus NN cord-266359-uf1ao1x1 121 3 lower low JJR cord-266359-uf1ao1x1 121 4 respiratory respiratory JJ cord-266359-uf1ao1x1 121 5 tract tract NN cord-266359-uf1ao1x1 121 6 disease disease NN cord-266359-uf1ao1x1 121 7 after after IN cord-266359-uf1ao1x1 121 8 hematopoietic hematopoietic JJ cord-266359-uf1ao1x1 121 9 cell cell NN cord-266359-uf1ao1x1 121 10 transplant transplant NN cord-266359-uf1ao1x1 121 11 : : : cord-266359-uf1ao1x1 121 12 viral viral JJ cord-266359-uf1ao1x1 121 13 detection detection NN cord-266359-uf1ao1x1 121 14 in in IN cord-266359-uf1ao1x1 121 15 the the DT cord-266359-uf1ao1x1 121 16 lung lung NN cord-266359-uf1ao1x1 121 17 predicts predict VBZ cord-266359-uf1ao1x1 121 18 outcome outcome NN cord-266359-uf1ao1x1 121 19 Clinical clinical JJ cord-266359-uf1ao1x1 121 20 disease disease NN cord-266359-uf1ao1x1 121 21 in in IN cord-266359-uf1ao1x1 121 22 children child NNS cord-266359-uf1ao1x1 121 23 associated associate VBN cord-266359-uf1ao1x1 121 24 with with IN cord-266359-uf1ao1x1 121 25 newly newly RB cord-266359-uf1ao1x1 121 26 described describe VBN cord-266359-uf1ao1x1 121 27 coronavirus coronavirus NN cord-266359-uf1ao1x1 121 28 subtypes subtype NNS cord-266359-uf1ao1x1 121 29 Epidemiology epidemiology NN cord-266359-uf1ao1x1 121 30 and and CC cord-266359-uf1ao1x1 121 31 clinical clinical JJ cord-266359-uf1ao1x1 121 32 presentations presentation NNS cord-266359-uf1ao1x1 121 33 of of IN cord-266359-uf1ao1x1 121 34 the the DT cord-266359-uf1ao1x1 121 35 four four CD cord-266359-uf1ao1x1 121 36 human human JJ cord-266359-uf1ao1x1 121 37 coronaviruses coronaviruse NNS cord-266359-uf1ao1x1 121 38 229E 229e CD cord-266359-uf1ao1x1 121 39 , , , cord-266359-uf1ao1x1 121 40 HKU1 HKU1 NNP cord-266359-uf1ao1x1 121 41 , , , cord-266359-uf1ao1x1 121 42 NL63 NL63 NNP cord-266359-uf1ao1x1 121 43 , , , cord-266359-uf1ao1x1 121 44 and and CC cord-266359-uf1ao1x1 121 45 OC43 OC43 NNP cord-266359-uf1ao1x1 121 46 detected detect VBD cord-266359-uf1ao1x1 121 47 over over IN cord-266359-uf1ao1x1 121 48 3 3 CD cord-266359-uf1ao1x1 121 49 years year NNS cord-266359-uf1ao1x1 121 50 using use VBG cord-266359-uf1ao1x1 121 51 a a DT cord-266359-uf1ao1x1 121 52 novel novel JJ cord-266359-uf1ao1x1 121 53 multiplex multiplex NN cord-266359-uf1ao1x1 121 54 real real JJ cord-266359-uf1ao1x1 121 55 - - HYPH cord-266359-uf1ao1x1 121 56 time time NN cord-266359-uf1ao1x1 121 57 PCR pcr NN cord-266359-uf1ao1x1 121 58 method method NN cord-266359-uf1ao1x1 121 59 Epidemiology epidemiology NN cord-266359-uf1ao1x1 121 60 of of IN cord-266359-uf1ao1x1 121 61 viral viral JJ cord-266359-uf1ao1x1 121 62 respiratory respiratory JJ cord-266359-uf1ao1x1 121 63 infections infection NNS cord-266359-uf1ao1x1 122 1 A a DT cord-266359-uf1ao1x1 122 2 prospective prospective JJ cord-266359-uf1ao1x1 122 3 molecular molecular JJ cord-266359-uf1ao1x1 122 4 surveillance surveillance NN cord-266359-uf1ao1x1 122 5 study study NN cord-266359-uf1ao1x1 122 6 evaluating evaluate VBG cord-266359-uf1ao1x1 122 7 the the DT cord-266359-uf1ao1x1 122 8 clinical clinical JJ cord-266359-uf1ao1x1 122 9 impact impact NN cord-266359-uf1ao1x1 122 10 of of IN cord-266359-uf1ao1x1 122 11 community community NN cord-266359-uf1ao1x1 122 12 - - HYPH cord-266359-uf1ao1x1 122 13 acquired acquire VBN cord-266359-uf1ao1x1 122 14 respiratory respiratory JJ cord-266359-uf1ao1x1 122 15 viruses virus NNS cord-266359-uf1ao1x1 122 16 in in IN cord-266359-uf1ao1x1 123 1 lung lung NN cord-266359-uf1ao1x1 123 2 transplant transplant NN cord-266359-uf1ao1x1 123 3 recipients recipient NNS cord-266359-uf1ao1x1 123 4 Human human JJ cord-266359-uf1ao1x1 123 5 coronavirus coronavirus NN cord-266359-uf1ao1x1 123 6 infections infection NNS cord-266359-uf1ao1x1 123 7 in in IN cord-266359-uf1ao1x1 123 8 rural rural JJ cord-266359-uf1ao1x1 123 9 Thailand Thailand NNP cord-266359-uf1ao1x1 123 10 : : : cord-266359-uf1ao1x1 123 11 a a DT cord-266359-uf1ao1x1 123 12 comprehensive comprehensive JJ cord-266359-uf1ao1x1 123 13 study study NN cord-266359-uf1ao1x1 123 14 using use VBG cord-266359-uf1ao1x1 123 15 real real JJ cord-266359-uf1ao1x1 123 16 - - HYPH cord-266359-uf1ao1x1 123 17 time time NN cord-266359-uf1ao1x1 123 18 reverse reverse NN cord-266359-uf1ao1x1 123 19 - - HYPH cord-266359-uf1ao1x1 123 20 transcription transcription NN cord-266359-uf1ao1x1 123 21 polymerase polymerase NN cord-266359-uf1ao1x1 123 22 chain chain NN cord-266359-uf1ao1x1 123 23 reaction reaction NN cord-266359-uf1ao1x1 123 24 assays assay NNS cord-266359-uf1ao1x1 123 25 Human human JJ cord-266359-uf1ao1x1 123 26 ( ( -LRB- cord-266359-uf1ao1x1 123 27 non non JJ cord-266359-uf1ao1x1 123 28 - - JJ cord-266359-uf1ao1x1 123 29 severe severe JJ cord-266359-uf1ao1x1 123 30 acute acute JJ cord-266359-uf1ao1x1 123 31 respiratory respiratory JJ cord-266359-uf1ao1x1 123 32 syndrome syndrome NN cord-266359-uf1ao1x1 123 33 ) ) -RRB- cord-266359-uf1ao1x1 123 34 coronavirus coronavirus NN cord-266359-uf1ao1x1 123 35 infections infection NNS cord-266359-uf1ao1x1 123 36 in in IN cord-266359-uf1ao1x1 123 37 hospitalised hospitalise VBN cord-266359-uf1ao1x1 123 38 children child NNS cord-266359-uf1ao1x1 123 39 in in IN cord-266359-uf1ao1x1 123 40 France France NNP cord-266359-uf1ao1x1 123 41 Coronavirus Coronavirus NNP cord-266359-uf1ao1x1 123 42 HKU1 HKU1 NNP cord-266359-uf1ao1x1 123 43 and and CC cord-266359-uf1ao1x1 123 44 other other JJ cord-266359-uf1ao1x1 123 45 coronavirus coronavirus NN cord-266359-uf1ao1x1 123 46 infections infection NNS cord-266359-uf1ao1x1 123 47 in in IN cord-266359-uf1ao1x1 123 48 Hong Hong NNP cord-266359-uf1ao1x1 123 49 Kong Kong NNP cord-266359-uf1ao1x1 123 50 New New NNP cord-266359-uf1ao1x1 123 51 Vaccine Vaccine NNP cord-266359-uf1ao1x1 123 52 Surveillance Surveillance NNP cord-266359-uf1ao1x1 123 53 Network Network NNP cord-266359-uf1ao1x1 123 54 , , , cord-266359-uf1ao1x1 123 55 Human human JJ cord-266359-uf1ao1x1 123 56 coronavirus coronavirus NN cord-266359-uf1ao1x1 123 57 in in IN cord-266359-uf1ao1x1 123 58 young young JJ cord-266359-uf1ao1x1 123 59 children child NNS cord-266359-uf1ao1x1 123 60 hospitalized hospitalize VBN cord-266359-uf1ao1x1 123 61 for for IN cord-266359-uf1ao1x1 123 62 acute acute JJ cord-266359-uf1ao1x1 123 63 respiratory respiratory JJ cord-266359-uf1ao1x1 123 64 illness illness NN cord-266359-uf1ao1x1 123 65 and and CC cord-266359-uf1ao1x1 123 66 asymptomatic asymptomatic JJ cord-266359-uf1ao1x1 123 67 controls control VBZ cord-266359-uf1ao1x1 123 68 Fields field NNS cord-266359-uf1ao1x1 123 69 Virology Virology NNP cord-266359-uf1ao1x1 124 1 The the DT cord-266359-uf1ao1x1 124 2 authors author NNS cord-266359-uf1ao1x1 124 3 wish wish VBP cord-266359-uf1ao1x1 124 4 to to TO cord-266359-uf1ao1x1 124 5 thank thank VB cord-266359-uf1ao1x1 124 6 Dr. Dr. NNP cord-266359-uf1ao1x1 124 7 Lynne Lynne NNP cord-266359-uf1ao1x1 124 8 M. M. NNP cord-266359-uf1ao1x1 124 9 Strasfeld Strasfeld NNP cord-266359-uf1ao1x1 124 10 and and CC cord-266359-uf1ao1x1 124 11 Kevin Kevin NNP cord-266359-uf1ao1x1 124 12 Langstaff Langstaff NNP cord-266359-uf1ao1x1 124 13 for for IN cord-266359-uf1ao1x1 124 14 providing provide VBG cord-266359-uf1ao1x1 124 15 data datum NNS cord-266359-uf1ao1x1 124 16 pertaining pertain VBG cord-266359-uf1ao1x1 124 17 to to IN cord-266359-uf1ao1x1 124 18 nosocomially nosocomially RB cord-266359-uf1ao1x1 124 19 - - HYPH cord-266359-uf1ao1x1 124 20 acquired acquire VBN cord-266359-uf1ao1x1 124 21 respiratory respiratory JJ cord-266359-uf1ao1x1 124 22 viral viral JJ cord-266359-uf1ao1x1 124 23 infections infection NNS cord-266359-uf1ao1x1 124 24 at at IN cord-266359-uf1ao1x1 124 25 OHSU OHSU NNP cord-266359-uf1ao1x1 124 26 . . . cord-266359-uf1ao1x1 125 1 No no DT cord-266359-uf1ao1x1 125 2 conflicts conflict NNS cord-266359-uf1ao1x1 125 3 of of IN cord-266359-uf1ao1x1 125 4 interest interest NN cord-266359-uf1ao1x1 125 5 . . . cord-266359-uf1ao1x1 126 1 None none NN cord-266359-uf1ao1x1 126 2 . . . cord-266359-uf1ao1x1 127 1 None none NN cord-266359-uf1ao1x1 127 2 declared declare VBD cord-266359-uf1ao1x1 127 3 . . . cord-266359-uf1ao1x1 128 1 Approval approval NN cord-266359-uf1ao1x1 128 2 from from IN cord-266359-uf1ao1x1 128 3 the the DT cord-266359-uf1ao1x1 128 4 Institutional Institutional NNP cord-266359-uf1ao1x1 128 5 Review Review NNP cord-266359-uf1ao1x1 128 6 Board Board NNP cord-266359-uf1ao1x1 128 7 of of IN cord-266359-uf1ao1x1 128 8 OHSU OHSU NNP cord-266359-uf1ao1x1 128 9 was be VBD cord-266359-uf1ao1x1 128 10 obtained obtain VBN cord-266359-uf1ao1x1 128 11 prior prior RB cord-266359-uf1ao1x1 128 12 to to IN cord-266359-uf1ao1x1 128 13 beginning begin VBG cord-266359-uf1ao1x1 128 14 this this DT cord-266359-uf1ao1x1 128 15 study study NN cord-266359-uf1ao1x1 128 16 . . .